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The organs in which lymphocytes function are low in oxygen (<5% oxygen) and 
even lower oxygen levels may be more prevalent in inflammatory tissues. In this 
thesis the effects of environmental oxygen on human CD4+ memory T lymphocyte 
function in vitro have been investigated. The level of oxygen in normal air (21%) 
which historically has been used for most in vitro experiments with immune cells 
was found result in suboptimal responses of this cell type, especially with regards to 
proliferation. At physiologically more appropriate oxygen levels of 8.5%, optimal 
proliferation was observed which coincided with an increase in Th2-associated 
markers. At 3% oxygen, the average level found in the inflamed joint in rheumatoid 
arthritis, a more sustained pro-inflammatory response was observed. In 1% oxygen, 
cytokine production was not maintained over time paralleling observations of CD4+ 
T lymphocyte behaviour in both the tumour and chronic inflammatory environment. 
This comparison was further supported by the increased expression of the 
activation marker CD69 and the depression of CD4+ T lymphocyte proliferation. A 
model of reperfusion injury also highlighted the effect that varying oxygen levels can 
have on CD4+ memory T lymphocytes. Proximal T cell receptor signalling was 
found to be altered after equilibration at different oxygen levels, and preliminary 
experiments investigating the potential role that redox plays in regulating CD4+ 
memory T lymphocyte functions were performed. It is concluded that environmental 
oxygen levels significantly influence CD4+ memory T lymphocyte responses, have 
implications for their function in inflammatory sites in vivo, and need to be 
considered when designing or interpreting in vitro experiments. 
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The focus of this thesis is the effect of varying oxygen levels on CD4+ T lymphocyte 
behaviour and function. The motivation behind this research is the low oxygen levels 
found in inflammatory environments, particularly those observed in the chronic, 
autoimmune-associated inflammatory environment of the joints of rheumatoid arthritis 
(RA) patients.  In this introduction, RA is discussed with a focus on CD4+ T 
lymphocytes. Then the effect of different oxygen levels on inflammatory cell 
behaviour and function are described.  
1.1 Autoimmunity and the rheumatoid joint 
1.1.1 An introduction to autoimmunity 
The immune system in vertebrates has evolved to protect these multi-organ life-forms 
from the pathogens present in their environment. This system is clearly effective as 
evidenced by the fact that we still exist today. In the process of protecting an 
organism from pathogenic attack the immune system can cause localised, and 
sometimes systemic, tissue damage. However, sustaining such collateral damage is 
a small price to pay to ensure that a life-threatening infection is cleared. There are 
instances when the immune system is persistently activated within a tissue, and this 
can result in autoimmune disease. In these situations inflammation persists without 
the usual resolution of the immune response and this process is often driven by the 
adaptive immune response targeting self-antigens [1-3].  
1.1.2 Rheumatoid arthritis 
RA is an autoimmune disease involving the synovial membrane of joints affecting 
around 1% of the world’s population [4, 5]. The normal synovial membrane is just 2-3 
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cells thick and consists of resident fibroblast and macrophage-like synoviocytes [6, 
7]. These cells form a protective layer around the synovial space, providing synovial 
fluid to lubricate the joint [8, 9]. In RA, synovial membrane hyperplasia occurs 
alongside an influx of inflammatory cells, causing swelling, soreness and dysfunction 
of the joint [4, 10]. The proliferating RA synovium - many cells thick - forms a pannus 
tissue which invades and destroys cartilage at the joint interface and causes bone 
destruction [11, 12].  
Although the reasons for disease onset are not fully understood, there are known risk 
factors. Concordant twin studies revealed that genetics can contribute around 60% of 
the risk of developing RA [13] and 98 genetic loci have been associated with the 
development of the disease [14]. The ‘shared epitope’ is a term used for certain 
alleles of HLA-DRβ1 gene associated with the greatest genetic risk of developing RA 
which contain differences in an amino acid sequence in the third hypervariable region 
of the Major histocompatibility complex (MHC) Class II molecules. Since MHC class II 
proteins are expressed by antigen presenting cells (APCs) that present antigen to T 
lymphocytes, it is speculated that the associated alleles may be involved in altering 
responder T lymphocyte behaviour, potentially promoting autoreactive T lymphocyte 
activation and survival [4, 15-17]. Additional to genetic risk, environment is also 
known to play a part in disease onset. For example smoking for over 20 years is 
associated with increased risk of developing RA [1, 18], potentially via the generation 
of autoantibody production in the lung [19, 20].  
It is not known whether proliferation of resident cells or infiltration of inflammatory 
cells drives the disease and the expansion of the synovium, although a mixture of the 
two is possible and potentially likely. When human fibroblasts from the RA joint are 
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placed into a  severe combined immunodeficiency (SCID) mouse, an arthritic 
phenotype is generated with infiltrating murine cells [8, 21, 22]. Notably in these 
experiments, pathology is limited to the joint the fibroblasts were initially transferred 
into, suggesting they are not involved in the ‘spread’ of the disease to unaffected 
symmetric joints [22]. Synoviocyte proliferation can occur before inflammatory onset, 
suggesting that synovial hyperplasia pre-dates inflammatory cell infiltration and 
involvement [8, 23]. RA synovial fibroblasts may therefore be almost transformed in 
nature, and the immune involvement in the disease may be separate or secondary 
[21, 24].  
1.1.3 Inflammatory cells of the rheumatoid joint 
Despite the role of stromal cells in RA pathology, inflammatory cells - both of the 
innate and adaptive immune systems - migrate into the joint tissue and show signs of 
activation [15, 21, 25-30]. Inflammatory cells are able to activate fibroblasts by the 
secretion of cytokines such as TNFα and IL-1β, and by the release of microparticles 
during proliferation [21, 28, 31-33] and may therefore promote the synovial lining 
hyperplasia observed in RA. Migrating monocytes differentiate into macrophages, 
dendritic cells (DCs) and osteoclasts, further adding to the tissue-resident 
populations already present [6, 28, 34]. Macrophages show a stimulated, pro-
inflammatory phenotype in the rheumatoid joint, producing pro-inflammatory 
cytokines such as TNF-α and IL-1. Furthermore, neutrophils (also known as 
polymorphonuclear leukocytes) are the most abundant cell observed in the RA 
synovial fluid and contribute to pathology by the production of factors that degrade 
tissue [26, 35, 36]. These factors include reactive oxygen species (ROS) that are 
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normally produced during the neutrophil respiratory burst, of which associated 
damage can be observed in the RA joint [36, 37].  
Adaptive immunity plays an important role in RA with both autoreactive B and T 
lymphocytes involved in pathology. Occasionally adaptive immune cells reveal a high 
level of organisation; in around one third of patients, germinal centre-like structures 
are formed with B lymphocytes, T lymphocytes and follicular DCs [21, 27, 38, 39]. 
Lymphocytes in the RA joint show signs of recent activation and express CD69 [40]. 
Despite this, overall lymphocyte proliferation and turnover is thought to be low [27, 
41]. B lymphocytes are important in the pathology of RA for several reasons. Firstly, 
they can act as APCs to autoreactive T lymphocytes [27, 42]. Secondly, their 
production of RANKL contributes to the formation of osteoclasts and bone destruction 
[29]. Thirdly, and most importantly, B lymphocyte autoantibody production is 
observed in a large number of patients [43, 44]. Rheumatoid factor (RF) - antibody 
targeted against the constant region of the IgG molecule - is present in over 80% of 
RA patients and was the first autoantibody associated with the disease. RF has been 
detected in patient samples’ obtained years before disease onset suggesting it plays 
a role in disease initiation [1, 15, 44, 45]. Anti-citrullinated protein antibodies are also 
highly prevalent in RA patients, and their presence are a potential indicator of 
expected disease progression in early RA patients [3, 15, 27]. These antibodies can 
be generated locally in the synovial tissue [3, 43].  
1.1.3.1 Basic biology of the CD4+ T lymphocyte 
CD4+ T lymphocytes are also observed in the RA joint, and are potentially important 
in pathology [29, 46]. Before CD4+ T lymphocytes in RA are discussed, their basic 
biology is described.  
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1.1.3.1.1The importance of CD4+ T lymphocytes 
T lymphocytes are necessary for a normally functioning immune system and severe 
disease results when T lymphocytes are physiologically lacking or present in low 
numbers [47, 48]. Genetic mutations associated with lymphocyte survival and 
function result in severe immunodeficiency. Patients with these mutations are prone 
to infectious diseases such as cytomegalovirus (CMV), and need to be rigorously 
treated early on in life [48]. Acquired immunodeficiency syndrome is an example of 
an acquired T lymphocyte deficiency and is most commonly caused by infection by 
human immunodeficiency virus (HIV) which causes depletion in peripheral CD4+ T 
lymphocyte numbers. When CD4+ T lymphocyte numbers drop below 200/mm2 
patients become susceptible to opportunistic infections such as bacterial pneumonia 
and candidiasis [47, 49]. T lymphocytes are therefore clearly important to maintaining 
human health, and are often described as having a ‘central role’ in immunity [50].  
 
1.1.3.1.2 The CD4+ T lymphocyte life cycle 
CD4+ T lymphocyte development 
T lymphocyte precursors develop alongside all other immune cell precursors in the 
bone marrow but migrate to the thymus to complete maturation to single-positive 
CD4+ or CD8+ expressing cells [51-53]. The T lymphocytes that emerge from the 
thymus are termed ‘naïve’, but will retain some autoreactivity due to the process of 
thymic selection which only allows cells with some self-recognition to survive [52, 53].  
CD4+ T lymphocyte response to antigenic exposure 
CD4+ T lymphocytes’ main roles are to manage the immune system and to provide 
immunological memory. Naïve CD4+ T lymphocytes cycle between blood and 
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secondary lymphoid organs (SLOs) in a resting state to increase their chances of 
finding their cognate antigen, spending around 6-24 hours in each lymph node before 
moving on [54, 55]. They are maintained in SLOs by exposure to IL-7 [56-58]. 
Therefore a heterogeneous pool of naïve CD4+ T lymphocytes (with regards to 
antigen specificity) resides within the lymphoid system [57]. Once activated, naïve 
CD4+ T lymphocytes will proliferate and differentiate into different ‘T helper’ subsets 
within the lymph node, and after 3-11 days will migrate via the lymphatic and 
circulatory system to the infected site as effector CD4+ T lymphocytes [59, 60]. 
Effector T lymphocytes produce a wide variety of cytokines that guide the ongoing 
inflammatory process [47]. The different T helper subsets are described in more 
detail below.  
 
Generation of CD4+ effector and CD4+ memory T lymphocytes 
Once an infection is cleared the majority (90-95%) of effector T lymphocytes involved 
will die by the process of apoptosis [55, 58, 60-62]. However, a small subset persist 
as a population of memory cells that are able to act if re-exposure to the same 
pathogen occurs [63, 64]. Knowledge about these retained CD4+ T lymphocyte 
populations is increasing with recent descriptions of a pool of memory T lymphocytes 
that only reside in tissue (tissue-resident memory T lymphocytes, or ‘TRM’) and 
cannot be isolated from blood samples as previously anticipated for memory T 
lymphocytes [55, 58, 61, 65]. In fact, the majority of memory T lymphocytes are found 
migrating through tissue, but, due to the ease of access, blood-borne memory T 
lymphocytes are the most widely investigated [55, 58]   
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Of the types of memory T lymphocyte that develop from an adaptive immune 
response,  effector memory (TEM) and central memory (TCM) CD4+ T lymphocytes are 
the most well characterised [63, 64]. TEM are able to act much more rapidly than both 
TCM and naïve T lymphocytes and hence can clear pathogens quickly. TEM directly 
enter infected tissues from blood and quickly produce cytokines such as IFNγ and IL-
4 in response to re-stimulation [55, 58, 60, 62-64]. In contrast, TCM circulate between 
blood and lymph tissues in a resting state and only become reactivated when antigen 
is again delivered to the lymph node. Unlike TEM, they express CCR7 and high levels 
of CD62L, which allows them to enter the lymph node via high-endothelial venules 
[61, 64]. Once re-stimulated by antigen, TCM readily proliferate and immediately 
produce IL-2 that is able to support the expansion and differentiation of any local 
naïve and regulatory T lymphocytes expressing the IL-2 receptor, CD25 [58, 60, 62]. 
They then differentiate into effector memory T lymphocytes, leave the lymph node 
and enter inflamed tissue as a secondary attack [55, 64].  
 
It is not fully understood how two separate CD4+ T lymphocyte memory populations 
arise from the same inflammatory response. TCM potentially arise after low-strength 
TCR-engagement [54, 61-63] although similar differentiation pathways may exist for 
the generation of both central and effector memory [58]. An elegant murine study 
showed that the differential generation of TCM and TEM may be due to the timings of 
the immune response. This was achieved by inhibiting lymphocyte entry into the 
lymph node at a specified time point during antigenic exposure. Naïve T lymphocytes 
present within a lymph node when antigen first entered became effector cells, 
whereas naïve T lymphocytes that migrated in after antigen differentiated into CCR7+ 
TCM[54]. The authors suggested that the naïve T lymphocytes migrating in later may 
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be exposed to a lower dose of antigen which may contribute to their final 
differentiation [54]. Therefore, it is possible that the differentiation program of T 
lymphocytes from a naïve phenotype to a memory may be dependent on antigen 
dose, as shown in figure 1.1. Effector memory cells may either become tissue-




Figure 1.1 The generation of memory T lymphocytes from naïve precursors. 
When exposed to antigen, naïve CD4+ T lymphocytes generate several populations 
of effector and memory cells. These include central memory T lymphocytes (TCM), 
that circulate between the blood and lymphoid organs; effector T lymphocytes, that 
immediately enter inflamed tissue and produce cytokines; and effector memory T 
lymphocytes (TEM), that circulate through blood and tissue. When TCM are re-
stimulated, they proliferate in lymph nodes and develop effector functions. Effector T 
lymphocytes and TEM enter tissue and are able to form a population of tissue-resident 
memory T lymphocytes, TRM. The degree of antigen exposure a naïve T lymphocyte 




1.1.3.2 Activating the CD4+ T lymphocyte 
1.1.3.2.1 T lymphocyte activation – the main players 
Antigen-dependent activation of T lymphocytes occurs via antigen presentation to the 
T cell receptor (TCR). TCR molecules are expressed on the surface of every CD4+ T 
lymphocyte and are members of the immunoglobulin superfamily [66]. The TCR exist 
as a heterodimer that associates with CD3 protein subunits to form a TCR:CD3 
complex. The CD3 subunits potentiate downstream signalling after TCR engagement 
with an antigen. The relationship between the CD3 subunits and the TCR 
heterodimers is still not completely understood, although potential binding sites for 
the CD3 molecules have been identified on the TCR subunits [66, 67].  
When CD4+ T lymphocytes are activated by APCs bearing peptide-loaded MHC II 
molecules, an ‘immunological synapse’ (IS) forms between the two cells [68]. On the 
T lymphocyte surface, an IS consists of concentric rings of molecules involved in T 
lymphocyte activation [68, 69]. CD3:TCR complexes are observed near the centre of 
the IS, but molecules with larger extracellular domains, such as CD45, are observed 
at the extremities [68, 70]. Signalling is thought to terminate in the very centre of the 
IS, with CD3:TCR complexes either being internalised [71], or secreted [72]. A brief 
migration of CD45 from the outermost rings of the IS to the centre is associated with 
this signal extermination [70, 73]. Additional molecular interactions contribute to the 
stability of the IS, such as the interaction between CD28 on T lymphocytes with CD80 
and CD86 on APCs. CD28 is itself co-stimulatory and provides further intracellular 
signals into the T lymphocytes [68, 69, 74].  
There are several schools of thought about how antigen binding to the TCR-CD3 
complex initiates signalling [67]. The CD3 cytoplasmic tails are bound to the 
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membrane in resting cells, and therefore antigen binding is required to cause the 
dissociation of basic residues in the CD3 tails to allow them to interact with 
cytoplasmic proteins [66, 75, 76]. This may be achieved by a change in the lipid 
environment around the TCR:CD3 complex [77] or by mechanical pressure forcing 
their removal from the lipid bilayer [66, 78]. The newly-exposed CD3 cytoplasmic tails 
are then phosphorylated at key Immunoreceptor Tyrosine-based Activation Motif 
(ITAM) that allow zeta-chain-associated protein kinase 70 (ZAP70) to bind and 
phosphorylate Linker of Activated T cells (LAT). LAT then forms a complex with other 
signalling molecules that send diverse signals into the cell, initiating activation and 
effector functions [67, 79, 80]. Different levels of ‘readiness’ of the TCR signalling 
complex can result in differential thresholds in antigen exposure being required for 
successful signalling to activate a T lymphocyte. A primed TCR signalling complex, 
with kinases at the ready for ITAM phosphorylation, will have a lower signalling 
threshold and therefore T lymphocytes will be more readily activated [81, 82]. 
However, T lymphocyte apoptosis occurs in response to too great an intracellular 
signal, such as that seen in the deletion of autoreactive T lymphocytes in the thymus 
[52, 83].  
Lck – a protein involved in proximal T lymphocyte signalling 
Lymphocyte-Specific Protein Tyrosine Kinase (Lck) is a key kinase that 
phosphorylates the CD3-tail ITAMs, permitting ZAP70 association with the TCR/ CD3 
complex. Lck can additionally phosphorylate and activate ZAP70 and other 
downstream signalling molecules [79, 80]. Lck is therefore extremely important in 
proximal T lymphocyte signalling and requires tight regulation. This regulation comes 
in the form of two key tyrosine residues – Y394 in the catalytic domain and Y505 in a 
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Src-homology 2 (SH2) domain [84-86]. Phosphorylation at Y505 is inhibitory as it 
causes the Lck molecule to fold into itself, obstructing the catalytic domain. 
Phosphorylation at Y394 is activatory and dominant over phosphorylation at Y505 
[75, 84]. Therefore, doubly-phosphorylated Lck molecules are still able to 
phosphorylate downstream targets. Y394 is auto-phosphorylated and is 
dephosphorylated by phosphatases including  lymphoid protein tyrosine phosphatase 
(LYP), CD45 and Src homology region 2 domain-containing phosphatase-1 (SHP-1) 
[73, 84, 85, 87, 88]. C-terminal Src kinase (Csk) phosphorylates the inhibitory Y505 
residue [79, 85, 89] but to counteract this inhibition a cytoplasmic domain in the CD45 





Figure 1.2. Activating the CD4+ T lymphocyte. An immunological synapse (IS) 
forms between an antigen presenting cell (APC) and a CD4+ T lymphocyte when an 
antigen fragment is presented to a T cell receptor (TCR) by a major histocompatibility 
complex (MHC) Class II molecule. CD45 is excluded from the IS due to its large size. 
Binding causes a conformational change in CD3 subunits associated with the TCR, 
and activated Lymphocyte-Specific Protein Tyrosine Kinase (Lck) (phosphorylated at 
tyrosine 394) - often in association with CD4 molecules - are able to phosphorylate 
key residues in the CD3 subunits to allow for zeta-chain-associated protein kinase 70 
(ZAP70) binding and initiation of downstream signalling. CD4 associated with the 
MHC Class II molecules acts to stabilise its interaction with the TCR.  
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Presence of activated Lck in resting cells 
The presence of activated Lck was recently described in resting human CD4+ and 
CD8+ T lymphocytes and in the T lymphocyte Jurkat cell line [75]. In naïve T 
lymphocytes, up to 37% intracellular Lck was found to be phosphorylated on the 
activatory tyrosine residue, Y394 [75]. This suggested that within a cell there was 
always a population of active Lck. This gave rise to a potential problem – if there is 
constitutively active Lck in T lymphocytes, how do unstimulated cells maintain a 
resting state without TCR signalling?  
The answer to this conundrum probably lies within the discovery of different domains 
of the plasma membrane [82, 85]. Stephen et al visualised the separation of Lck from 
the TCR in maturing thymocytes by transition electron microscopy and gold particle 
staining. In ‘untuned’ thymocytes that had not experienced medullary MHC, Lck and 
the TCR could be seen to inhabit the same membrane domains, whereas in wild type 
thymocytes that had undergone thymic selection, Lck and TCR clearly inhabited 
separate domains within the membrane [82]. Therefore, it was concluded that when 
thymocytes undergo thymic selection, they reduce their chances of disorganised TCR 
signalling by separating the TCR from Lck, potentially reducing spontaneous 
autoreactivity within the periphery [82].  
The separate zones that these molecules inhabit within the membrane are most 
probably due to membrane rafts, although regulation of protein transport and actin 
organisation may also play a role [85, 91]. Membrane rafts are areas of the plasma 
membrane rich in saturated lipids and provide an additional layer of regulation for 
TCR downstream signalling. There have been some discrepancies in their 
description due to the different experimental approaches used to investigate them, 
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including the use of different detergents [85]. Lck is thought to interact with 
membrane rafts via post-translational modifications of its Src Homology 4 (SH4) 
domain [85]. CD45 is also exposed to - and can dephosphorylate - Lck in resting 
cells, but when cells are activated it is isolated from Lck due to the movement of the 
latter into lipid rafts [73].  
 
1.1.3.3 Processes and functions of CD4+ T lymphocytes 
There are several defined subsets of CD4+ effector T cell with distinct cytokine-
producing capabilities. These subsets are thought to be generated from the 
stimulation of naïve T lymphocytes in the lymph node [47]. The main subsets 
discovered to date include Th1, Th2, Th17 and regulatory T cells. However, there are 
also more recently described subsets including Th9, Th22 and T follicular helper 
cells. Distinct subsets are formed by differential priming by APCs involving exposure 
to cytokines and co-stimulatory molecules [47, 50, 92-94]. The cytokines produced by 
Th1 and Th2 cells also inhibit the differentiation of the alternate subsets [50, 95, 96], 
promoting the formation of discrete populations. The main subsets of CD4+ T 
lymphocytes are described in the sections below.  
 
1.1.3.3.1 Th1 CD4+ effector T lymphocytes 
Th1 cells, alongside Th2 cells, were one of the first T helper subsets to be officially 
recognised [97]. Th1 cells are associated with a more pro-inflammatory T helper cell 
phenotype, characterised by production of IFNγ, TNFα, lymphotoxin-α and high 
quantities of IL-2 [47, 50, 92, 97]. In Th1-polarised cells, the ifnγ locus is 
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hyperacetylated [98, 99] allowing for easy transcription of the gene. Th1 cells can 
also be identified by the expression of other markers such as CXCR3, a surface 
chemokine receptor [47, 50, 63, 100, 101].  
Th1 cells are particularly effective in the reduction in load of intracellular pathogens 
such as mycobacterium and viruses [50, 92, 99]. This is due to their ability to activate 
phagocytic cells such as macrophages via IFNγ expression [102, 103]. Th1-like 
diseases are often described as ‘granulomatous’ due to the high number of 
macrophages present in the inflamed tissue [50]. Th1-produced IL-2 promotes CD8 
memory cell formation, which will enable rapid destruction of virally infected cells if 
re-exposure should occur [92]. Several autoimmune diseases are also associated 
with a Th1 mediated inflammatory response, such as Type 1 diabetes, where IFNγ is 
thought to contribute to pathology [104, 105].  
The production of IL-12 by APCs results in the polarisation of naïve T lymphocytes to 
Th1 effector cells [50, 92, 106, 107]. Additionally, IFNγ signalling from DCs and NK 
cells, and from autocrine mechanisms, can promote Th1 differentiation. Signalling of 
IL-12 and IFNγ results in the upregulation of the transcription factors Signal 
Transducers and Activators of Transcription (STAT)-4 and STAT1, respectively [92, 
107]. STAT1 induces the expression of T-bet, deemed the ‘master-regulator’ of Th1 
polarisation [47, 50, 92, 99, 108]. T-bet is important in the generation of the Th1 
phenotype, and binds the ifnγ locus [99, 109, 110].  
 
1.1.3.3.2 Th2 CD4+ effector T lymphocytes 
Th2 are characterised by the expression of cytokines IL-4, IL-5, IL-9, IL-10, IL-13, IL-
25 and low quantities of IL-2. Similar to the ifnγ gene in Th1 cells, the il4-il13 gene 
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locus within Th2-polarised cells is hyperacetylated allowing for easy transcription [97, 
98, 109, 111, 112]. Th2 cells are adapted to respond to extracellular parasitic 
infections such as helminths [47, 50, 92]. A Th2-mediated inflammatory response 
effectively seals off the area around large extra-cellular pathogens, containing the 
parasite by promoting the proliferation and activation of stromal cells [113]. The 
cytokines IL-4 and IL-13 are important in this role as they promote the tissue-
regenerative activities of macrophages, and Th2-mediated immune responses are 
therefore associated with wound healing and fibrosis [113, 114]. Pathogenic Th2 cell 
activity is associated with allergy, for example Th2 cells are the predominant CD4+ T 
lymphocyte population in the asthmatic airway [115, 116]. Th2 cells are also involved 
in promoting the humoral immune response, as Th2-produced IL-4 is highly 
associated with B lymphocyte antibody production and IgE class-switching which is 
involved in the opsonisation of extracellular parasites [59, 92]. IL-4, IL-2 and IL-6 
cytokine signalling promotes the generation of Th2 cells from naïve precursors [92], 
although the source of IL-4 for this differentiation has not been fully elucidated [50]. 
Differentiated Th2 cells are distinguishable by their expression of the transcription 
factors STAT5 and GATA-3 [92, 109, 117], and surface markers CCR4 and CrTH2 
[63, 100, 101, 118] although CCR4 can also be detected on the surface of Th17 cells 
[119].  
 
1.1.3.3.3 Th17 CD4+ effector T lymphocytes 
Th17 cells are generated in response to extracellular bacterial and fungal infection 
[50, 92] and are characterised by their production of IL-17A, IL-17F, IL-21 and IL-22 
[47, 50, 92]. Th17 cells are also capable of producing TNFα [120, 121] and therefore 
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have previously been confused with Th1 cells, partly resulting in their delayed 
description and classification [122]. CCR6 is a marker upregulated on Th17 cells and 
is therefore useful in their detection [32, 121], although it is also expressed on Th17 
cells converting to a more Th1-like phenotype [123]. Many tissues contain IL-17 
receptors [92, 93] but one of Th17 cells’ main effect is to stimulate neutrophil pro-
inflammatory activities [50, 92, 124] by promoting their survival [25] and proliferation 
in bone marrow [125]. Th17 are generated in response to low levels of TGF-β and IL-
6 [50, 126], although the requirement of TGFβ in vivo has been questioned [127]. IL-
21 further promotes Th17 differentiation, and DC-produced IL-23 maintains the Th17 
phenotype [92, 126]. RORγt (also known as RORc) has been identified as a master 
regulator of Th17 cells. Another transcription factor, it promotes the expression of IL-
17, and is absolutely required for Th17 differentiation [92, 122, 128, 129]. 
 
Since their discovery, Th17 cells have been found to be involved in autoimmune 
diseases previously attributed to Th1 cells, such as multiple sclerosis (MS) [93, 121, 
122, 130, 131]. There are still some disagreements as to the designation of Th1 or 
Th17-mediated pathology in certain diseases [105, 131] and it is possible a 
combination of both subsets, or phenotypic plasticity, contributes to some conditions 
[127]. In a model of autoimmune uveitis, inflammation was induced and sustained by 
either Th1 or Th17 cells, and each subset was not reliant on the presence of the 
other. Instead, IL-23 was found to be absolutely required for pathology [132]. IL-23, 
as already mentioned, is known to be important in the maintenance of the Th17 
phenotype, but it may have other roles within immunity [132]. Varying animal models 
involving different CD4+ subsets associated with similar pathologies also confuse 




1.1.3.3.4 Regulatory T lymphocytes 
Regulatory T lymphocytes are distinct from the other T lymphocyte subsets in that 
their main role is to suppress inflammation. There are several types of regulatory T 
lymphocyte classified mainly by their origin. Natural regulatory T lymphocyte (nTreg) 
are generated in the thymus and are therefore a first line of defence against over-
aggressive inflammatory responses. nTregs are CD4+ Foxp3+ CD25+ CD127lo 
expressing cells [133-135] and have been shown to suppress CD4+ effector T 
lymphocyte behaviour in vivo by reducing their activation [136].  
 
CD4+ lymphocytes with regulatory functions can also be generated in the periphery 
from naïve T lymphocyte precursors, and are designated as inducible Tregs (iTregs) 
[47, 133, 137]. However, there is some uncertainty as to the nature of iTreg due to 
the fact that all T lymphocytes upregulate regulatory markers and are suppressive in 
nature post-stimulation [138]. Despite this added complexity, two main types of 
iTregs have been described in both humans and mice: Foxp3+ Th3 and Foxp3- Tr1 
[139, 140] . There is some debate as to the extent of iTregs’ immunosuppressive 
nature in human disease, although they do appear to be immunosuppressive in vitro 
and in mouse in vivo models [47, 133].  A recent paper has highlighted a potentially 
important role in iTreg suppression of overt Th2-mediated pathology at mucosal sites 
in both the gut and lung [137], a role that may delineate them from nTregs.  
 
Recent data suggests that Tr1 do function in human immunity. Lack of them is 
associated with inflammatory conditions such as Crohn’s disease [133], and IL-10 
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(which is produced by Tr1 cells) has been suggested to be important in regulating 
inflammation in the gut, lung and skin [137, 141]. Patients who develop drug-
independent tolerance from mixed chimerism after allogeneic haematopoietic stem 
cell transplant have higher numbers of circulating Tr1 [139, 140]. Additionally, 
Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) 
patients (who have mutations in Foxp3 and are therefore unable to generate nTregs) 
are able to generate Tr1 in the periphery, although these regulatory lymphocytes are 
not enough to stop overt inflammation [139].  
 
1.1.3.3.5 The plasticity of CD4+ T lymphocytes 
There seems to be some disparity between the generation of T helper cell subsets in 
mouse and human, with mouse CD4+ T lymphocytes forming more distinct and 
discrete subsets in in vitro experiments [142] whereas human CD4+ T helper 
lymphocytes appear to have increased plasticity between the different subsets, with 
characteristics associated with more than one subset present in a single cell [63, 98, 
101, 143]. This may be due to procedural differences between murine and human 
experiments, and increased murine plasticity of similarities have been proposed more 
recently [127]. Furthermore, humans experience a wide range of pathogens in their 
environment, whereas mice used experimentally for research have a more restricted 
exposure to pathogens. Nonetheless, it is therefore important to bear cell origin in 
mind when comparing data from mouse and human studies.  
 
The greatest plasticity amongst the subsets appears to lie with Th17 cells which have 
been observed to co- express cytokines associated with alternative subsets, 
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including IFNγ [93, 121, 144-146] and IL-10 [128]. Indeed, some Th17 cells appear to 
become IFNγ-single expressing cells [147]. Unlike Th1 and Th2 cells, Th17 cells 
have been reported as transient and unstable in their phenotype [93, 127, 132], but 
conversely have also been described as long-lived effector memory cells [120]. It 
must be stated that in the publication that made this latter claim the stimulation 
method used (including the duration) was not stated [120]. Therefore the phenotype 
observed may have been due to the fact that stimulating CD4+ T lymphocytes 
inherently leads to loss of CD45RA expression [148]. Genetic imprinting in Th17 cells 
appears to be less stable than in Th1 or Th2, again pointing to a less terminally 
differentiated phenotype [144]. 
Ex vivo, Th17-like cells from both blood and tissues have been observed to express 
both IFNγ and IL-17, suggesting these double positive cells have physiological 
relevance [145, 149]. Hence there is now a considerable amount of evidence that a 
Th17 to Th1 conversion occurs physiologically [93, 95, 145, 149], and this may even 
be the normal course of differentiation for Th17 cells. T-bet expression has been 
identified in pathologic Th17 cells [93, 128, 147], and it is therefore possible that 
Th17 conversion to a more Th1-like phenotype is associated with greater pro-
inflammatory effector functions. IFNγ+ IL-17+ double positive cells have been 
observed physiologically in autoimmune conditions such as MS [93, 145]. IFNγ+IL-
17A+ cells were also detected in the synovial fluid of juvenile idiopathic arthritis 
patients and shared TCR clonotype with Th17 cells isolated from the same joint, 
suggesting they had originated from IL-17 single positive cells [145]. 
Th17 plasticity is thought to be regulated epigenetically. Th17 cells in Th1-favouring 
conditions contain ‘open’ ifnγ loci and limit transcriptional access to their il-17 loci 
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[144]. Interestingly, Th17 cells re-stimulated in Th17 –favouring conditions still 
upregulate IFNγ transcription, further supporting the notion that a Th17 to Th1 switch 
is normal for Th17 biology [144]. Murine Th17 cells have also been shown to convert 
to a Th2 phenotype under the right polarising conditions [95, 149]. An increasing 
number of publications have also highlighted the stem-cell like nature of Th17 cells 
compared to more differentiated Th1 and Th2 cells [93, 128] and propose that Th17 
cells are less determined in their phenotype, thus facilitating their more effective 
response to environmental cues.  
Markers associated with Th17 and Treg phenotypes have also been shown co-exist 
within the same cell [95, 146, 150, 151]. Both Foxp3+ RORγt+ and Foxp3+ T-bet+ T 
lymphocytes have been identified [146, 152] and a recent study has suggested that 
the conversion of Treg to Th17 cells occurs in human RA patients [151]. However, 
the lack of specific Treg-cell markers can make such analysis fraught and more work 
needs to be done to validate the assumptions made from these studies. As Foxp3 
can be expressed transiently in all activated T lymphocytes [146, 153] it is possible 
that the Foxp3+ cells detected in some experiments are not true Tregs.  
Th1 and Th2 cells are thought to be more set in their phenotype but there is evidence 
that phenotypic switches can occur [95, 146, 154]. A murine in vivo study found that 
previously Th1 and Th2-differentiated cells could switch phenotype when challenged 
with an antigen that normally promoted the opposite subset to develop [154]. 
Interestingly, Th2 memory cells revealed more plasticity than Th1 memory cells. 
However, central memory cells revealed the greatest plasticity in this study. Central 
memory cells hypoacetylate their cytokine genes resulting in a natural plasticity 
compared to effector memory cells [98].  As this in vivo model used APCs loaded 
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with antigen, it is possible that these APCs migrated to lymph nodes and activated 
central memory cells [98]. Furthermore, an in vitro murine study found that after a 
certain number of divisions in specific polarising conditions, CD4+ T lymphocytes 
were reported to become fixed in their phenotype, even when exposed to reciprocal 
polarising conditions [142].  
Th1 and Th2 differentiated lymphocytes are not able to produce IL-17 when re-
stimulated in Th17 differentiating conditions, and epigenetically completely inhibit 
transcription of RORγt, signifying that the phenotypic switch of these subsets may be 
limited [93, 149, 150]. As Th1 and Th2 may be more terminally differentiated than 
Th17 cells, the ‘de-differentiation’ this may entail may be the reason for the lack of 
plasticity to a Th17 phenotype.  
 
1.1.3.4 CD4+ T lymphocyte function in the RA joint 
This project is primarily concerned with CD4+ T lymphocytes and the role they play in 
low-oxygen environments such as the RA joint; the autoimmune disease used as a 
model for this research. The role of CD4+ T lymphocytes in RA is not completely 
understood but evidence does suggest they play an important role. As already 
alluded to, genetic mutations associated with RA are related to CD4+ T lymphocyte 
function [14, 35, 45, 155, 156]  including the genes of ptpn22, cytotoxic T-lymphocyte 
antigen-4 (ctla-4), and ccr6  [1, 14, 15, 157, 158]. ptpn22 encodes the phosphatase, 
LYP [159-162], and the polymorphic variant associated with RA is thought to be a 
gain-of-function [159, 161, 162]. CTLA-4 is a surface molecules involved in Treg 
function that reduces CD28 co-stimulation on effector T lymphocytes [74, 163]. 
Interestingly, Treg cells were found to have the genes of many of the polymorphisms 
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associated with RA in an epigenetically ‘open’ conformation, suggesting that these 
cells may be the most susceptible to genetic mutations [14].  
Experimental data has also suggested that CD4+ T lymphocytes are important in the 
pathology of RA. Injection of human synovial T lymphocytes from a subset of RA 
patients into the joints of SCID mice initiated synovial hyperplasia. Interestingly, the T 
lymphocytes that caused positive transfer of disease were from patients with disease 
duration of 6 years or less, suggesting that distinct cell types may be involved in 
pathology at different times during the course of the disease [164, 165]. Additionally, 
an upregulation in the number of both CD4+ and CD8+ T lymphocytes expressing the 
activation marker CD69 in lymph nodes has been observed in both early RA patients, 
and in non-diseased individuals carrying autoantibodies  [166]. The CD4+ T 
lymphocytes present in the RA joint show a memory phenotype [46, 156, 167-170] 
and constitute around 20-30% of the overall inflammatory cell infiltrate in the RA joint, 
[35, 46], although some papers report even higher percentages and describe T 
lymphocyte-rich zones [40, 164, 171]. Varying numbers of lymphocytes may be found 
due to the different stages of disease, and higher numbers of CD4+ T lymphocytes 
may be more associated with established disease [171].  
Despite evidence suggesting CD4+ T lymphocytes do play a role in the pathology of 
RA, some data indicates that their behaviour is odd. For example, synovial fluid T 
lymphocytes have reduced proliferation [172-174]. Furthermore, despite T 
lymphocyte-related cytokines being detected in early arthritis [33], it seems that in 
more established RA T lymphocyte cytokine production is depressed [175, 176]. 
Further to this, decreasing numbers of CD4+ T lymphocytes have been associated 
with increased pain in RA, suggesting that CD4+ T lymphocytes may play a 
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protective role in the disease [30]. Smeets et al compared CD4+ T lymphocytes 
taken from RA patient biopsies to cells of removed tonsils. CD4+ T lymphocytes from 
both early and late RA patient biopsies showed a reduction in expression of IFNγ, the 
proliferation marker Ki67 and the activation marker CD25 [176]. However, all the RA 
patients in this study were on Nonsteroidal anti-inflammatory drugs (NSAIDs), 
whereas it was not clarified whether tonsillitis patients were on anti-inflammatory 
drugs. Additionally, lymphoid tissue such as tonsils may be a hot-bed for recent 
lymphocyte activation and expansion and thus it is possible that the comparison 
between peripheral inflammatory and lymphoid tissue is not completely viable, as T 
lymphocytes will be in different stages of development and maturation.  Effector cells 
found in peripheral tissue routinely need to be re-stimulated for investigation ex vivo 
[60, 132], suggesting that there is a small window of opportunity to detect effector 
functions in vivo in tissue.  
In general, Th2 cells are not thought to be associated with established RA as IL-4 is 
only detected at low levels in samples [177], and van Hamburg et al found that 
overexpression of GATA-3 resulted in decreased arthritis [178]. However, early 
arthritis patients’ samples revealed increased levels of both IL-13 and IL-4 in patients 
who went on to develop RA, suggesting that Th2 and humoral immune mechanisms 
may play a role in the early stages of the disease [33]. Oddly, RA patients do show 
an increase in the numbers of CCR4+ CD4+ T lymphocytes in peripheral blood [179]. 
As explained, CCR4 is a chemokine receptor associated with Th2 cells but it can also 
be expressed on Th17 cells [119]. Ratios in the periphery may also be a 
consequence of increased depletion of particular subsets of T lymphocytes as they 
preferentially migrate in to inflamed tissue.  
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It was initially suggested that RA is a Th1-like disease after an increase in the 
amount of IFNγ was detected in the rheumatoid synovium of established RA patients’ 
samples compared to osteoarthritic joints [176]. However, double staining revealed 
that only 1% of CD3+ T lymphocytes were expressing IFNγ in rheumatoid joints, and 
other cell types, perhaps macrophages, were expressing the majority of IFNγ [180]. 
Additional evidence further questions a Th1-polarisation in RA, as one study found 
no IFNγ in the synovial fluid of early arthritis patients who went on to develop RA, and 
little was detected in the synovial fluid of established arthritis patients [33]. Some 
murine models of inflammatory arthritis find IFNγ deficiency, either by genetic 
deletion of systemic removal, can lead to exacerbated disease [35, 45, 181], 
although local administration can enhance inflammation [35, 182]. Additionally, 
synovial membrane IFNγ mRNA levels negatively correlated with disease 
progression in the 2006 DAMAGE study, suggesting again that IFNγ is protective or 
non-pathological [183]. However, a lack of IFNγ detection may be due to its 
increased uptake, and this would need to be addressed in future studies.  
Recently it has become apparent that it is not just Th1-associated mechanisms 
involved with the disease as Th17 cells are now known to play an important role in 
the pathology of RA [31, 122, 155, 184]. IL-17A has been detected in greater 
amounts compared to healthy and disease controls in RA synovial fluid in both early 
and late RA patients, and in the synovial tissue of established RA [31, 33, 184-187]. 
IL-17 is important in the development of murine models of arthritis, including the 
ZAP70 KO arthritis models, Collagen Induced Arthritis (CIA) and a model of 
spontaneous arthritis [130, 155]. IL-17 producing cells in the rheumatoid joint are 
associated with CCR6+ CD45RO+ T lymphocytes, which are able to migrate in to the 
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RA joint in response to increased CCL20 levels [32]. Increased numbers of IL-17 
producing Th17 cells have also been observed in the peripheral blood of reactive 
arthritis patients, ankylosing spondylitis and RA patients, suggesting a systemic 
alteration in the immune system [119, 131, 188], although they do not necessarily 
correlate with disease activity [105].  
Evidence thus far has therefore led some to conclude that Th17 cells play an 
important role in RA pathology. However, histology of rheumatoid synovial membrane 
suggests that the percentage of IL17+ T lymphocytes is similar to the number of 
IFNγ+ T lymphocytes – only around 1%-8% [185, 189, 190] and it is possible that 
neutrophils and mast cells produce the most IL-17 in this tissue [189, 190]. 
Additionally, in the DAMAGE study, all patients’ synovial membrane samples 
expressed mRNA for TNFα and IL-10, but only 28% of patients’ samples expressed 
IL-17 mRNA [183].  
RA patients have increased numbers of circulating Tregs in their periphery and within 
their synovial fluid compared to healthy controls [168]. However, there are some 
disagreements as to whether synovial Tregs are functionally suppressive. Some in 
vitro assays have reported successful suppression of effector T lymphocyte 
proliferation [168, 191] whereas others have observed a reduction in suppressive 
capabilities compared to matched peripheral blood Tregs [151]. Conflict has also 
arisen over whether RA patients Tregs are able to suppress effector T lymphocyte 
cytokine production. Peripheral blood CD25+ Tregs from RA patients showed reduced 
ability in suppressing TNFα and IFNγ by CD4+ CD25- T lymphocyte effector cells, 
even though their ability to suppress proliferation was intact. In these experiments, 
anti-TNFα treatment restored the suppressive capabilities of peripheral Tregs three 
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months after treatment [192]. Synovial Tregs cells express more CTLA-4 than their 
equivalent peripheral blood regulatory counterparts but, as mentioned, contact with 
APCs is required for CTLA-4 to function. Suppression physiologically in the RA joint 
may therefore be partly dependent upon cellular organisation and locality [163, 168, 
191].  
Although cytokine production by T lymphocytes in RA may be diminished, the role of 
cell contact may still play an important role. Fixed T lymphocyte clones were able to 
induce the production of IL-1β from cells of the THP-1 macrophage cell line [193]. T 
lymphocyte contact with macrophages also results in the production of TNFα, IL-6, 
MMPs and other pro-inflammatory mediators [40, 155, 194]. In ex vivo RA synovial 
samples, isolated RA CD4+ T lymphocytes were only able to induce TNFα production 
from peripheral blood monocytes when contact was uninhibited [40, 194]. These RA 
CD4+ T lymphocytes mimicked cytokine-stimulated peripheral blood CD4+ T 
lymphocytes in their response to PI3K inhibitors, suggesting that in the joint they had 
been stimulated by cytokines such as IL-6, IL-2, IL-15 and TNFα [40]. The activation 
marker CD69 may be important in these cell-contact dependent mechanisms, as 
blocking CD69 inhibits TNFα production from synovial macrophages in these models 
[155, 164, 194, 195]. However, T lymphocytes do not inhabit similar regions as TNFα 
producing macrophages in the RA joint and therefore the extent of cell contact that 
occurs physiologically may be minimal [175].  
 
1.2. Hypoxia at inflammatory sites  
A link between hypoxia and inflammation is becoming increasingly apparent. Altitude 
sickness, in which blood oxygen levels are decreased, is associated with a systemic 
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increase in pro-inflammatory cytokines [196, 197]. Furthermore sleep apnoea, a 
condition in which blood oxygen levels drop during sleep due to airway blockage, is 
associated with an increase in circulating pro-inflammatory cytokines and a decrease 
in regulatory-associated markers [198]. Thus, systemic hypoxia appears to be linked 
with pro-inflammatory mechanisms.  
 
Microelectrodes have been utilised to measure oxygen levels of tissues 
experimentally, and averages of around 3% oxygen have been recorded in RA joints 
[199-202]. This is lower than those that have been found for osteoarthritic (5.6% 
oxygen) and healthy joints that had experienced trauma (8.2% oxygen) [199]. In RA, 
joint oxygen levels negatively correlate with macroscopic synovitis [200], mutations in 
mitochondrial DNA [202], lipid peroxidation [201] and lactate production [203] 
highlighting the glycolytic switch that occurs when oxygen is more limited. Hypoxia is 
also known to prevail in other autoimmune conditions such as systemic sclerosis, and 
also in the tumour microenvironment [204-206]. One reason for this includes poor 
oxygen delivery. Blood vessel occlusion caused by infiltrating phagocytes and the 
increasing distance between blood vessels caused by oedema result in decreased 
oxygen perfusion of tissue. Additionally, infiltrating cells place extra demands on the 
local oxygen supply, causing its localised depletion [200, 201, 207, 208]. Many 
chronic inflammatory conditions are associated with neovascularisation, and this is 
often thought to be in response to hypoxia found in the inflammatory environment [9, 
209]. This neovascularisation can often be disorganised and inadequate, resulting in 
badly formed vessels that can be detrimental to the environment and actually reduce 
oxygen delivery to the tissue, further contributing to hypoxia [9, 35, 196, 210] .This is 
probably the case in RA, where blood vessels are immature and unstable, and are 
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associated with low oxygen levels. It is therefore possible that the hypoxic 
environment in the joint may cause constant remodelling of blood vessels and 
contribute to pathology [210]. In effect, angiogenesis never seems to catch up with 
oxygen turnover, and hypoxia therefore prevails [210].  However, it is not known 
whether low environment oxygen levels contribute to the initiation of the disease. 
 
1.2.1 Reperfusion injury after hypoxia 
Reperfusion injury is a phenomenon where a previously sustained hypoxic site is 
again exposed to higher oxygen levels. Reperfusion injury is associated with 
ischaemic inflammatory conditions such as graft rejection, stroke and myocardial 
infarction [211-213], and if not caused by an inflammatory response, is normally 
accompanied by one. In a reperfused tissue endothelial cells activate incoming 
inflammatory cells by upregulating the expression of adhesion molecules and 
releasing inflammatory mediators [211-214]. Reperfused tissues are associated with 
oxidative damage of cellular structures and signalling molecules and can result in 
tissue damage [215, 216]. Both endothelial cells and activated neutrophils contribute 
to oxidative stress associated with reperfusion injury due to the release of ROS [211, 
214, 216]. These ROS originate from several sources including the enzyme xanthine 
oxidoreductase and mitochondria [211, 214, 215, 217]. Xanthine oxidoreductase is 
an enzyme normally involved in oxidising hypoxanthine to xanthine, but during 
ischaemia it is converted to a form that preferentially reduces oxygen to superoxide. 
When oxygen becomes more readily available during reperfusion the presence of this 
converted form of the enzyme increases cellular ROS production [211, 215, 218]. 
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However, its involvement in reperfusion-injury associated pathology has been 
questioned due to its production of vaso-protective nitric oxide [218].  
With regards to chronic inflammatory diseases, reperfusion injury is thought to play a 
role in pathology in liver disease [219] and autoimmune diseases such as RA [220-
222]. The healthy joint is thought to maintain a similar intra-articular pressure even 
when pressure is placed on it. In RA, however, intra-articular pressures fluctuate in 
response to pressure and exercise. These changes in pressure can alter blood flow 
through the joint, and therefore give rise to periods of ischaemia and reperfusion 
[199, 220, 222]. Additional evidence of reperfusion injury in the rheumatoid joint 
comes from the oxidative damage of joints structures, and the detection of xanthine 
oxidoreductase [221, 223].  
  
1.2.2 Hypoxia’s effect on gene regulation: Introducing hypoxia inducible factor 
(HIF) 
1.2.2.1 HIF 
One of the best understood responses to cellular hypoxia is the stabilisation of the 
transcription factor HIF. HIF is a heterodimeric transcription factor consisting of α and 
β subunits. The β subunit (also known as aryl hydrocarbon receptor nuclear 
translocator or ‘ARNT’) is constitutively found in the nucleus. The α subunits are 
constitutively transcribed but their protein stability is variable depending on 
environmental oxygen levels and other stimuli [204, 224]. Three HIF- α subunits have 
been described but HIF-1α is the most well-understood. Normally they are found in 
the cytoplasm and are degraded rapidly in the presence of oxygen. However, when 
stabilised, they translocate to the nucleus, where they dimerise with β subunits, bind 
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hypoxia-response elements (HREs) in the DNA and initiate transcription of genes 
involved in metabolism (including pyruvate dehydrogenase kinase), angiogenesis 
(such as Vascular Endothelial Growth Factor (VEGF)), cell cycle and many other 
aspects of cellular biology [224-227].  
 
1.2.2.2 Regulation of HIF 
As shown in figure 1.3, two hydroxylated proline residues on HIF-α subunits allows 
the von Hippel Lindau tumour suppressor gene (VHL) complex to bind, targeting 
them for proteasomal degradation via ubiquitinylation. Hydroxylation at these key 
residues is due to the action of prolyl hydroxylase domain enzymes (PHDs) that use 
dioxygen as a substrate and act as direct sensors of environmental oxygen. Fe(II) is 
additionally required as a co-factor for successful PHD-directed proline hydroxylation, 
providing a means for in vitro manipulation of this system [224, 225, 228]. HIF-α 
subunits are also further regulated by Factor Inhibiting HIF-1 (FIH-1), another 
oxygen-sensitive regulatory enzyme that hydroxylates a key asparagine residue on 
HIF-α molecules. The asparagine residue hydroxylated by FIH-1 is normally involved 
in the binding of CBP/p300, a key co-factor for HIF-α transcriptional activity [225, 
226]. As FIH-1 is active at lower oxygen levels than PHDs due to its higher affinity for 
oxygen [229], it exerts further delicate regulation of HIF activity.  
 
1.2.2.3 Stabilisation of HIF 
When oxygen is deficient, PHDs and FIH-1 are no longer able to hydroxylate the 
proline residues on HIF-α subunits. This stabilises cytoplasmic HIF-α subunits, 
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allowing them to translocate to the nucleus. The oxygen level that HIF-α stabilisation 
occurs at varies depending on cell type and HIF-α isotype. In a study where oxygen 
was increasingly depleted, HIF-1α protein detection increased between 5-2% oxygen 
in all cell lines tested [230]. HIF-1α is also only stabilised in stimulated T lymphocytes 
at 5% oxygen, but is more strongly stabilised at 3% oxygen and below [204]. 
Variability in the oxygen level at which HIF-1α is stabilised may be due to intrinsic 
differences in cellular metabolism and thus different oxygen turnover rates within the 
cytoplasm [225, 230]. Therefore, in this thesis, oxygen levels of below 5% are 
deemed ‘hypoxic’ which is in agreement with much of the literature [204, 230-240]. 
5% oxygen itself is probably a reasonably normal and healthy oxygen level 
physiologically, and found in smaller blood vessels and some tissues [204, 235, 236, 
241-244]. This definition does mean that several physiologically ‘normal’ oxygen 






Figure 1.3 The stabilisation of HIF-α subunits under reduced oxygen 
conditions. In normal oxygen conditions, prolyl hydroxylases domain enzymes 
(PHDs) hydroxlate two prolyl residues in the HIF-α subunits, targeting them for 
proteasomal degradation via ubiquitinylation via von Hippel Lindau tumour 
suppressor gene (VHL) complexes. Furthermore, Factor Inhibiting HIF (FIH) 
hydroxylates an asparagine residue important for transcriptional co-factor binding, 
converting oxygen to carbon dioxide in the process. When oxygen is reduced, both 
the PHDs and FIH-1 are inhibited in their action due to the lack of oxygen, and hence 
HIF-1α can translocate to the nucleus, dimerise with HIF-β and its transcriptional co-
factors, and initiate transcription of genes associated with multiple cellular processes. 
Adapted from [224].  
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1.2.2.4 Expression of HIF in inflammation 
HIF-1α expression has been detected in several inflammatory sites. In RA, both HIF-
1α and 2α expression has been detected [208, 248-252]. Specifically, HIF-1α 
expression has been observed in RA macrophages [250, 252] synoviocytes [251, 
252], T lymphocytes [204, 252] and plasma cells [252] indicating that all of these cell 
types may experience hypoxia in the RA joint. HIF expression is also detected in 
other inflammatory tissues associated with autoimmune diseases including MS [253] 
and inflammatory bowel disease [234].  
 
1.2.3 Mitochondrial responses to hypoxia and reperfusion injury 
Low environmental oxygen levels can result in the increase in ROS production from 
the mitochondria [254-256]. Counterintuitively, this requires dioxygen, and therefore 
has the potential to perpetuate intracellular hypoxia [254, 255]. ROS production from 
the electron transport chain in reasonable oxygen levels most commonly occurs at 
complex I. During hypoxia, however, complex III has been credited with most ROS 
production [254, 256], producing superoxide which is rapidly converted to hydrogen 
peroxide (H2O2) by mitochondrial superoxide dismutase (MnSOD) which then leaks 
out of the mitochondria. It is now understood that this ROS signal is important in 
cellular responses to hypoxia. For example, mitochondrial ROS can stabilise NFκB 
[257], and is probably supported by the hypoxic-induced downregulation of anti-
oxidants such as thioredoxin [258, 259]. There is also evidence that mitochondrial 
ROS can stabilise HIF-α by inhibiting PHD activity [255, 256], although this has been 
challenged [258].  
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Hypoxia also alters mitochondrial biology during reperfusion [211, 260, 261]. Post-
transcription alterations in mitochondrial membrane proteins occur during oxygen 
deprivation [215, 260], and mitochondrial anti-oxidants become less available [211, 
258, 259]. This therefore limits the capability of mitochondria to deal with subsequent 
re-exposure to oxygen and can result in mitochondrial ROS production. The 
membrane potential of the mitochondria is also depressed during hypoxia, reducing 
the mitochondria’s ability to generate ATP [211, 215, 261]. When oxygen is re-
introduced the membrane will instead hyperpolarise; a state in which ROS production 
is more favoured [261]. The combination of activated inflammatory cells and ROS 
can result in considerable tissue damage [212].  
 
1.2.4 Hypoxia and its effect on the innate immune system 
Innate cells of the immune system are often the first cells to respond to a pathogen or 
inflammatory stimuli. The environments into which these cells migrate can be 
physiologically harsh, being both low in oxygen and depleted of other key nutrients. 
However, evidence suggests that innate immune cells are well-adapted to the 
hypoxic environment. For example, macrophages and neutrophils utilise glycolysis 
even when oxygen is abundant [262], and neutrophils have delayed apoptosis in 
hypoxic conditions [25, 263]. Macrophages and neutrophils also both show increased 
phagocytic activity at low oxygen levels, and HIF-1α expression appears to be 
imperative for their proper pathogenic clearance [227, 242, 262, 264-266]. HIF-1α 
also regulates macrophage cytokine production, as TNF-α production is depleted in 
HIF-deficient macrophages [227]. In contrast, hypoxia may depress neutrophil 
cytokine production [267]. Interestingly, animals with myeloid-specific HIF-1α 
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deficiency had lower clinical scores of arthritis, indicating that hypoxia and HIF-1α 
stabilisation may play a role in maintaining pathology via the activities of innate 
immune cells [227, 242]. Oxygen levels can also influence the behaviour of APCs. 
One study using kidney tubule clamping, a model of reperfusion injury, observed an 
increase in the maturation of resident DCs [268] and an increase in the expression of 
CD80 and CD86 has also been observed on DCs cultured at constant 1% oxygen 
and below [268, 269].  
 
1.2.5 Low environmental oxygen levels and their effect on the adaptive immune 
system 
Akin to innate immune cells, the cells of the adaptive immune system are not likely to 
experience high oxygen levels physiologically. Measurements with microelectrodes 
have shown the murine thymic oxygen partial pressure to be around 10mmHg 
(around 1.3% oxygen) [243, 245, 246]. Furthermore, measurements of the murine 
spleen revealed changeable oxygen levels, varying between 0.5-4.5% oxygen in one 
study [239], and 1.3-3.3% oxygen in another study [245]. Rabbit spleens have higher 
measured oxygen levels than those recorded in mouse [245], and it therefore cannot 
be ruled out that human lymphoid organ oxygen levels vary from what has been 
reported in the literature. 
In both the thymus and spleen, proximity to blood vessels  influences local hypoxia, 
with increasing distance from the blood vessel resulting in reduced oxygen levels 
[239, 246]. Increased metabolic activity in these tissues may also deplete hypoxia 
[245]. Lymph fluid is also hypoxic, with decreasing oxygen levels compared to 
corresponding tissue and blood vessels [270]. Lymphatic vessels contain varying 
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oxygen levels, with the greatest oxygen levels in large lymphatics due to increased 
proximity to blood vessels [270]. Lymphocytes will also experience a wide variety of 
oxygen levels in blood circulation, depending on whether they are in well-oxygen 
perfused alveolar capillaries, or less oxygenated venous capillaries [224]. With 
regards to chronic inflammatory environments observed in autoimmune diseases, the 
hypoxic environment will be acute to any T lymphocyte migrating in. However, they 
soon become part of the chronic architecture of the disease. Thus, oxygen levels will 
peak and trough throughout a CD4+ T lymphocyte’s lifetime, but they often are 
exposed to oxygen levels below 5% oxygen, and never will experience 21% oxygen 
physiologically.  
 
1.2.5.1 Experimental observations of the effect of hypoxia on T cells 
The majority of in vitro work carried out with T lymphocytes is performed at 21% 
oxygen, the oxygen level of air at sea level. However, as already outlined, this 
experimental condition is inappropriate. In the literature, terminology with regards to 
hypoxia can be slightly misleading. Some papers will label 21% oxygen as 
‘normoxia’. It is ‘normal’ in respect to current experimental procedures, but is not a 
‘normal’ oxygen level found physiologically. In fact, T lymphocytes will never 
experience this oxygen level physiologically, and it may be better to term 21% 
oxygen as ‘hyperoxia’. Several studies have investigated the effect of low oxygen on 
T lymphocyte activity and behaviour, and have revealed varying reponses from T 
lymphocytes at different oxygen levels.  
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1.2.5.1.1 Varying oxygen levels: effect on CD4+ T cell activation and signalling 
Effect of environmental oxygen levels on the T lymphocyte oxidative response 
Culture of mixed CD4+ and CD8+ T lymphocytes at 21% oxygen reduces levels of 
glutathione, a major cellular antioxidant, compared to culture at 5% oxygen [244]. 
Concurrent with this observation, increased oxidative damage has been reported 
during 21% oxygen culture [271]. CD4+ T lymphocytes reveal different patterns of 
intracellular ROS production in response to 1% oxygen compared to 21% oxygen, 
with a delay in initial intracellular ROS in hypoxia, but a steady subsequent increase 
observed thenceforth [235]. 5% oxygen revealed similar patterns to culture at 21% 
oxygen, with only an initial peak in ROS observed (associated with the initial TCR 
signal) [235]. Hence lymphocytes cultured at different oxygen levels have altered 
behaviour as soon as signalling is initiated, and this may take the form of altered 
resilience to oxidative attack.  
 
Effect of hypoxia on calcium influx 
One of the first events to happen after T lymphocytes signalling is the mobilisation of 
calcium stores resulting in a calcium signal [68, 272]. The potential of the T 
lymphocyte outer membrane is maintained by differential expression and activation of 
calcium and potassium channels [273, 274]. Activation of T lymphocytes causes 
mobilisation of intracellular calcium stores, which subsequently results in the 
activation of plasma membrane calcium release activated channel (CRACs), giving 
rise to extracellular calcium influx and intracellular calcium oscillations. Membrane 
potential is maintained, and balanced, by the expression of potassium channels such 
as Kv1.3. Potassium channels are able to hyperpolarise the membrane by the 
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removal of cellular potassium, thus increasing the electrochemical gradient across 
the membrane and promoting the movement of calcium into the cell [273, 274]. 
Hypoxia (1% oxygen) inhibits Kv1.3 channel function in T lymphocytes [275] resulting 
in the depolarisation of the membrane, and reducing extracellular calcium influx and 
the calcium oscillations required for T cell activation. This alteration in membrane 
potential was observed as soon as T lymphocytes were placed into a hypoxic 
environment and resulted in a depression in calcium signalling in around half of T 
lymphocytes pre-stimulated by phytohaemagglutinin (PHA). Calcium influx was very 
variable depending on donor and cell subsets present within the population, revealing 
the complex nature of calcium signalling in different T lymphocyte subsets [273]. 
These observations are particularly interesting as T lymphocytes in the rheumatoid 
joint have reduced calcium signalling [41]. A longer duration of exposure to 1% 
oxygen also reduced Kv1.3 membrane expression [275].  
 
Effect of HIF on activation and signalling 
In T lymphocytes, TCR engagement – via mammalian target of rapamycin (mTOR)-
dependent processes - is required for the hypoxic-induced stabilisation of HIF-1α 
protein, whereas resting cells do not appear to stabilise its protein expression [204, 
224, 238, 276, 277]. VHL deficient T lymphocytes, (in which HIF-1α is constitutively 
stabilised), have reduced calcium signalling in response to TCR signalling caused by 
increased endoplasmic reticulum and mitochondrial uptake of cytoplasmic calcium 
[278]. It is therefore possible that the stabilisation of HIF-1α post-TCR signalling may 
function as a negative feedback regulatory mechanism, inhibiting further calcium 




A considerable number of studies do not observe a difference in apoptosis or viability 
in peripheral blood mononuclear cell (PBMC) or CD4+ T lymphocytes stimulated in 
hypoxia compared to culture at higher oxygen levels [237, 280-283], even up to 7 
days culture [283]. In fact some papers describe an increased viability at lower 
oxygen levels [204, 284, 285], and this may be potentially due to the stabilisation of 
HIF-1α [204, 224]. However, there are some reports of increasing apoptosis in low 
environmental oxygen conditions of both PBMC mixed cultures and pure T 
lymphocyte populations [240, 244] and HIF has been implicated as a cause [279, 
286] contradicting other literature [204, 224]. PHA stimulation of CD4+ T lymphocytes 
at 1% oxygen resulted in increased apoptosis compared to 5 and 21% oxygen but 
resting cells were unaffected [235] . Naïve T lymphocytes may be more susceptible 
to apoptosis in low environmental oxygen [236, 287], whereas effector T lymphocytes 
appear to be much more protected and resilient [287]. As different experimental 
procedures exist between laboratories, it is possible that simple variance in cell 
density or the presence of anti-oxidants in medium may give rise to contradictions 
within the literature. 
 
1.2.5.2 Proliferation 
1.2.5.2.1 Proliferation in more than 5% oxygen 
Physiologically healthy oxygen levels of 5% and above generally reveal a different 
pattern in proliferation compared to 21% oxygen cell culture, however, the literature is 
contradictory. Several groups have observed an increase in proliferation at 5% 
oxygen in PBMC cultures compared to 21% oxygen culture [284, 285, 288], whereas 
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alternative studies have found the opposite [244, 281] or find culture at 5% similar to 
21% oxygen [235].  
 
1.2.5.2.2. Proliferation in less than 5%oxygen 
At oxygen levels less than 5%, a different pattern begins to emerge in the 
proliferative capacity of T lymphocytes revealing the intricate and subtle influence 
environmental oxygen levels can have on lymphocyte biology. Several reports 
indicate that proliferation is reduced in oxygen levels lower than 3% [235, 236, 240, 
275, 280, 282, 287, 289, 290]. For example, PBMC stimulated with PHA for 40 hours 
at 2% oxygen had a lower DNA content than those stimulated at 21% oxygen [282]. 
Additionally, pure CD4+ T lymphocytes populations cultured in low environmental 
oxygen levels revealed a reduction in proliferation when stimulation with PHA [235, 
289] or with anti-CD3/anti-CD28 antibodies [240] compared to those cultured in 21% 
oxygen oxygen. This reduction in proliferation maybe subset-specific, with a greater 
proliferative defect in effector CD4+ T lymphocyte subsets compared to cells with a 
more regulatory phenotype [291]. Furthermore, a study that generated T lymphocyte 
clones from healthy donors observed that long-term culture at 3% oxygen reduced 
replication compared to 21% oxygen culture [271]. However, observations of no 
difference in proliferation between low oxygen (2%) and 21% oxygen culture have 




1.2.5.2.3 Differences in the literature regarding effects of environmental oxygen on 
proliferation 
Differences in the literature may have arisen due to the different experimental 
procedures used including the selection of particular CD4+ T lymphocyte subsets, 
purity of lymphocyte populations investigated, and stimulation methods examined. It 
is possible that differences in response to environmental oxygen may only be 
observed after stimulation through the TCR, as some report no differences in 
response to PMA/ ionomycin stimulation in hypoxia compared to membrane-receptor 
engagement [275]. However, this is not consistently observed. Indeed, one study 
found that whilst a difference in proliferation could be observed at different oxygen 
levels after Con A or anti-CD3/ anti-CD28 stimulation, no difference could be found 
after PHA stimulation [281]. This lack of difference after PHA stimulation was also 
observed in another study, whereas PMA/ ionomycin stimulation did reveal a 
difference [235], questioning the role of signalling through the TCR. Therefore, the 
picture is still incomplete as to how environmental oxygen levels influence T 
lymphocyte proliferation.  
 
1.2.5.3 Cytokine production and Polarisation of CD4+ T lymphocytes 
The effects of hypoxia on purified T lymphocyte cytokine production is also not 
completely clear. Some papers find an increase in cytokine production in hypoxia 
[205, 235, 237, 292], whereas others find a reduction [204, 236, 239, 243, 289, 293].  
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1.2.5.3.1 An increase in T lymphocyte cytokine production in response to low 
environmental oxygen 
An increase in cytokine production at lower oxygen levels has been observed in 
response to several different stimulation methods. Roman et al found that stimulating 
murine CD4+ T lymphocytes for 48 hours with anti-CD3/ anti-CD28 resulted in 
increased detection of IL-2, IL-4 and IFNγ levels at 1% compared to 21% oxygen, 
although IFNγ mRNA was reduced. IFNγ and IL-4 secretion levels continued to 
increase over 72 hours. Preliminary investigations into the role of cytokine turnover 
and receptor expression showed that this did not play a large role in the difference in 
cytokine levels observed [237] suggesting the increase was due to heightened 
expression. In another study, PHA stimulation revealed an increase IL-2, IL-3 and IL-
6 production at 1% oxygen compared to 21% oxygen [235]. In addition, a PHA-
stimulated transcriptome analysis of T lymphocytes stimulated under different oxygen 
levels also found an increase in pro-inflammatory cytokine transcript levels in 
hypoxia; IL-6, IL-1β, IL-23A and TNFα transcripts were increased in human CD4+ T 
lymphocytes placed in 1% oxygen compared to 21% oxygen [205]. Pure CD4+ 
cultures placed in cumulative hypoxia by the use of a sealed container also increased 
production of IL-2, IL-6, IL-8, IL-10 and IL-1β in response to PMA/ ionomycin 
stimulation [292].  
 
1.2.5.3.2 Reduced T lymphocyte cytokine production in low environmental oxygen 
In other studies, a drop in CD4+ T lymphocyte cytokine production has been 
observed at lower oxygen levels [204, 236, 239, 243, 289, 293]. Murine naïve CD4+ 
T lymphocyte IFNγ and IL-17A intracellular staining was reduced at 1% oxygen 
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stimulation compared to both 5% and 21% oxygen [236]. A DNA microarray of 
peripheral human T lymphocytes found no change in the expression of some 
cytokines in response to stimulation in hypoxia but IFNγ, GM-CSF and TNFα 
transcripts were downregulated compared to stimulation at 21% oxygen [204].  
 
1.2.5.3.3 The effect of HIF on cytokine production 
The deletion of HIF-1α has provided some interesting results with regards to 
explaining the effects of hypoxia on cytokine production. HIF-1α deficient T 
lymphocytes produce more IFNγ, TNFα, IL-4, IL-13 and IL-2 [243, 293, 294]. 
However, the ifnγ and il2 genes are known to not contain HREs [239], suggesting 
complex mechanisms may be involved in the regulation of these cytokines in 
response to differing environmental oxygen. In a murine model of colitis IL-10. IL-1β, 
IL-6, IL-17, IL-23, IFNγ, IL-12a and TNFα were all significantly upregulated in the 
colonic mucosa of T lymphocyte-specific HIF1α-deficient mice compared to wild type 




Observations of the effect of hypoxia on cytokine production begins to give some 
clues as to the effect hypoxia has on CD4+ T lymphocyte polarisation. However, 
current literature is somewhat contradictory. Some papers have found increases in 
cytokines associated with both Th1 and Th2 subsets [237, 282], suggesting that 
hypoxia may not influence polarisation, but enable better overall effector functions. 
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However, other papers suggest that hypoxia favours the formation of distinct CD4+ T 
lymphocyte subsets, although there is some disagreement as to which subsets are 
favoured. The strongest evidence for the role of hypoxia in the regulation of T 
lymphocyte phenotype is in differentiation to Th17 and Treg subtypes, as discussed 
below. The different metabolic requirements of the various T helper cell subsets 
needs to be considered when probing the literature. Th17, Th2 and Th1 upregulate 
glycolysis upon activation [276, 295], whereas Tregs appear to utilise fatty acid 
oxidation [295]. This will influence their oxygen requirements and utilisation, and 
therefore their response to hypoxia.  
 
1.2.5.4.1 Th1 or Th2? 
The effect of hypoxia on Th1 and Th2 cell differentiation and function is not well 
understood. As already mentioned, cytokines associated with both Th1 and Th2 
phenotypes are upregulated in response to hypoxia in certain models [237, 282]. 
However, it is possible that Th1 differentiation is favoured more than Th2 in an 
hypoxic environment [237]. Studies looking at HIF-1α expression in lung epithelial 
cells found that when HIF-1α was deleted, an eosinophilic, Th2-like inflammatory 
response ensued in response to cobalt treatment [296]. Cobalt normally results in the 
stabilisation of HIF-1α and is therefore used as a hypoxic mimetic. When HIF-1α was 
intact, a more pro-inflammatory response occurred associated with an increase in 
TNFα, suggesting the cobalt-stabilisation of HIF-1α  reduced Th2 responses [296]. 
Lymphocytes were not directly investigated in this study, but the results give an 




Th1-associated cytokine secretion has been found to be upregulated in response to 
hypoxia in some studies [204, 205, 237]. Despite this, both IFNγ and T-bet mRNA 
have been observed to be downregulated at 1% oxygen [237]. HIF-1α 
overexpression results in IFNγ inhibition [297], whereas HIF-1α deletion appears to 
upregulate IFNγ production [293, 294]. As HIF-1α deficiency has resulted in the 
upregulation of many cytokines’ expression [234] there may be additional regulatory 
factors at work here yet to be discovered, especially that, as already stated, the ifnγ 
gene locus does not contain an HRE [239]. Interestingly Th2 cells were observed to 
utilise glycolysis more than Th1 and Th17 cells during differentiation, but in a HIF-1α 
independent fashion, unlike Th17 cells [276]. Further understanding about Th2 cells’ 
response to hypoxia is somewhat lacking. Despite an increase in IL-4 being found in 
response to hypoxia in some studies [237, 280, 282], a reduction in GATA3 mRNA 
has also been reported [237].  
 
1.2.5.4.2 Th17and Treg cells 
Pro-inflammatory Th17s response to hypoxia 
Th17 and Treg cells differentiation follows similar pathways, and in murine cells both 
differentiate in response to TGF-β stimulation (with Th17 differentiation also requiring 
IL-6). However, it appears Th17 differentiation may be more favoured in low oxygen-
conditions. Obstructive sleep apnoea syndrome (OSAS) is a disorder where blood 
oxygen levels can considerably drop during sleep, essentially causing whole-body 
hypoxia. Sleep apnoea has been found to increase the ratio of Th17 cells compared 
to Treg cells circulating in OSAS patients’ blood [198]. The stabilisation of HIF-1α is 
potentially important in the differentiation of Th17 cells from naïve precursors. 
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Increased HIF-1α expression has been observed in Th17 polarised T lymphocytes 
[120, 236, 276, 298], with Th17 cells upregulating HIF-1α mRNA more than their Th1, 
Th2 and Treg counterparts [276]. HIF-1α deficiency is associated with protection from 
the development of experimental autoimmune encephalomyelitis (EAE) which is 
commonly associated with Th17-mediated pathology [276, 277]. In in vitro 
experiments performed at 21% oxygen, HIF-1α deficiency was found to inhibit the 
expression of RORγt and IL-17 in stimulated murine CD4+ T lymphocytes polarised 
towards a Th17 phenotype. True to HIF-1α’s function as an oxygen sensor, HIF-1α-
intact cells doubled IL-17 production in hypoxia compared to their 21% equivalents, 
whereas limited IL-17 was detected in HIF-1α deficient T lymphocytes [276, 277]. 
Additionally, a model of reperfusion injury found that initial stimulation of 
differentiating Th17 cells at 3% and 5% oxygen resulted in increased, HIF-1α-
dependent IL-17 production. However, at 1% oxygen with reperfusion injury, IL-17 
production was reduced [236].   
Stabilisation of HIF-1α in Th17 cells has been found to be via both STAT-3 induction 
[277] and mTOR signalling [276] and may provide an additional advantage to Th17 
cells in an hypoxic inflammatory environment, promoting their survival and function. 
Indeed, HIF-1α expression in Th17 cells is associated with an upregulation of 
glycolysis [276] and the inhibition of apoptosis [120]. HIF-1α also appears to promote 
the Th17 phenotype through its master regulator, RORγt, as these two proteins co-
operate (and co-immunoprecipitate) to promote IL-17 expression, and potentially 
cause the degradation of Foxp3 [277, 299], although this result has been questioned 
[291]. Furthermore, the RORγt promoter contains an HRE, making it HIF-1α-
responsive [277, 299].  
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Other factors present in the hypoxic environment also seem to promote Th17 
differentiation. For example, IL-6 is required for naïve T lymphocyte differentiation to 
a Th17 phenotype and IL-6 has been found to be upregulated in response to hypoxia 
[205, 282]. Additionally, mitochondrial ROS can promote IL-17 production. In 
immediate early response gene X-1 (IEX-1)-deficient mice mitochondrial ROS is 
increased. When T lymphocytes from these mice were differentiated to a Th17 
phenotype, IL-17 production was upregulated, but anti-oxidants were able to 
abrogate this response [300].  
 
Hypoxia favours a regulatory phenotype? 
There is ongoing debate as to the role of HIF-1α in the development of Th17 and 
Treg cells [276, 277], with cells needing to make a ‘checkpoint decision’ about which 
way to differentiate. As discussed, strong evidence favours Th17 differentiation from 
a naïve T lymphocyte. As nTregs are formed in the thymus, and are often selected 
for in in vitro experiments due to their CD25 expression even when resting, it is 
difficult, and potentially ill-advised to compare them to Th17 cells differentiated from 
naïve T lymphocytes in the periphery. iTregs do not always express all the markers 
associated with nTregs, and therefore are not always compared correctly with Th17 
cells. Despite this, there is some evidence to suggest that once cells are on the 
differentiation pathway to becoming, or already are fully differentiated to a Treg, 
hypoxia and stabilisation of HIF-1α may promote regulatory function. Indeed, hypoxic 
tumours preferentially recruit differentiated Tregs, suggesting that Tregs are primed 
to function in environments low in oxygen [301].  
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Hypoxia promotes FOXP3 transcription in resting CD4+ T lymphocytes [234], 
potentially via HIF-1α stabilisation due to the FOXP3 promoter containing a HRE 
[291, 302] and Foxp3 expression is upregulated in HIF-1-intact cells [234]. 
Suppressive capabilities of CD4+CD25+ T lymphocytes were increased after hypoxic 
exposure (although the experiment modelled reperfusion injury to some extent) and 
hypoxic CD4+CD25+ cells were found to express more Foxp3 than their counterparts 
exposed to higher oxygen environmental oxygen levels [302].  Whole body hypoxia 
also increased Treg expression of CD25 and CTLA-4 [291].  
When CD4+ CD25+ Tregs deficient in HIF-1α were transferred alongside 
CD45RBhigh effector cells in a model of colitis, the inflammation that followed was 
much more severe than if HIF-1α-intact Tregs were transferred, suggesting proper 
HIF-1α expression and function was required in vivo for differentiated Treg 
suppression [291].  Interestingly, overexpression of HIF-1α results in the upregulation 
of IL-10 and TGF-β in murine splenocytes, suggesting anti-inflammatory mechanisms 
may be promoted in hypoxic environments [297]. Despite this, HIF-1α deficiency has 
also been found to increase the number of Foxp3+ cells detected in lymphoid tissue 
[277], adding confusion to the current literature.  
 
1.2.5.4.3 Reperfusion injury and polarisation 
CD4+ T lymphocytes are known to play a role in reperfusion injury [215, 303] as the 
depletion of CD4+ T lymphocytes before reperfusion can protect from tissue damage 
[303]. TEM can be detected up to 11 weeks after reperfusion, and are most probably 
pro-inflammatory in nature [303, 304]. IL-12 deficient mice are protected from 
reperfusion injury, whereas IL-4 deficient mice develop exacerbated tissue damage 
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[305], suggesting  intermittent hypoxia promotes the development of Th1-associated 
inflammatory responses via APC priming. Additionally, increased IFNγ has been 
detected in reperfusion models, and Th2 phenotypes have been described as 
protective [304, 305]. However, in naïve T lymphocytes differentiated under different 
polarising conditions, an inhibition in both IL-17A and IFNγ production resulted after 
culture at 1% oxygen with reperfusion injury (by being moved to 21% oxygen) 
compared with 5% oxygen and constant 21% oxygen [236].Therefore, the effects of 
reperfusion injury on CD4+ T lymphocyte polarisation needs further investigation.  
 
1.3 Hypothesis 
CD4+ T lymphocytes will experience many different oxygen levels physiologically, 
and low oxygen levels are prevalent in the inflammatory environments such as those 
seen in RA. In this thesis, CD4+ CD45RO+ T lymphocytes cells were chosen for 
most of the investigation as they are the CD4+ subsets most commonly observed in 
the RA joint [40, 156, 306], and will be the majority of cells that migrate out of the 
lymph node and into inflamed tissues [148]. The effect of various, physiologically-
relevant oxygen levels on the activation and function of this cell population has not 
been previously determined.  
It is hypothesised that environmental oxygen levels regulate CD45RO+CD4+ T 
lymphocyte proliferation, cytokine production and polarisation. Furthermore, it is 
predicted that this is caused by fundamental alterations in T lymphocyte activation 
due to differences in cellular homeostasis and signalling machinery. Five different 
oxygen levels were selected for analysis; 21% as an example of what most in vitro 
work is performed in; 8.5% as a potential example of the average healthy joint [199, 
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208, 307]; 3% as an example of the average of a RA joint and some physiological 
environments such as the lymph node [199-202, 208, 239]; constant 1% oxygen as 
an example of a more severely inflamed joint [200]; and reperfusion injury as an 





The effect of various oxygen levels on CD4+ CD45RO+ T lymphocytes was 
assessed by using a hypoxystation that allowed close control of environmental 
oxygen levels. CD4+ CD45RO+ T lymphocytes were isolated from healthy donors 
and frozen until required. Cells were equilibrated to the desired oxygen level for 24 
hours before being stimulated and assessed for different outcomes, such as surface 
marker expression, cytokine secretion, and intracellular cytokine production. 
Treatment with deferoxamine mesylate (DFX) and H2O2 allowed for further 
investigation of HIF-1α stabilisation and ROS on these outcomes, respectively.  
2.1 Antibodies and Reagents 
Antibody Company Catalogue 
Number 
Use 




Purified anti-CD28 21270030 




PE mouse IgG2a k isotype 
control  
400212 
PE anti-human CD3 300308 
PE Mouse IgG2b k isotype 
control 
400312 
APC Cy7 anti-human CD69  310914 
APC/Cy7 Mouse IgG1 k isotype 
control 
400128 
APC Cy7 anti-HLA-DR  307618 
APC/Cy7 Mouse IgG2a k 
Isotype control 
400230 
Pacific Blue anti-human IFNγ 502522 
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Pacific Blue Mouse IgG1 k 
isotype control 
400151 
PE anti-human IL-17A 512306 
PE Mouse IgG1 k isotype 
control 
400140 
FITC anti-human IL-4 500806 
FITC Rat IgG1 k isotype Ctrl 400406 
PE/Cy7 anti-human IL-10 501420 
PE/Cy7 Rat IgG1 k isotype 
control 
400415 




PerCP/Cy5.5 mouse IgG2b k 
isotype ctrl 
400338 
APC anti-human CD183 
(CXCR3) 
353708 
APC Mouse IgG1 K isotype 
control 
400120 
PE anti-human CD152 (CTLA-
4) 
349906 
Alexa-Fluor 647 mouse IgG1 k 
isotype control 
400130 





Anti-human Foxp3 eFluor 450 48-4777 
Mouse IgG1 K isotype control 
eFluor 450 
48-4714 
Mouse IgG1 k isotype control 
Pe-Cy7 
25-4714 
Mouse IgG1 K Isotype Control 
PerCP-Cy5.5 
45-4714 







Table 2.1. Antibodies and reagents used experimentally, including their 
sources and function 
 
2.2 CD4+ memory T lymphocyte isolation and purification 
PBMCs were obtained from buffy coats from the National Blood Service or from 
healthy controls under ethics code 12/WM/0077. Ficoll paque density gradient 
centrifugation was used to obtain PBMCs. Blood was layered above 10ml Ficoll 
paque (GE Healthcare, Buckinghamshire, UK) (Cat. No. 17-1440-03) and centrifuged 
for 30 minutes with no brakes or acceleration at 21°C. Memory CD4+ T cell isolation 
kit (human) (Miltenyi MACs, Surrey, UK) (Cat. No. 130-091-893) was used to isolate 
CD4+ memory T lymphocytes for experimentation from the whole PBMC population. 
Alexa Fluor 647 Mouse anti-
GATA3 
560068 















lymphocytes Purified anti-human IL-4 500701 
Purified anti-IFNγ pure Miltenyi (Surrey, UK) Cat. No. 130-095-
743 
Recombinant human IL-4 stock 
10μg/ml 
peprotech 200-04 
Recombinant human IL-12 
stock 10μg/ml 
200-12 
Hydrogen peroxide (H2O2) Sigma-Aldrich (St. 
Louis, MO, USA) 
H-1009 Treating cells 
Deferoxamine mesylate (DFX) D9533-1G 
N-acetyl-L-cysteine (NAC) A9165 
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Briefly, PBMCs were incubated with a biotin-labelled antibody cocktail against CD8, 
CD14, CD16, CD19, CCD45RA, CD56, CD123, TCRγδ and glycophorin A. Cells 
were then washed in sterile 0.5% bovine serum albumin (BSA)/ 2mM 
ethylenediaminetetraacetic acid (EDTA)// phosphate buffered saline (PBS) and 
incubated with anti-biotin microbeads. When placed through a separation column 
placed on a magnet, labelled cells were retained and unlabelled CD4+ CD45RO+ 
cells passed through the column and collected. Double isolations were routinely 
performed to obtain optimum purity. Populations over 95% pure, as assessed by 
CD45RO and CD3 expression, were used experimentally. Cell populations were 
stored at -80˚C before use in 10% dimethyl sulfoxide (DMSO)/heat-inactivated fetal 
calf serum (FCS). Naïve CD4+ T lymphocytes were isolated using the same 
technique with the miltenyi MACs Naïve CD4+ T cell isolation kit II (human) (Cat. No. 
130-094-131).  
 
2.3 CD4+ memory T lymphocyte cell culture at varying oxygen levels 
Cell populations were removed from the freezer and defrosted rapidly at 37°C. Cells 
were washed in culture medium (RPMI-1640 (Sigma Aldrich (St. Louis, MO, USA) 
(R0883)/ 10% FCS (Labtech (East Sussex, England) (10454) / 1% L-Glutamine-
Penicillin-Streptomycin solution (Sigma-Aldrich (St Louis, MO, USA) (G1146)) and 
cell counted using trypan blue to exclude dead cells. Cells were again washed in 
culture medium and plated at 1x106 cells/ml in 200μl culture medium in 96-well 
round-bottomed tissue culture plates. Cells were placed on ice before being placed in 
either a normal CO2 incubator (Function Line, Thermo scientific) or H35 
Hypoxystation (Don Whitley, West Yorkshire, England). Both incubators maintained 
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37˚C and 5% CO2, and in the hypoxystation oxygen levels were balanced using 
nitrogen gas. Cells were equilibrated to the desired oxygen level in the correct 
incubator for 24 hours before stimulation with plate bound 2μg/ml anti-CD3// 5μg/ml 
anti-CD28. 96-well round-bottomed stimulation plates were prepared by placing 50μl 
2μg/ml anti-CD3// 5μg/ml anti-CD28 in sterile PBS over night at 4°C. The following 
day the stimulation mix was removed and replaced with 100μl sterile PBS. Plates 
were stored frozen at -20˚C before use.  
After cells had been stimulated for the required amount of time, they were placed on 
ice for 4-5 minutes at the oxygen level they had been cultured at to avoid the effects 
of reperfusion injury at 37˚C. For the reperfusion injury model, a Mini Galaxy A 
hypoxystation (Wolf Laboratories (York, England)) was sometimes used for culture at 
1% oxygen. With all reperfusion experiments, cells were equilibrated at 1% oxygen 
but stimulated at 21% oxygen levels and kept there for a further 24 hours before 
being removed back to 1% oxygen for 48 hour stimulations. For 4 day stimulations, 
there was an additional 24 hour stint at 21% oxygen levels. This regimen was 
selected as a more physiological relevant oxygen level, such as 8.5%, could not be 
used due to other hypoxystation users.  
For treatment of cultures with N-acetyl-L-cysteine (NAC), cells were placed directly in 
medium containing 1mM NAC and equilibrated to the indicated oxygen level. For 
treatment with DFX or H2O2 , cells were set up in 100μl culture medium at 2x10
6 
cells/ml and equilibrated to the indicated oxygen levels. 50μl of 10μM DFX or 40μM 
H2O2 were added, and the wells were made up to 200μl with oxygen-equilibrated 




Figure 2.1. The Don Whitley H35 hypoxystation. This hypoxystation allows for set 
regulation of internal oxygen levels by balancing oxygen and nitrogen levels. These 
oxygen levels are maintained even when in use by the use of rubber sleeves and an 
airlock chamber that equilibrates to the desired oxygen level before allowing access 
to the inner oxygen-regulated chamber. Any oxygen level between 0-21% oxygen 




2.4 CD4+ memory T lymphocyte CFSE staining for proliferation 
To assess proliferation, cells were incubated with 1μM carboxyfluorescein diacetate 
succinimidyl ester (CFSE) /PBS (Invitrogen (Camarillo, CA, USA) C34554) for 15 
minutes at 37˚C before being quenched with ice-cold culture medium. Three washes 
in culture medium were performed before cells were equilibrated at the intended 
oxygen level for 24 hours. Cells were stimulated as described above for four days 
before proliferation was assessed on a CyAn ADP Analyser, Beckman Coulter (High 
Wycombe, UK). Stimulated cells were gated on for assessment of proliferation.  
 
2.5 Cell viability assessment using Sytox 
Cell viability can be assessed by using a dead cell exclusion DNA-stain, Sytox-Blue 
(Invitrogen, (Camarillo, CA, USA)) (Cat. No. S34857).  Sytox-Blue associated 
fluorescence is detected when cells have a compromised membrane, and therefore 
is an excellent marker of dead cells and assessor of overall cell viability. 1ul Sytox 
was added to 500μl PBS, and then 30μl of this was subsequently added to 300μl cell 
suspension in 2% BSA/PBS for 30 seconds before analysis by flow cytometry using a 
405nm laser. Sytox-Blue was kept away from light sources until used to limit 
degradation.  
 
2.6 Naïve CD4+ T lymphocyte polarisation 
Naïve CD4+ T lymphocytes were polarised to a Th1, Th2 or Th0 phenotype at the 
different oxygen levels investigated in this thesis. Cells were plated at 5x 105 cells/ml 
// 100μl/ well of a round-bottomed 96 well plate. After equilibration to the desired 
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oxygen level for 24 hours, the cells were stimulated with plate bound anti-CD3/ anti-
CD28, as described, and 100μl 2x polarisation mix (made up in culture media) was 
added. Final concentrations for each polarisation condition were as follows:  
 Th1; 5ng/ml recombinant IL-12// 2.5μg/ml anti- IL-4 
 Th2; 50ng/ml recombinant IL-4// 20μg/ml anti-IFNγ// 5μg/ml anti-IL-12 
Recombinant IL-2 was also added to a final concentration of 10ng/ml to each 
condition, including the Th0 control. Cells were stimulated for 36 hours before being 
assessed for surface marker expression. 
 
2.7 Flow cytometry 
For intracellular cytokine staining, cells were treated with 2μg/ml Brefeldin A (Sigma-
Aldrich (St. Louis, MO, USA) Brefeldin A Ready Made Solution (B5936)) 3 hours 
before the end of the indicated stimulation period to inhibit extracellular cytokine 
release. Cells were stained for flow cytometry after being washed in 2% BSA/ PBS, 
and all surface-marker antibodies were diluted in 2% BSA/PBS. Surface marker 
staining was performed for 30 minutes on ice in 50μl antibody cocktail.For 
intracellular staining, cells were subsequently fixed (Invitrogen (Camarillo, CA, USA) 
Fixation Medium (A) (GAS001S100)), washed twice in 2% BSA/PBS and further 
stained in intracellular antibody cocktails diluted in permeabilisation buffer 
((Invitrogen (Camarillo, CA ,USA) Permeabilisation Medium (B) (GAS002S100)) for 
30 minutes on ice. In all flow cytometry panels, isotype controls were used at the 
matched concentration.  
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For assessment of Lck tyrosine-394 phosphorylation, cells were fixed at the oxygen 
level they were maintained at. This was achieved by adding paraformaldehyde/PBS 
to the final concentration of 4% directly to the 200μl cell populations. Cells were then 
spun at 300g and stained for Lck-394 in permeabilisation buffer as before.  
A CyAn ADP Analyser, Beckman Coulter(High Wycombe, UK) was used to 
determine expression of markers. Countbright Absolute Counting Beads (Life 
Technologies (Eugene, OR, USA) (C36950) were used to maintain consistent MFI 
values over time. Several different panels were used, including a pro-inflammatory 
panel, an anti-inflammatory panel, a cytokine panel, a CD69/CD45RO panel and a 
HLA-DR/CD3 panel. For compensation, BD CompBeads Anti-mouse Ig, k/Negative 
Control (FBS) Compensation Particles Set (552843), and Anti-Rat IgG/ Negative 
Control (FBS) Compensation Particles Set (552844) were used. For the larger panels 
(of six colours), an experiment employing fluorescence-minus-one was done to 
determine the isotype allowance of each colour. Briefly, the panel was run on a 
population of CD4+ CD45RO+ T lymphocytes, but each colour was removed 
sequentially from a test and replaced with the equivalent isotype, thereby allowing 
the amount of crossover colour bleed (after compensation) within the panel to be 
determined and accounted for in further analysis. Details of the larger panels can be 
found in the appendices. Summit v4.3 software was used to analyse results.  
 
2.8 Enzyme-linked immunosorbent assay ELISA 
Supernatants were collected from 48 hour stimulated samples (with 3 hours Brefeldin 
A treatment at the end of the stimulation period) and stored at -80˚C until required. 
eBioscience (San Diego, CA, USA) Ready-SET-Go! ELISA kits were used to assess 
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supernatant cytokine levels; IL-4 (88-7046), IL-5 (88-7056), IL-17A (88-7176), IL-10 ( 
88-7106), IFNγ (88-7316) and TNFα (88-7346). Briefly, Nunc maxisorp immunoplates 
(sigma Aldrich, Cat. No.  M9410-1CS) were incubated with capture antibody diluted 
in coating buffer overnight at 4°C, were washed with 0.05% Tween-20/PBS. Wells 
were then incubated for 2 hours at room temperature with supernatant or standard 
prepared as according to the protocol. Wells were washed as before and incubated 
with detection antibody diluted in assay diluent. Wells were again washed and 
incubated with Avidin-HRP diluted in assay diluent before being washed and 
incubated with Substrate Solution. Development of ELISAs was stopped by using the 
half-volume of 2M H2SO4. Plates were read at 450/550nm using a plate reader and 
supernatant pg/ml values interpolated from the standard curve using Graph Prism 5 
software.  
A titration was performed on one supernatant to find the optimum dilutions to run the 
supernatants on (figure 2.2). The supernatants were diluted as follows; IFNγ 1/160; 
TNFα 1/80; IL-17A 1/4; IL-4 1/8; IL-5 1/4; and IL-10 1/40.  
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Figure 2.2 Determining the dilution factor required for ELISA. One supernatant 
from a 48 hour stimulation (with the last 3 hours brefeldin A treated) was selected 
and diluted from between 1/8 and 1/256 with RPMI. ELISAs were done on the 
different dilutions for IFNγ, TNFα, IL-17A, IL-4, IL-5 and IL-10, and colorimetric 
results were read at 450/550nm using a plate reader. The readings were plotted 
against their corresponding dilution factor.  
 
2.9 Confocal microscopy 
Confocal microscopy was performed on CD4+ CD45RO+ T lymphocytes that had 
been treated with several concentrations of DFX. Briefly, 1x 106 cells were left to 
equilibrate for 24 hours before being stimulated with 2μg/ml anti-CD3// 5μg/ml anti-
CD28 whilst simultaneously being treated with concentrations of DFX varying 
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between 2.5μM to 10μM. 18 hours later the cells were directly fixed with 
paraformaldehyde to a final concentration of 4%. Fixed cells were washed twice in 
PBS at 4°C and then spun onto cytospins at 300g for 5 minutes. Slides were air dried 
and stored at -20°C until required for staining.  
Staining for confocal microscopy was carried out as follows. Cytospin slides were 
defrosted and blocked with 1% BSA/ PBS for 30 minutes. Anti-HIF-1α 
(Thermoscientific, Hemel Hempstead, UK) (Cat. No. MA1-516) diluted 1/100 in 1% 
BSA/ PBS and incubated on the slides overnight at 4°C. Appropriate isotype controls 
were also used. Slides were washed three times in PBS and incubated with 
secondary antibody conjugated to Cy5 (diluted 1/250) for 1 hour at room 
temperature. Slides were washed as before and placed in 20μg/ml Hoescht solution 
for 1.5 minutes to stain the nucleus. Slides were mounted with a coverslip using 
DABCO and assessed for staining using a Zeiss LSM 510 confocal microscope. To 
analyse slides, ImageJ software was used. Lines were drawn through the nucleus 
and the number of Cy5-positive pixels determined.  
 
2.10 Microarray 
CD4+ CD45RO+ T lymphocytes, derived from the same donor, were stimulated at 
8.5% and 1% oxygen as in section 2.3. RNA was isolated from 48 hour stimulations 
using a Qiagen RNeasy Mini RNA isolation kit. (Qiagen, Manchester, UK) (Cat. No. 
74104). Briefly,cells were pelleted at 300g at then lysed using Buffer RLT. Equal 
volume of 70% ethanol was added and the lysis solution was placed on a silica 
membrane in a spin column. The membrane was washed with Buffer RW1 and Buffer 
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RPE, and the RNA was eluted from the membrane using 30ul RNase-free dH2O. 
RNA in solution was stored at -80°C until required.  
To run the microarray, equal μg of RNA was first converted to cDNA using the 
Qiagen RT2 First Strand Kit (Cat. No.330401). 96μl cDNA was then mixed with 
1350μl Qiagen RT² SYBR® Green qPCR Mastermix (Cat. No  330520) and 12μl 
dH2O and 25μl mix was added to each well of a microarray plate (two plates were 
used, one for the 8.5% oxygen sample, and the other for the 1% oxygen sample). 
The microarray kit used was Qiagen’s Human Th17 for autoimmunity and 
inflammation (Cat. No. 330221), of which the details can be found in the appendices. 
The plates were run on an Applied Biosystems 7500HT rtPCR machine running 1 
cycle for 10 minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C and 1 
minute at 60°C. GAPDH was selected for as the housekeeping gene control.  
 
2.11 Statistical analysis 
For statistical analysis, the Mann Whitney U test was used as a test of non-
parametric, non-paired statistical differences. Graph Prism 5 software was used for 
the generation of graphs and performing statistical analysis.  
 
2.12 Method development 
Fresh/frozen analysis 
Due to the nature of the project, it was necessary to isolate CD4+ CD45RO+ T 
lymphocyte populations from several donors and then freeze them down before using 
them experimentally. The reasons behind this were twofold: Firstly, it allowed one 
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donor’s T lymphocytes to be assessed at several oxygen levels. As only one Don 
Whitley hypoxystation was available for use, the number of oxygen levels that could 
be assessed at one time was limited. Therefore, freezing down samples allowed for 
fractions of an original donation to be used at different times, allowing for some 
homogeneity of donors across the data set. Secondly, it allowed more than one 
donor to be investigated at one time. As the hypoxystation worked by a booking 
system, oxygen levels had to be selected in advance. Due to this time constraint, and 
overall time constraints, it was necessary to have several donors ready to assess for 
each session at a specified oxygen level. As the hypoxystation maintained oxygen 
levels well, experimental variance was limited when investigating the same oxygen 
level at two difference time points.  
The effects of freezing on the CD4+ CD45RO+ T lymphocyte populations on cytokine 
production and markers associated with polarisation was therefore investigated after 
24 hours stimulation at 21% oxygen. As the cells investigated in this thesis were left 
for 24 hours to equilibrate to their oxygen environment, this additional equilibration 
step before stimulation was also included.  
IL-17A, TNFα and IL-10 cytokine secretion appeared to be depressed in the frozen 
population (figure 2.3), whereas IL-4 and IL-5 cytokine production appeared to be 
less affected by freezing. In contrast, IFNγ cytokine production appeared increased in 





Figure 2.3. Assessment of cytokine production from fresh cells and those that 
had been frozen. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi 
MACs CD4+ memory isolation kit and either directly assessed or frozen at -80°C for 
later analysis. ELISA was performed on supernatants of T lymphocytes stimulated for 
24 hours at 21% oxygen (with the last 3 hours brefeldin A treated concurrent with 
subsequent intracellular staining). 2x105 cells were equilibrated to the stated oxygen 
level for 24 hours before stimulation. Supernatant pg/ml was determined before 
further analysis was performed. Six cytokines were chosen for investigation. Cells 
were either assessed directly after isolation from PBMC populations (fresh), or after 
isolation and freezing at -80˚C (frozen). Data shows median values and range. n=3 
per experiment. No significant differences were observed by Mann Whitney statistical 
analysis. Differential effects of the freezing process were observed depending on the 
cytokine concerned.  
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Intracellular cytokine staining was also performed on the two polarisation panels 
described in section 2.7 and the Appendices. A large difference in the FS/SS plots 
was observed between the fresh and frozen cells, with the frozen population 
appearing to split into two different populations – one that did expand in size in 
response to stimulation (as expected), and one that did not (figure 2.5). These 
distinct populations could also be seen in non-stimulated controls (figure 2.4) and 
suggested that freezing cells resulted in a population of cells of diminishing size that 
subsequently appeared to not respond to stimulation (figure 2.5). In these non-
stimulated controls no monocytic populations were observed, further confirming that 
the cells in the stimulation gate in stimulated populations were of lymphocytic origin. 
These non-stimulated controls therefore instructed further selection of FS/SS 
stimulation gates.  
In comparison, most fresh cells all appeared to respond to stimulation, albeit in a 
varied fashion. Therefore, gates were used that selected the cells increasing in size 
in the frozen cell populations, and this also selected the majority of stimulated cells 
within the fresh population. This alteration in cellular responses to stimulation could 
be the reason that a drop in cytokine secretion was observed for IL-17A, TNFα, IL-4 
and IL-10. It is possible that the freezing process inhibited some cells response to 
TCR stimulation.  
Intracellular cytokine staining showed that IFNγ production was again increased in 
cells that had undergone freezing, and, in contrast to the secretion data, so was IL-
17A production (figure 2.5). However, IL-10 production was again depressed in 
frozen cells. With regards to surface markers, CXCR3 and CCR4 also showed a mild 
increase in expression in frozen cells. In contrast, the expression of CCR6 and 
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CTLA-4 was reduced in cells that had been frozen. Freezing, therefore, may select 
for cells that are likely to express certain markers experimentally, or may reduce the 
expression of certain markers within a population. These data, alongside the cytokine 
stimulation data, suggests that frozen T lymphocytes may be altered in their 
response to stimulation compared to freshly isolated T lymphocytes, and the 
differences observed need to be considered in relation to the results presented in 







Figure 2.4. The FS/SS side profiles of non-stimulated fresh and frozen 
lymphocytes are different. CD4+ CD45RO+ T lymphocytes were isolated using a 
Miltenyi MACs CD4+ memory isolation kit and either directly assessed or frozen at -
80°C for later analysis. Forward scatter (FS)/ side scatter (SS) plots are shown here 
for non-stimulated cells freshly isolated (A) and cells that underwent the freezing 
process (B). Cells were plated at 2x105 and left to equilibrate for 24 hours to the 
desired oxygen levels. They were then left for a further 24 hours before analysis on a 
flow cytometer. The star symbol indicates the extra population of lymphocytes that 



















Figure 2.5. Markers associated with T helper subsets were assessed by 
intracellular staining and flow cytometry at 21% oxygen. CD4+ CD45RO+ T 
lymphocytes were isolated using a Miltenyi MACs CD4+ memory isolation kit and 
either directly assessed or frozen at -80°C for later analysis. 2x105 cells were 
equilibrated to the stated oxygen level for 24 hours before stimulation with 2μg/ml 
anti-CD3// 5μg/ml anti-CD28 for 24 hours.  2μg/ml brefeldin A treatment was given for 
the last three hours of stimulation for cytokine analysis. FS/SS plots for the fresh and 
frozen cells are shown in A) showing the selected gate for analysis. As fresh and 
frozen cells differed in their FS/SS plots after stimulation, a gate around the 
stimulated cells in the frozen population was selected for analysis, as this also 
selected the majority of stimulated cells in the fresh populations. The star symbol 
highlights the population observed in cells that had undergone the freezing process 
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that was reduced in size and that did not respond to stimulation. The results from 
staining using the two polarisation staining panels are shown in B). n=3 per 
experiment. No significant differences were observed by Mann Whitney statistical 
analysis. Differences in the responses of several markers were observed when 




3. RESULTS: DO ENVIRONMENTAL OXYGEN LEVELS INFLUENCE CD4+ 
MEMORY T LYMPHOCYTE ACTIVATION AND PROLIFERATION? 
3.1 Introduction 
As T lymphocytes experience several different oxygen levels physiologically, it was 
important to determine whether these alterations had any effect on their biology. 
Within this first chapter the effect of varying oxygen levels on basic CD4+ CD45RO+ 
T lymphocyte biology was examined.   
 
3.1.1Proliferation   
One of the cardinal responses of T lymphocytes to antigenic stimulation is 
proliferation [63, 81]. This serves to increase the number of antigen-specific T 
lymphocytes available, amassing a population of effector cells able to respond to a 
specific antigen, and improving the chances of disease resolution. Central memory T 
lymphocytes are expected to proliferate more in response to stimulation than effector 
memory T lymphocytes [54].  
 
3.1.2 Markers of T cell activation 
Activation markers have been identified that enable the assessment of activated T 
lymphocytes within a population. These markers are generally upregulated on the cell 
surface post-stimulation and are classified on the timings of their expression. CD69 is 
a very early marker of activation, whereas intermediate markers include CD25 and 
CD71. HLA-DR is a late activation marker [308]. Within the rheumatoid joint CD69 
and HLA-DR expression has been observed on CD4+ T lymphocytes [170], whereas 
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intermediate markers are not as well expressed. This is somewhat confusing, and 
suggests that CD69 expression may be sustained in the rheumatoid joint abnormally. 
We therefore initially investigated the effect of differing oxygen levels on CD69 and 
HLA-DR expression. 
3.1.2.1 CD69 
CD69 is a heavily glycosylated C-type II lectin present on the surface of cells as a 
homodimer with no known extracellular ligand or receptor. The cd69 gene is found 
within the natural killer gene complex on chromosome 12 [169, 309-311]. In T 
lymphocyte biology, CD69 is one of the first activation markers upregulated in 
response to T lymphocyte stimulation. Time taken for expression can be dependent 
on the stimulation method used. Following PHA stimulation, CD69 expression is 
initially detected 3 hours post-activation with a peak in expression at around 15 hours 
[308]. After TCR engagement, CD69 transcripts can be detected within the first hour 
post stimulation, and surface expression peaks between 18-24 hours [312].  
Thymocytes express CD69 [313], and a role for CD69 has been identified in the 
regulation of lymphocyte egress from the thymus and lymph nodes [314] by binding 
the sphingosine-1-phosphate receptor resulting in its internalisation. Sphingosine-1-
phosphate (S1P) is expressed at increasing gradients in lymph nodes and the 
thymus. When bound to its receptor on thymocytes and lymphocytes, S1P promotes 
egress, for example, by promoting migration into cortical sinuses in the lymph node. 
CD69 internalisation of the S1P receptor therefore inhibits this process, maintaining 




CD69 expression is also found in chronic inflammatory environments. The 
rheumatoid joint and infiltrating tumour lymphocytes have all been shown to express 
high levels of CD69, suggesting the cells within these environments have been 
recently or persistently activated [40, 170, 311, 316]. One study found that around 
60% of CD4+ T lymphocytes from RA synovial tissue were CD69 positive [40]. As 
CD69 expression is observed alongside late activation markers in the RA joint [170], 
its expression may not only be a marker for recently-activated T lymphocytes, but 
also be associated with a particular population of T lymphocyte found in chronic 
inflammatory environments. Furthermore, anti-CD69 autoantibodies are found in 
some patients with RA [317, 318] but the role CD69 may play in chronic inflammatory 
sites is somewhat controversial, with opposing results reported [317, 319, 320].  
 
3.1.3 General surface markers of CD4+ T lymphocytes 
3.1.3.1 CD45RO 
CD45 is a key molecule involved in the regulation of T lymphocyte signalling. CD45 
can be extensively glycosylated and is therefore a relatively large molecule on the 
lymphocyte cell surface [160]. It comprises around 10% of the total surface protein in 
T lymphocytes but has no known ligand [160, 161]. However, it has several biological 
functions, including the dephosphorylation of both the inhibitory and activatory 
tyrosine residues on the Lck molecule [73, 85, 90, 160, 161]. Indeed, CD45 
dephosphorylation of Y394 is associated with the termination of signalling in the IS 
[70, 73]. CD45 therefore plays a key role in T cell signalling, and its knockout results 
in an increase in both positive and negative selection [73]. Despite this, CD45 is 
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thought to be excluded from the IS due to its large size, potentially limiting its contact 
with its substrates during stimulation [67, 70].  
There are several different isoforms of CD45 differing in their extracellular domains 
[160]. Naïve and memory T lymphocytes can be separated by their expression of the 
CD45RA and CD45RO isoforms, respectively. Indeed, these markers are used for 
the magnetic isolation of these different cell populations. CD45RO isoforms have 
smaller extracellular domains than their RA counterparts due to exon splicing [160]. 
CD45RA to RO isoform switching begins within the first 48 hours post-stimulation of 
naïve T lymphocytes, and CD45RO is also a marker for recently activated CD4+ T 
lymphocytes [148]. Isotype switching may have several effects – it may allow the 
CD45RO monomers to dimerise more easily, potentially resulting in the 
downregulation of phosphatase activity. Alternatively, the smaller space occupied by 
the CD45RO molecule in the extracellular milieu may allow it to migrate more easily 
into the signalling synapse formed between a T lymphocyte and an APC [85]. 
 
3.1.3.2 CD3 
CD3 is regularly used to identify T lymphocyte populations. There are four CD3 
subunits  that form hetero- or homo- dimers within the cell: CD3ε, CD3γ,CD3 δ and 
CD3ζ. [67]. As described in chapter 1, the CD3 subunits complex with the TCR and 
provide intracellular cytoplasmic domains for downstream signalling from the 
TCR:CD3 protein complex post-TCR ligation. Through mechanisms still being 
elucidated, CD3 ITAM motifs are phosphorylated, allowing for docking of downstream 
signalling molecules [67, 321]. After T lymphocyte activation, TCR:CD3 complex 
expression is reduced [322-325] limiting any further TCR ligation and subsequent 
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stimulation. T lymphocytes start to re-express the TCR:CD3 complex around two 
days after stimulation, but rates of re-expression vary and depend on the length of 
initial stimulation [322].  
 
3.1.4 This chapter’s aims 
In this chapter the effect of hypoxia on basic T lymphocyte biology has been 
investigated. CD4+ CD45RO+ T lymphocytes were isolated from PBMC populations 
and frozen at -80˚C until required. Proliferation, expression of activatory and 
identifying markers, cell size and complexity, and viability were examined to provide 
initial clues as to the effect of varying oxygen level on the biology of CD4+ CD45RO+ 
T lymphocytes. Immunofluorescent staining and flow cytometry were utilised in these 
assessments. The FS/SS stimulation gates were determined by comparison to non-






3.2.1 Physiologically healthy oxygen levels promote increased proliferation in 
CD4+ effector memory T lymphocytes 
CD4+ memory T lymphocytes were isolated from healthy control PBMC populations 
and frozen at -80°C. When required, they were defrosted and loaded with CFSE and 
equilibrated at the desired oxygen level for 24 hours. They were then stimulated with 
plate-bound anti-CD3/ anti-CD28 and left to proliferate for four days. Proliferation was 
assessed by flow cytometry and the stimulated cells were gated upon for analysis 
(figure 3.1B). Equal sized bars were applied to each peak representing a division. 
Non-stimulated controls were also left for four days to confirm CFSE integrity over 
time (figure 3.1A). This also showed that it was the lymphocyte population that had 
expanded into the stimulation gate selected in figure 3.1B. The cells that had not 
responded to stimulation have previously been shown to be lymphocytes that 
respond differently to the freezing process (figure 2.4 and figure 2.5).  
Proliferation at 21% oxygen was significantly lower than at 8.5%, 3% and 1% oxygen 
(figure 3.1E). Fewer cells initiated cell division at 21% oxygen, despite their cell size 
increasing into the stimulation gate and hence resulting in their inclusion within the 
results (figure 3.1C). Proliferation at 21% oxygen appeared inhibited after 3 rounds of 
division, as a large drop was observed in the number of cells completing four rounds 
of division compared to those completing three (figure 3.1D). This is also revealed in 
the proliferative index (PI) (figure 3.1E), which highlights the depressed rounds of 
divisions. This index is generated by dividing the total number of cells in the 
stimulation gate by the estimated number of starting cells, and so gives an arbitrary 
measurement of proliferation. 
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Significantly enhanced proliferation was observed at 8.5% oxygen, and a step-wise 
decrease occurred as oxygen became less available (figure 3.1C). At 8.5% oxygen, 
more cells entered 4 or 5 rounds of division compared to the other oxygen levels, 
(figure 3.1D) and the PI was highest (figure 3.1E). This therefore suggested that cells 
were most likely to divide at this oxygen level.  
At lower oxygen levels the number of cellular divisions was reduced in comparison 
but 3% oxygen provided a relatively good environment for proliferation, having the 
second highest number of cells entering five rounds of division compared to 8.5% 
oxygen. Reperfusion injury and constant 1% oxygen differed slightly in their 
proliferation profiles, with the exposure to higher oxygen in reperfusion injury 
treatments resulting in slightly more cellular divisions than constant 1% oxygen in 
which proliferation appeared to be more depressed. These results therefore 
suggested that physiological variances in oxygen level can influence downstream 
proliferative responses. Consequently, lymphocytes may proliferate more readily in a 







Figure 3.1 (Part 1) Proliferation of CD4+ memory T lymphocytes is increased at 
physiologically healthy oxygen levels. CD4+ CD45RO+ T lymphocytes were 
isolated using a Miltenyi MACs CD4+ memory isolation kit and were frozen at -80°C 
for later analysis. Once required, CD4+ memory T lymphocytes were defrosted and 
loaded with 1μM CFSE and plated at 2x105 cells before being equilibrated to the 
stated oxygen level for 24 hours. They were then stimulated with plate bound anti-
CD3/ anti-CD28 and left for 4 days when proliferation was determined. A) Non-
stimulated lymphocytes after 4 days stimulation and their corresponding CFSE 
loading as assessed by the 488 laser. B) Stimulated lymphocytes from the same 
donor as in (A) after 4 days stimulation. Gating strategy used showing selection of 





Figure 3.1(Part 2) Proliferation of CD4+ memory T lymphocytes is increased at 
physiologically healthy oxygen levels.  C) Example CFSE plots after 4 days 
stimulations at different oxygen levels. Black box shows 5 cell divisions. D) A line 
graph to depict the number of cell divisions at each oxygen level. All data obtained 
were included in this summarisation. E) The proliferative index was determined by 
dividing the total number of cells with the estimated number of original cell (as 
determined from the gates applied). Data shows the median values. Analysis was 
performed using Mann Whitney statistical test. *=p<0.05, ***=p<0.001. # p<0.05 for 
8.5% oxygen compared with 1% oxygen, and p<0.005 for 8.5% compared to 21%, 
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after 5 divisions. 1%C = constant 1% oxygen. 1% IR = 1% oxygen with reperfusion 
injury. Data is representative of a minimum of 7 donors per oxygen level, from 3 or 
more separate experiments and is representative of at least 2500 cells in the 




3.2.2 Cell viability after four days stimulation is reduced at 8.5% oxygen 
Cell viability was assessed by Sytox staining after four days stimulation (the same 
duration of stimulation used for assessment of proliferation).  At 8.5% oxygen, an 
increase in the number of Sytox-positive cells was observed compared to the other 
oxygen levels (figure 3.2). This suggested that the cells were the least viable at this 
oxygen level. At the other oxygen levels there were no significant differences in 
viability suggesting that the difference in oxygen availability does not influence cell 
viability in hyper- or hyp- oxia, atleast in pure CD4+ CD45RO+ T lymphocyte 


























Figure 3.2. The number of Sytox positive cells is increased at 8.5% oxygen. 
CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs CD4+ memory 
isolation kit and were frozen at -80°C for later analysis. Once required, cells were 
defrosted and 2x105 T lymphocytes were equilibrated for 24 hours at the desired 
oxygen level before being stimulated with plate bound anti-CD3/anti-CD28. After four 
days the cells were stained with Sytox Dead Cell stain and assessed by flow 
cytometry using the 405 laser. A) shows the gate selection applied to stimulated cells 
(stimulated cells were selected as these were the cells assessed in other analysis 
and therefore made the data comparable) and the histograms obtained from this 
data. Bars in histograms were set within <1% of non-sytox treated cells. B) 
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Summarisation of sytox assessment at different oxygen level.  Analysis was 
performed using Mann Whitney statistical test.*=p<0.05. 1%C = constant 1% oxygen. 
1% IR = 1% oxygen with reperfusion injury. Data is representative of at least 2500 
cells in the stimulation gate and median values are shown. A minimum of 4 donors 
were examined at each oxygen level. An increase in the number of Sytox positive 
cells was observed at 8.5% oxygen, suggesting that viability was reduced at this 
oxygen level.  
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3.2.3 The expression of the activation marker CD69 is increased in hypoxia 
The expression of the early activation marker, CD69, was altered at varying oxygen 
levels. Both the percentage of CD69 positive cells and the intensity of CD69 
expression, as determined by the mean fluorescence intensity (MFI), were 
upregulated at constant 1% oxygen after 48 hours stimulation (figure 3.4 and figure 
3.3A, respectively). Both 3% oxygen and reperfusion injury treated cells showed a 
slight drop in CD69 expression in comparison, having equivalent average CD69 MFI 
values. 
At the physiologically healthy oxygen levels of 8.5% oxygen for the joint, both the 
percentage of CD69 positive cells and intensity of CD69 expression were the most 
reduced compared to other oxygen levels, although a similar drop in expression was 
observed at 21% oxygen (figures 3.3 and 3.4).  
CD69 is an early activation marker normally downregulated 24 hours post-stimulation 
[310, 312]. Cell cycle inhibition in hypoxic conditions has been reported previously 
[282] and therefore the increased CD69 expression detected at 48 hours at 1% 
oxygen could have been  due to the CD4+ T lymphocytes being ‘stuck’ in their 
progression when exposed to hypoxia. The delay in proliferation at lower oxygen 
levels also suggested that this could be the case. CD69 expression was therefore 
further examined after 24 hours stimulation. Constant 1% oxygen and 8.5% oxygen 
were selected for these additional experiments as these two oxygen levels revealed 
the extremes in CD69 expression after 48 hours stimulation.  
An upregulation in expression at the lower oxygen level was again observed (figure 
3.5), suggesting that the upregulation at 48 hours observed was not necessarily due 
to the cells in hypoxia falling behind their 8.5% oxygen counterparts in cell cycle and 
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expression profiles, but because CD69 upregulation was an intrinsic response of 
CD4+ T lymphocytes to hypoxia. After 24 hours stimulation at 8.5% oxygen, CD69 
expression MFI values did not reach the values obtained at 1% oxygen after 48 
hours stimulation, further revealing the decreased CD69 expression at 8.5% oxygen.  
No differences in the percentage of the HLA-DR positive cells after 48 hours 
stimulation were observed at varying oxygen levels (figure 3.4B), suggesting that late 
























Figure 3.3. Varying responses of the activation marker CD69 associated with 
CD4+ T lymphocytes stimulated at different oxygen levels. CD4+ CD45RO+ T 
lymphocytes were isolated using a Miltenyi MACs CD4+ memory isolation kit and 
were frozen at -80°C for later analysis. Once required, cells were defrosted and 
2x105 T lymphocytes were equilibrated for 24 hours at the desired oxygen level 
before being stimulated with plate bound anti-CD3/anti-CD28. T lymphocytes were 
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stimulated for 48 hours at the stated oxygen levels. Cells were stained for expression 
of CD69 (APC-Cy7) and CD45RO (PE) and assessed by flow cytometry. A) Example 
forward scatter (FS)/ side scatter (SS) plots for analysis. The SS was depressed as 
cell counting beads were occasionally used alongside this protocol. Example dot 
plots of CD45RO vs CD69 expression are shown from one donor at the different 
oxygen levels investigated. Quadrants were applied with respect to the respective 
isotype control ran on the same day at the same oxygen level. B) shows the CD69 
MFI values at the different oxygen levels investigated. Median values are shown. 
Statistical analysis was performed using Mann Whitney test. 1%C = constant 1% 
oxygen. 1% IR = 1% oxygen with reperfusion injury. * p< 0.05, **p< 0.01, ***p<0.001. 
Data is representative of at least 2500 cells in the stimulation gate. A minimum of 8 

















Figure 3.4 The percentage of CD69 and HLA-DR positive cells at different 
oxygen levels. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs 
CD4+ memory isolation kit and were frozen at -80°C for later analysis. Once 
required, cells were defrosted and 2x105 T lymphocytes were equilibrated for 24 
hours at the desired oxygen level before being stimulated with plate bound anti-
CD3/anti-CD28. T lymphocytes were stimulated for 48 hours at the stated oxygen 
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levels. Cells were stained for expression of CD69 (APC-Cy7) and CD45RO (PE) or 
HLA-DR (APC-Cy7) and CD3 (PE) and assessed by flow cytometry using stimulation 
gates as in figure 3.3. The percentage of A) CD69 and B) HLA-DR positive cells are 
shown. Example dot plots of HLA-DR vs CD3 are shown in B) against the equivalent 
isotype control (the same donor ran on the same day after stimulation at the same 
oxygen level). Median values are shown. Statistical analysis was performed using 
Mann Whitney test. * p< 0.05, **p< 0.01, ***p<0.001.1%C = constant 1% oxygen. 1% 
IR = 1% oxygen with reperfusion injury. Data is representative of at least 2500 cells 
in the stimulation gate. A minimum of 6 donors were investigated at each oxygen 
level. The percentage of CD69 positive cells was increased at lower oxygen levels, 




Figure 3.5. CD69 expression is upregulated at 24 and 48 hours in hypoxia 
compared to 8.5% oxygen. CD4+ CD45RO+ T lymphocytes were isolated using a 
Miltenyi MACs CD4+ memory isolation kit and were frozen at -80°C for later analysis. 
Once required, cells were defrosted and 2x105 T lymphocytes were equilibrated for 
24 hours at the desired oxygen level before being stimulated with plate bound anti-
CD3/anti-CD28. T lymphocytes were stimulated for 24 and 48 hours at 8.5% and 
constant 1% oxygen. Cells were stained for expression of CD69 and assessed by 
flow cytometry, with stimulated cells selected for as in figure 3.3. Median values are 
shown in the data with the range. Statistical analysis was performed using the Mann 
Whitney test. ***= p<0.001 at 48 hours between 1% and 8.5% oxygen. **=p<0.01 
between 24 and 48 hours in 8.5% oxygen treatments. Data is representative of at 
least 2500 cells in the stimulation gate and a minimum of n=6 at each treatment at 
each time point.  A drop in CD69 expression was observed over time at both oxygen 




3.2.4 The expression of other surface markers is altered at different oxygen 
levels 
3.2.4.1 CD45RO 
CD45RO expression was expressed on all of the cells used experimentally in this 
chapter. Over 95% CD45RO positivity was therefore a precondition of every culture, 
therefore the intensity of its expression per oxygen level could be assessed by 
determining the MFI after flow cytometry.  
CD45RO expression intensity is not reported to change in response to antigenic 
stimulation [73]. However, a greater intensity in CD45RO expression at 3% oxygen 
compared to the other oxygen levels investigated was observed, significantly in 
comparison to 8.5% oxygen. At 21% oxygen, constant 1% oxygen and 1% oxygen 
with reperfusion injury, CD45RO levels appeared similar (dot plots figure 3.3 and 
graphs figure 3.6B).   
 
3.2.4.2 CD3 
The TCR:CD3 complex is thought to be internalised and recycled as a complete 
complex after antigenic stimulation [322-324] and therefore any component of the 
complex can be assessed to make general investigations into its overall surface 
expression level. We selected an antibody against CD3ε to examine the expression 
of the complex on the membrane surface, as it has been used as a marker to 
observe the cycling of the TCR:CD3 complex previously [323].  
After 48 hours expression of CD3ε expression at constant 1% oxygen was increased 
compared to the other oxygen levels assessed (figure 3.6A). This result was similar 
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to the pattern of CD69 expression and therefore led us to also examine the 
expression of CD3ε after 24 hours stimulation, again at constant 1% and 8.5% 
oxygen. Results from these experiments revealed a pattern of expression that 
differed from the surface expression of the CD69 molecule (figure 3.7). Expression at 
8.5% oxygen was slightly increased compared to 1% oxygen treatments after 24 
hours. Stimulation at 8.5% oxygen followed the expected pattern of downregulation 
of CD3ε expression over time. However, the pattern of CD3ε surface expression at 




























Figure 3.6. Alternative markers of CD4+ memory T lymphocytes reveal variable 
expression at different oxygen levels. CD4+ CD45RO+ T lymphocytes were 
isolated using a Miltenyi MACs CD4+ memory isolation kit and were frozen at -80°C 
for later analysis. Once required, cells were defrosted and 2x105 T lymphocytes were 
equilibrated for 24 hours at the desired oxygen level before being stimulated with 
plate bound anti-CD3/anti-CD28. T lymphocytes were stimulated for 48 hours at the 
stated oxygen levels. Cells were stained for expression of CD45RO (PE) and CD3 
(PE) and assessed by flow cytometry using stimulation gates as in figure 3.3 and 
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shown in (A). The mean fluorescence intensity (MFI) of A) CD3ε and B) CD45RO 
expression are shown with median values. 1%C = constant 1% oxygen. 1% IR = 1% 
oxygen with reperfusion injury. Statistical analysis was performed using the Mann 
Whitney test * p< 0.05.  ***p<0.001. Data is representative of at least 2500 cells in 
the stimulation gate and a minimum of n=5 per oxygen level. Differences in CD3ε 




Figure 3.7. CD3ε expression over time has different patterns of expression at 
different oxygen levels. CD4+ CD45RO+ T lymphocytes were isolated using a 
Miltenyi MACs CD4+ memory isolation kit and were frozen at -80°C for later analysis. 
Once required, cells were defrosted and 2x105 T lymphocytes were equilibrated for 
24 hours at the desired oxygen level before being stimulated with plate bound anti-
CD3/anti-CD28. T lymphocytes were stimulated for 24 and 48 hours at 8.5% and 
constant 1% oxygen. Cells were stained for expression of CD3ε and assessed by 
flow cytometry, with stimulated cells selected for as in figure 3.3. Median values are 
shown in the data with the range. Statistical analysis was performed using the Mann 
Whitney test. ***= p<0.001 at 48 hours between 1% and 8.5% oxygen. **=p<0.01 
between 24 and 48 hours in 8.5% oxygen treatments. Data is representative of at 
least 2500 cells in the stimulation gate and a minimum of n=5 at each treatment at 
each time point.  A drop in CD3e expression was observed over time at 8.5% oxygen 
levels, but was increased over time at 1% oxygen.  
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3.2.5 Cell size and granularity is altered at different oxygen levels 
To determine whether the alterations in surface molecule expression were due to 
differences in cell size, the forward scatter (FS) results obtained from the flow 
cytometry assessment of activation marker expression were analysed. This revealed 
a pattern of significantly decreased cell size at 3% oxygen compared to the oxygen 
levels (figure 3.8A). Highest cell size was observed at 8.5% and constant 1% oxygen. 
However, there was no correlation between CD69 MFI, which was greatest at 1% 
oxygen, and FS mean (figure 3.8B). As this pattern also did not correlate with CD3ε 
or CD45RO expression, it is likely that differences in surface marker expression 
intensity were not due to differences in cell size.  
Differences in the granularity of the cells could also be assessed by using the side 
scatter (SS) data from the flow cytometry assays due to the fact that the cell 
populations were over 95% pure. Granularity values varied somewhat over time due 
to equipment variability, but a pattern was apparent after stimulation at different 
oxygen levels (figure 3.8C). Granularity increased as oxygen level decreased, with 
the highest granularity observed at constant 1% oxygen after 48 hours stimulation 








Figure 3.8. Cell size varies considerably at different oxygen levels after 48 
hours stimulation, but does not correlate with CD69 expression. CD4+ 
CD45RO+ T lymphocytes were isolated using a Miltenyi MACs CD4+ memory 
isolation kit and were frozen at -80°C for later analysis. Once required, cells were 
defrosted and 2x105 T lymphocytes were equilibrated for 24 hours at the desired 
oxygen level before being stimulated with plate bound anti-CD3/anti-CD28. T 
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lymphocytes were stimulated for 48 hours at the stated oxygen levels. Flow 
cytometry was used to assess cell size according to the linear forward scatter (FS) 
mean (A) and cell granularity according to linear side scatter (SS) mean (C). 
Stimulated cells were selected on from the lymphocyte populations. Statistical 
analysis was performed using Mann Whitney test and median values are shown. 
**=p<0.01, ***=p< 0.001.  Cell size varies considerably depending on the oxygen 
level stimulated at, with a reduction in cell size observed at 3% oxygen. B) 
Correlation of CD69 MFI vs linear forward scatter mean was analysed by determining 
the Spearman Rank Correlation Coefficient. No correlation was observed. Data is 
representative of at least 2500 cells in the stimulation gate. A minimum of 28 FS/SS 




The data presented within this chapter reveal the varied response of CD4+ T 
lymphocytes to different environmental oxygen levels. Proliferation and surface 
protein expression were altered at different oxygen levels and basic cellular biology, 
such as size and granularity, also appeared to differ. Hence, the data supports the 
hypothesis that environmental oxygen influences CD4+ CD45RO+ T lymphocyte 
function.   
 
3.3.1 Proliferation 
Memory T lymphocytes proliferate more readily than naïve T lymphocytes due to their 
lower threshold for activation [63], and within the CD4+ CD45RO+ memory T 
lymphocyte population it is expected that the central memory compartment would 
proliferate the most readily compared to effector memory T lymphocytes [54, 58]. 
Therefore, it is possible the data obtained in this study regarding proliferation is 
mainly descriptive of the central memory response to different oxygen levels. 
Proliferation appeared inhibited in 21% oxygen, and this was contradictory to 
previous reports. However, much of this literature has focussed on naïve and mixed 
CD4+ T lymphocyte populations. Memory T lymphocytes are generated from, and 
are thus adapted to, previous infectious stimuli, and therefore may be more tailored 
to function in an oxygen environment much lower than 21%. 
At the physiological healthy oxygen level of 8.5% an increase in proliferation was 
observed compared to both hyper- and hypo- oxic conditions (figure 3.1), suggesting 
that this may be close to the optimum oxygen level required for maximal CD4+ T 
lymphocyte proliferation. Indeed, the increase in the number of cells produced after 
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four days stimulation could have contributed to the decrease in cell viability observed 
at 8.5% oxygen (figure 3.2), as visually the cultures were larger at 8.5% oxygen (as 
observed with a brightfield microscope) and became more acidic (as observed by the 
colour of the culture medium), most probably due to increased lactic acid caused by 
increased cellularity. Further studies where cell medium is replenished mid-
experiment may help to determine whether this was the reason for decreased cell 
viability at physiologically healthy oxygen levels. This would also replenish nutrients 
such as the essential amino acid tryptophan, which when lost from the local 
environment can result in T lymphocyte apoptosis [326].  
The greater proliferation observed at 8.5% oxygen may highlight the ‘healthiness’ of 
this oxygen level, as it may provide the cells with the right amount of oxygen for 
cellular division, but not place too much of an oxidative strain to inhibit cellular 
processes. Investigation of proliferative responses at 8.5% oxygen is, to our 
knowledge, novel, and this condition may represent what is present when T 
lymphocytes are stimulated in well-perfused tissues. However, this is unlikely 
physiologically, as CD4+ memory T lymphocyte stimulation will normally occur in 
oxygen-low tissues such as the thymus [243, 245, 246], lymphoid organ [239, 245] 
and inflamed tissue [9]; tissues not thought to reach 8.5% oxygen. The reduction in 
proliferation at lower oxygen levels, however, provides further evidence that the 
oxygen environment regulates CD4+ T lymphocyte responses. This limitation of 
proliferation may be beneficial, as overt proliferative responses can be associated 
with pathology [327]. Significant differences in cell size at different oxygen levels may 





3.3.2 The activation marker CD69  
In this study, an increase in CD69 expression was observed in constant 1% oxygen 
after both 24 and 48 hours stimulation. This upregulation appeared to be much 
greater than that observed at 8.5% oxygen (figure 3.4). Increasing CD69 expression 
at 5% oxygen compared to 21% oxygen has been previously reported, [244, 288] 
which is in slight contrast with the results found in this study, as both 8.5% and 3% 
oxygen revealed a slight drop in CD69 expression compared to 21% oxygen. The 
reasons for this difference may be due to the use of CD4+ CD45RO+ T lymphocytes 
experimentally. The increase in the percentage of cells expressing CD69 at constant 
1% oxygen suggested that the cells at this oxygen level may have been more 
activated, but the proliferation data suggested otherwise. Therefore, it could be 
possible that cells at 1% oxygen immediately ‘fall behind’ higher oxygen level 
treatments after stimulation, resulting in a lengthier expression of CD69, and a lower 
proliferative response. Although CD69 is a marker of activation per se, the intensity of 
its expression may therefore not reflect a cells level of activation.  
 
The increased CD69 expression observed in the RA joint alongside late markers of 
activation corroborates with this in vitro data, as both environments would have been 
hypoxic. Therefore, low environmental oxygen levels may result in altered CD69 
expression compared to what is normally observed in 21% oxygen in vitro 
experiments. CD69 does not seem to play a large role in T lymphocytes activation 
(although cross-linking can result in cell proliferation [313]) but its upregulation in 
hypoxia may still influence T lymphocyte downstream biological functions. For 
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example, CD69 is involved in inhibiting cell egress out of tissues [314, 315] and 
therefore may contribute to the ‘stuck’ phenotype of T lymphocytes in the RA joint 
[306]. A second potential role for CD69 is in cell contact between T lymphocytes and 
macrophages [28, 169, 195], particularly in inducing TNFα production [194, 195]. 
Synovial T lymphocytes have been found to be able to elicit TNFα production from 
monocytes, and this cell-contact dependent activity has been implicated as the main 
source of TNFα in the RA joint [40, 194, 195]. Blocking CD69 significantly reduces 
this production [195].  
 
3.3.3 General markers of CD4+ memory T lymphocytes 
In resting cells, the maintenance of the TCR:CD3 expression at the membrane is an 
active process, with constant recycling of the complex [323]. The detection of the 
TCR:CD3 complex on the surface of CD4+ T lymphocytes is reduced after 
stimulation [322-325] but there is some disagreement as to how. Some studies 
observe a decrease in exocytosis [323], others an increase in endocytosis [325], 
whereas another described a decrease in the TCR:CD3 complex half-life post-
stimulation [324]. Recent data suggesting TCR-containing microvesicles are released 
from the immunological synapse post-stimulation may also provide an additional 
mechanism by which TCR:CD3 complex expression is reduced post-stimulation [72].  
In this study the effect of hypoxia on the TCR:CD3 complex was investigated by 
assessing surface expression of CD3ε. Significant differences in the expression of 
CD3ε after 48 hours stimulation at different oxygen levels were observed (figures 3.5 
and 3.6), with an increase at lower oxygen levels compared to physiologically healthy 
oxygen levels. Further investigations revealed that the pattern of CD3ε over time was 
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altered dependent on which oxygen level they were maintained at. At 8.5% oxygen 
CD3ε expression continued to decrease to 48 hours, which would be expected with 
the duration of stimulation provided [322]. At constant 1% oxygen, however, 
expression rose significantly from 24 to 48 hours (figure 3.6). This could be due to an 
increase in TCR:CD3 recycling in hypoxia, with more CD3 being returned to the 
surface of the cell after the initial downregulation. An increase in cellular granularity 
was observed at 1% oxygen (figure 3.7C), but unfortunately could not be correlated 
with CD3 expression due to equipment variance over time. However, this granularity 
could be due to increased vesicle cycling, and this could result in increased 
expression of recycled proteins on the surface membrane. This pattern could also be 
due to an upregulation in expression in hypoxia or an increase in TCR:CD3 release 
over time at 8.5% oxygen. Functionally, these results could mean that re-stimulation 
may occur more rapidly at lower oxygen levels, whereas re-stimulation may be 
limited at 8.5% oxygen. Furthermore, it has been previously reported that a longer 
stimulation period results in a more delayed re-expression of the TCR:CD3 complex 
[322] and in this study cells were not removed from stimulation plates. Future 
investigations where cells are removed from stimulation plates after a shorter amount 
of time may provide more clarity as to the effect of different oxygen levels on 
TCR:CD3 expression. 
CD45 is one of the most highly expressed molecules on the surface of lymphocytes 
[160]. In the current study the CD45RO isotype was assessed as it is expressed on 
the memory T lymphocytes present within the populations [160]. At 21% oxygen, 
constant 1% oxygen and reperfusion treatments, the oxygen levels thought to most 
upregulate ROS (due to over-exposure to oxygen, hypoxic-mitochondrial leak, and 
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mitochondrial over-production post-ischemia, respectively), CD45RO levels were 
similar. However, an increase in CD45RO expression at 3% oxygen was observed 
and may give some clues as to the effect of further re-stimulations would have on 
cells in this environment.  
As CD45RO is smaller than other isotypes, it may be able to diffuse more easily into 
the IS formed between an APC and a lymphocyte, and thereby may be one of the 
reasons for the differences in activation threshold between naïve and memory T 
lymphocytes. Knock-down and over-expression studies have given some insight into 
how it regulates lymphocyte activation [88, 160, 328] and suggest that CD45RO 
expression levels may need to be tightly controlled to allow for proper T lymphocyte 
signalling and function. Overexpression of CD45RO resulted in increased 
downstream signalling after TCR activation and increased proliferation [328].  
Furthermore, an increase in negative selection was observed in CD4+CD8+ double 
positive thymocytes overexpressing CD45RO, suggesting that a larger proportion of 
the thymocyte population had received larger intracellular signals in response to 
thymic antigen presentation, and that these signals had been higher than the 
threshold required to initiate cell apoptosis [328]. Therefore the upregulation at 3% 
oxygen may be a regulatory response if further stimulation should occur. However, 
the CD45RO pattern of expression would need to be maintained until re-stimulation 
for this to play any role in deciding cell fate. This cannot be confirmed from the 
current data and CD45RO expression would need to be examined over a longer time 
period to further assess whether this is the case. 
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4. RESULTS: DO ENVIRONMENTAL OXYGEN LEVELS INFLUENCE CD4+ 
MEMORY T LYMPHOCYTE POLARISATION AND CYTOKINE PRODUCTION? 
4.1 Introduction 
In the previous chapter the basic biology of CD4+ T lymphocyte responses to 
stimulation were assessed. In this chapter another cardinal response to stimulation is 
examined; CD4+ CD45RO+ T lymphocyte cytokine production and polarisation. As 
CD4+ central memory T lymphocytes are not expected to produce much effector 
cytokine immediately post-stimulation in response to artificial stimulation (and in the 
absence of exogenous polarising conditions), except for IL-2 [64, 98], it has been 
assumed that most of the data obtained is relevant to effector memory T lymphocytes 
present within our populations. However, central memory T lymphocytes may 
immediately produce cytokine when stimulated with the antigen they are specific for, 
or with bacterial toxins [329]. Therefore, in a less artificial system, central memory T 
lymphocytes may have the ability to rapidly contribute to the cytokine milieu present 
in the lymph node.  
Pro-inflammatory Th1 and Th17 cells play an important role in controlling infection 
but are also thought to be involved in the chronic inflammation observed in 
autoimmune diseases [31, 176, 180, 184] - physiological environments that are often 
hypoxic [199, 200, 202, 204, 208]. Th2-like responses are more commonly 
associated with allergic immune responses. This can involve tissues that are well 
oxygen-perfused, such as the airway [47, 115, 116], but also hypoxic sites such as 
the skin [330]. It therefore is interesting to examine whether environmental oxygen 
levels can influence and regulate the development of different T helper cell subsets.  
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Cytokines are often used to aid the classification of T helper cells, but there are 
alternative markers also associated with the distinct subsets, including chemokine 
receptors. Chemokines and their receptors are of vital importance in the organisation 
of T lymphocyte biology [331] and their expression varies on T helper effector and 
effector memory cells. CXCR3 is a chemokine receptor upregulated on naïve T 
lymphocytes post-stimulation [332]. Its expression is lost over time on cells polarised 
to a Th2 phenotype, but is maintained on Th1 cells [332]. CXCR3 expression is 
associated with autoimmune disease infiltrates [63, 333, 334], and the expression of 
its chemokine ligands have also been observed in autoimmune sites such as the 
inflamed RA synovium [175, 334]. These ligands include CXCL9, CXCL10 and 
CXCL11 [331, 333, 335] and are expressed highly by DCs and macrophages [332].  
CXCR3+ lymphocytes have been found to preferentially migrate into inflammatory 
sites in graft-versus-host-disease (GVHD) with high serum levels of CXCL9 and 
CXCL10 [336]. This increased migration resulted in a reduction in peripheral blood 
CXCR3+ cells, highlighting that examinations of the cellular content of peripheral 
blood cannot always be diagnostic or conclusive about ensuing inflammatory 
responses [336]. CXCR3 is thought to be important in the specific generation of Th1 
cells in the lymph node, especially via CXCL10 [335], which may provide some 
explanation for its sustained expression on this particular cell type. Within the lymph 
node, IFNγ positive cells have a higher CXCR3 MFI, and CXCR3 expression is 
required for proper IFNγ production in response to viral antigens [331]. With regards 
to pro-inflammatory Th17 cells, CCR6 was originally identified as being associated as 
a Th17 marker from an animal model of RA, and responds to the chemokine ligands 
CCL20 [32]. CCR6 expression has been observed in human RA [31] and has also 
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been detected in Reactive Arthritis [188]. However, Th17 cells differentiating to a 
more Th1-like phenotype are also thought to maintain their CCR6 expression [123], 
so the use of it as a marker for Th17 cells has to be done with caution.  
CCR4 is a marker associated with Th2 cells [331, 337], and is a chemokine receptor 
for the ligands CCL17 and CCL22 [331]. CCR4 has been used to identify Th2 cells in 
many previous studies [100, 118, 337], and more recently an upregulation of CCR4 in 
peripheral blood T lymphocytes was found associated with hyper-immunoglobulin E 
syndrome, where overt IgE production results in an atopic phenotype [338], again 
suggesting its expression is associated with a Th2 phenotype. Interestingly, an 
increase in CCR4 expression has been observed in RA, ankylosing spondylitis and 
systemic lupus erythematosus patient’s blood [179]. As all three of these conditions 
are associated with antibody production [4, 339, 340] it is possible that an increase in 
circulating CCR4-positive cells correlates with an increase in Th2-support for 
pathologic B lymphocyte antibody production.  
Further non-chemokine receptor surface markers also aid the delineation of T helper 
subsets, including markers associated with a regulatory phenotype, such as CTLA-4, 
that aid their suppression of inflammatory responses [74, 163]. CTLA-4 is a 
particularly interesting molecule as it appears to have multiple effects. Firstly, it 
competes for binding to the co-stimulatory molecules CD80 and CD86 on APC, 
therefore reducing full activation of naïve T lymphocytes [74]. It also ‘rips’ these 
molecules off the surface of APCs, internalising them and therefore further reducing 
the magnitude of APC co-stimulation [74, 163]. Additionally, CTLA-4 promotes the 
production of indoleamine 2,3-dioxygenase (IDO) from APC, which is associated with 
the promotion of Treg activities but inhibits effector T lymphocyte proliferation by 
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degrading tryptophan [74, 341, 342]. CTLA-4 expression has been found to not be 
restricted to only Tregs as recently activated effector cells also upregulate it [74, 138, 
343], potentially limiting local inflammation.  
However, these surface markers do not completely distinguish different subtypes. For 
example, CCR4 can also be expressed on both Th17 [119] and Treg cells [344]. 
Therefore, it can be of benefit to look at the proteins involved in regulating cytokine 
production and polarisation. ‘Master regulators’ have been identified for each of the 
main T helper subsets. These regulators are transcription factors whose expression 
has been found to be necessary for a specific T helper subset differentiation. T-bet 
has been identified for Th1 cells, GATA-3 for or Th2, RORγt for Th17 and Foxp3 for 
regulatory T lymphocytes [47, 108]. The expression of T-bet is induced mainly as a 
response to IFNγ receptor binding via STAT1 signalling [47, 108, 345] but also as a 
response to IL-12 signalling via STAT4 [107, 110, 346]. IL-12 and IFNγ can both be 
produced by primed DCs [94] and IFNγ production by CD4+ T helper cells can act in 
an autocrine manner. T-bet has been detected bound to DNA at the site of the start 
of transcription for many Th1-associated genes [99]. Its most well-documented role is 
the remodelling of the ifnγ gene promoting increased IFNγ expression [347, 348]. 
This is further emphasised by experiments in which forced expression of T-bet in Th2 
cells results in IFNγ expression [98, 345, 348]. However, T-bet is not absolutely 
required for IFNγ transcription [110, 345] as T-bet deficient CD4+ T lymphocytes are 
still able to produce reasonable amounts of this cytokine. This is probably due to the 
activity of STAT4 [345, 347].  
T-bet is also involved in the upregulation of Th1-associated molecules such as 
CXCR3 [47] and IL-12Rβ [47, 345]. Increased expression of IL-12Rβ promotes 
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further IL-12 signalling which promotes Th1 differentiation by signalling via STAT-4. 
Activated STAT-4 induces the expression of T-bet and other Th1-associated 
molecules, and thus T-bet induced expression of IL-12Rβ further propagates the 
development of a Th1 phenotype [47]. A vital role T-bet may have in Th1 
development could involve its ability to antagonise the expression and function of 
GATA-3, [47, 108, 110, 129], and RORγt [108, 129, 349]. The inhibition of GATA3 by 
T-bet is a result of phosphorylation of  tyrosine residue 525 on T-bet, which allows it 
to interact with GATA-3 and inhibits its binding to target promoters, such as IL-5 
[350]. Similarly, T-bet-mediated inhibition of RORγt activity is achieved by inhibiting 
the binding of Runx1 to the Rorc locus, thus halting transcription of the Th17 master 
regulator [349]. Therefore, an important function of T-bet may be to limit the 
differentiation of CD4+ T lymphocytes into alternative subsets and therefore by 
default promote Th1-differentiation programs [110].  
Alongside its role in Th2 cells, GATA-3 expression is involved in CD4+ maintenance 
in single positive thymocytes [47, 351], and is expressed at detectable levels in Th1 
cells [98, 99]. In Th2 cells it acts to open up the chromatin at the il4-il13 locus [111, 
112], allowing for easy transcription of cytokine genes associated with the Th2 
phenotype. It itself also binds to the promoters for il5 and il13 expression [117, 352], 
and is able to bind to non-promoter il4 regulatory regions [99]. GATA-3 also 
antagonises the generation of the Th1 phenotype by inhibiting the expression of key 
molecules involved in early Th1 induction [111]. 
Foxp3 mutation or deletion is associated with a severe autoimmune phenotype, and 
its re-introduction into the immune system can drastically alleviate inflammatory 
manifestations [353]. As well as being associated with nTreg, Foxp3 expression is 
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also linked to a population of inducible Tregs - Th3s - that produce TGF-β and also 
express CTLA-4 [139]. Thymic-derived Treg were initially identified as the adaptive 
immune system’s main suppressive cells, but more recent data has highlighted the 
important role that iTregs play in regulating peripheral immunity [137, 139]. However, 
Foxp3 is not expressed in all iTreg populations [139]. The mechanisms behind 
Foxp3-mediated induction of a regulatory phenotype is still not fully understood. 
Foxp3 appears to regulate two important mechanisms of suppression – the inhibition 
of IL-2 production and the induction of CTLA-4 expression [354]. Both of these 
mechanisms may be by an interaction with NFAT1, a transcription also involved in 
the activation of il2 gene expression [355]. Foxp3 is an incredibly complex molecule, 
with three separate domains that can interact with both DNA and proteins in many 
different ways [356, 357]. There is increasing evidence that conventional CD4+ T 
lymphocytes may upregulate regulatory markers, including Foxp3, post-stimulation, 
and that this upregulation could be functional to limit exaggerated immune responses 
[138]. All cells with a suppressive phenotype will need to be able to function in low 
oxygen levels in parallel to their effector counterparts, and it is interesting to note that 
less Foxp3 expression has been observed in RA [167]. Therefore markers associated 
with suppressive function have been evaluated in this study. 
Most of the understanding about the effects of hypoxia on CD4+ T lymphocyte 
phenotype and function have come from studies looking at naïve or mixed CD4+ T 
lymphocyte populations [204, 235, 236, 238, 289, 292]. However, it will be CD4+  
CD45RO+ cells that enter an inflammatory site responding to re-exposure to the 
same antigen such as in the RA joint [148, 160, 306]. If these cells are re-activated in 
the tissue they will assert regulation over the inflammatory process and it is therefore 
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important to understand the effects of differing oxygen levels on this important CD4+ 
T lymphocyte population.  
CD4+ CD45RO+ T lymphocytes used in this study were isolated from PBMC 
populations. Predominantly these cells will have been generated from a previous 
pathogen/antigen exposure, and will have circulated between the blood and tissue as 
effector and central memory cells. Immune responses in which TEM cells are 
generated determine their subsequent phenotypic preference, laying down epigenetic 
markers that dictate gene transcription after further stimulations [63, 95, 144]. 
Therefore, the effector memory T lymphocytes present most likely would have been 
generated from a Th1, Th2 or Th17-like response, and would have continued to carry 
this identity into the experiments performed. This is a beneficial trait of the 
mammalian immune system, since if a Th1 response was the most desirable means 
of limiting a pathogen in a previous immune response, it is best to have a Th1 
response at the ready in the memory population for identical exposures in the future. 
In contrast, central memory T lymphocytes have been described as losing epigenetic 
markers associated with certain T helper subsets [98]. 
Despite the described ‘set’ nature of CD4+ memory T lymphocytes after 
differentiation from naïve T lymphocytes, in vivo it is possible they do have some 
phenotypic plasticity [95, 146] as already discussed in the main introduction. This 
plasticity is mainly understood with regards to recently generated effector T 
lymphocytes thus far [95]. However, there are some suggestions that both central 
and effector memory T lymphocytes do also have the potential for plasticity from an 
in vivo murine study [154] and an in vitro human study [98]. Further aspects 
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associated with T lymphocyte polarisation will be introduced within the various sub-
headings of this chapter.  
 
4.1.1 This chapter’s aims 
The aim of this chapter is to investigate whether differing oxygen levels can influence 
cytokine production and polarisation of CD4+ CD45RO+ T lymphocyte populations, 
and to examine whether certain subsets are selected for at specific oxygen levels. 
CD4+ CD45RO+ T lymphocytes were again frozen at -80˚C before use 
experimentally. Markers associated with different T helper subsets were assessed to 
aid these observations. ELISA was used to assess cytokine production, and flow 
cytometry was utilised to assess cytokines and markers associated with different T 
helper subsets. In flow cytometric analysis, the FS/SS stimulation gates were 
determined by comparison to non-stimulated controls, as in chapter 2, and were used 







4.2 Results  
4.2.1 The cytokine population is more pro-inflammatory at lower oxygen levels 
To assess the effect of varying oxygen levels on CD4+ CD45RO+ T lymphocytes, 
cytokine secretion was examined by ELISA on CD4+ CD45RO+ T lymphocytes 
isolated from healthy control PBMC populations and frozen at -80°C until required. 
Six cytokines were selected for investigation; IFNγ, TNFα and IL-17A to examine pro-
inflammatory effector functions; IL-4, IL-5 and IL-10 to investigate Th2-associated 
and anti-inflammatory effector functions. Supernatants from 45 hour stimulated 
populations (plus 3 hour brefeldin A-treated as cells were used for intracellular 
staining) were frozen at -80˚C until analysis.  
Cytokine production at different oxygen levels did not differ greatly and only IL-10 
production was significantly increased at 21% oxygen compared to constant 1% 
oxygen (P<0.05). However, certain trends became evident. IFNγ and TNFα 
production showed a trend for increased production at constant 1% oxygen and in 
reperfusion injury treatments. In contrast, at 8.5% oxygen the lowest IFNγ and TNFα 
was detected. IL-17A production did not fit the same pattern as IFNγ and TNFα with 
a drop in production occurring at constant 1% oxygen, although again this was not 
significant. IFNγ and TNFα were the most prominent cytokines produced at all 







Figure 4.1. Cytokines show a significant increase in IL-10 at 21% oxygen and a 
slight increase in pro-inflammatory expression at 3%. CD4+ CD45RO+ T 
lymphocytes were isolated using a Miltenyi MACs CD4+ memory isolation kit and 
frozen at -80°C for later analysis. ELISA was performed on supernatants of T 
lymphocytes stimulated for 48 hours at the stated oxygen levels (with the last 3 hours 
brefeldin A treated concurrent with subsequent intracellular staining). 2x105 cells 
were equilibrated to the stated oxygen level for 24 hours before stimulation. 
Supernatant pg/ml was determined before further analysis was performed. Six 
cytokines were chosen for investigation. A minimum of 7 donors were investigated at 
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each oxygen level. Data shows medians. Statistical analysis was performed using 
Mann Whitney test.  *=p.0.05. 1%C = constant 1% oxygen. 1% IR = 1% oxygen with 
reperfusion injury. Slight trends in cytokine production could be observed, with an 
upregulation in IFNγ and TNFα at constant 1% oxygen, but a drop in IL-10 at this 




Despite observing no statistical differences in overall cytokine production, the data 
from ELISAs suggested that there may be subtle patterns of cytokine expression that 
could be important in the microenvironment of a chronic inflammatory site. The 
overall equilibrium of a cytokine population may be important in determining an 
inflammatory response. It was therefore decided to investigate the effect of varying 
oxygen levels on cytokine production more closely, examining the results on a per-
supernatant basis. Each cytokine was expressed as a percentage of the total 
population of the six cytokines investigated for each donor at each oxygen level. This 
helped eliminate the effects of donor-specific differences in volume of cytokine 
production. This analysis revealed a more pro-inflammatory pattern of cytokine 
production at constant 1% oxygen. Indeed, the combination of IFNγ, TNFα and IL-
17A at constant 1% oxygen was significantly higher than at 8.5% oxygen. It was 
further apparent that IL-17A production was reduced at constant 1% oxygen 
compared to 8.5%, suggesting that it was mainly IFNγ and TNFα that were promoting 
the pro-inflammatory phenotype (figure 4.2). 
This data was probed further by directly comparing two cytokines in the same 
supernatant. When IFNγ or TNFα were compared to IL-10, IL-4 or IL-5, the 
generated ratios again revealed a favouring of pro-inflammatory cytokine production 
in hypoxia with a decrease as oxygen increased to 8.5%. This further suggests that 
IFNγ and TNFα contribute more to the overall cytokine population when oxygen is 
increasingly scarce, whereas anti-inflammatory cytokines appear to play more of a 
role at physiologically healthy oxygen levels of 8.5% oxygen (figures 4.3, 4.4, 4.5).  
IL-17A showed a different pattern of secretion. When looking at its contribution to the 
overall cytokine population it appears to play the greatest role at 8.5% oxygen (figure 
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4.2). However the highest ratios compared to the anti-inflammatory cytokines were 
observed at 3% oxygen, implying that its role in altering the balance between pro- 
and anti-inflammatory mechanisms may be more important at this oxygen level 
instead of at 8.5% oxygen. These ratios again dropped at constant 1% oxygen 
suggesting it did not play an important role in promoting pro-inflammatory processes 
at lower oxygen levels as its contribution to the overall cytokine population was on a 
par with the anti-inflammatory cytokines investigated. IL-17A levels were also 
reduced at constant 1% oxygen when compared to IFNγ and TNFα (figure 4.6).  
Reperfusion injury at 1% oxygen appeared to counteract the effects of constant 1% 
oxygen to some extent. The role played by pro-inflammatory cytokines was reduced 
as revealed by the general trend of decreasing ratios in figures 4.3, 4.4 and 4.5. Anti-
inflammatory cytokine production appeared to be more promoted in reperfusion injury 
treatments, as the percentage of total IL-4, IL-5 and IL-10 to the six cytokines 
investigated was higher than at constant 1% oxygen (figure 4.2).  
IL-10 played a surprisingly large role in the overall cytokine population at 21% 
oxygen, and also appeared to play an important role at 8.5% oxygen (figure 4.2). 
When IFNγ and TNFα were directly compared to IL-10 the resulting ratios were again 
reduced at 21% and 8.5% oxygen, further confirming the involvement of this cytokine 
at these higher oxygen levels.  IL-10 ratios were also non-significantly increased 
when compared to IL-4 and IL-5 at 21% oxygen (figure 4.6). The combination of this 
evidence suggests that the secretion of this anti-inflammatory cytokine is promoted in 
hyperoxic conditions. No significant differences in ratios between other alike 





Figure 4.2. The cytokine population is more pro-inflammatory at lower oxygen 
levels. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs CD4+ 
memory isolation kit and frozen at -80°C for later analysis. ELISA was performed on 
supernatants from CD4+ memory T lymphocytes stimulated for 48 hours (with the 
last 3 hours brefeldin A treated concurrent with subsequent intracellular staining). 
2x105 cells were equilibrated to the stated oxygen level for 24 hours before 
stimulation. Supernatant pg/ml was determined before further analysis was 
performed. Six cytokines were chosen for investigation. A minimum of 7 donors were 
investigated at each oxygen level and each cytokine was investigated in each donor. 
The overall contribution of the individual cytokines to the cytokine population was 
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assessed as a percentage of the six cytokines investigated. Statistical analysis was 
performed using Mann Whitney test.  # p<0.001 for cumulative percentages of pro-
inflammatory cytokine IFNγ, TNFα IL-17A at constant 1% oxygen, compared to 8.5% 
oxygen. 1%C = constant 1% oxygen. 1% IR = 1% oxygen with reperfusion injury. 
Pro-inflammatory cytokines played a greater role in the overall cytokine population at 






Figure 4.3. Direct pairwise comparisons of cytokine production at different 
oxygen levels with IL-10 cytokine production. CD4+ CD45RO+ T lymphocytes 
were isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C 
for later analysis. ELISA was performed on supernatants from CD4+ memory T 
lymphocytes stimulated for 48 hours (with the last 3 hours brefeldin A treated 
concurrent with subsequent intracellular staining). 2x105 cells were equilibrated to the 
stated oxygen level for 24 hours before stimulation. Supernatant pg/ml was 
determined before further analysis was performed. Six cytokines were chosen for 
investigation. A minimum of 7 donors were investigated at each oxygen level and 
each cytokine was investigated in each donor. Ratios of IL-10 with A) IFNγ, B) TNFα 
and C) IL-17A were determined. Statistical analysis was performed using Mann 
Whitney test and medians are shown in the data. *=p<0.05. **=p<0.005. ***=p<0.001. 
1%C = constant 1% oxygen. 1% IR = 1% oxygen with reperfusion injury. Pro-






Figure 4.4. Direct pairwise comparisons of cytokine production at different 
oxygen levels with IL-4 cytokine production. CD4+ CD45RO+ T lymphocytes 
were isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C 
for later analysis. ELISA was performed on supernatants from CD4+ memory T 
lymphocytes stimulated for 48 hours (with the last 3 hours brefeldin A treated 
concurrent with subsequent intracellular staining). 2x105 cells were equilibrated to the 
stated oxygen level for 24 hours before stimulation. Supernatant pg/ml was 
determined before further analysis was performed. Six cytokines were chosen for 
investigation. A minimum of 7 donors were investigated at each oxygen level and 
each cytokine was investigated in each donor. Ratios of IL-4 with A) IFNγ, B) TNFα 
and C) IL-17A were determined. Statistical analysis was performed using Mann 
Whitney test and medians are shown in the data. *=p<0.05. 1%C = constant 1% 
oxygen. 1% IR = 1% oxygen with reperfusion injury. Pro-inflammatory cytokine IFNγ 






Figure 4.5. Direct pairwise comparisons of cytokine production at different 
oxygen levels with IL-5 cytokine production. CD4+ CD45RO+ T lymphocytes 
were isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C 
for later analysis. ELISA was performed on supernatants from CD4+ memory T 
lymphocytes stimulated for 48 hours (with the last 3 hours brefeldin A treated 
concurrent with subsequent intracellular staining). 2x105 cells were equilibrated to the 
stated oxygen level for 24 hours before stimulation. Supernatant pg/ml was 
determined before further analysis was performed. Six cytokines were chosen for 
investigation. A minimum of 7 donors were investigated at each oxygen level and 
each cytokine was investigated in each donor. Ratios of IL-5 with A) IFNγ, B) TNFα 
and C) IL-17A were determined. Statistical analysis was performed using Mann 
Whitney test and medians are shown in the data. *=p<0.05. 1%C = constant 1% 
oxygen. 1% IR = 1% oxygen with reperfusion injury. Pro-inflammatory cytokines IFNγ 






Figure 4.6. Direct pairwise comparisons of cytokine production at different 
oxygen levels between alike cytokines. CD4+ CD45RO+ T lymphocytes were 
isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for 
later analysis. ELISA was performed on supernatants from CD4+ memory T 
lymphocytes stimulated for 48 hours (with the last 3 hours brefeldin A treated 
concurrent with subsequent intracellular staining). 2x105 cells were equilibrated to the 
stated oxygen level for 24 hours before stimulation. Supernatant pg/ml was 
determined before further analysis was performed. Six cytokines were chosen for 
investigation. A minimum of 7 donors were investigated at each oxygen level and 
each cytokine was investigated in each donor. Ratios of were as follows A) IFNγ/ 
TNFα B) IFNγ/IL-17A C) TNFα/IL-17A D) IL-10/IL-4 E) IL-10/IL-5 and F) IL-4/ IL-5. 
Statistical analysis was performed using Mann Whitney test and medians are shown 
in the data. *=p<0.05. **=p<0.005. 1%C = constant 1% oxygen. 1% IR = 1% oxygen 
with reperfusion injury. Alike cytokines do not differ in their ratios across different 
oxygen levels, excepting IL-17A.  
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Further analysis of T helper polarisation using flow cytometry 
To further clarify the effect of varying oxygen levels on CD4+ CD45RO+ T 
lymphocyte cytokine production, intracellular cytokine staining was performed on the 
same cell populations. Three panels were employed to investigate this. The first set 
of panels (discussed in greater detail in later sub-chapters) investigated cytokine 
production alongside alternative markers of T helper cells subsets; Panel 1 assessed 
IFNγ and IL-17A production alongside CXCR3, CCR6, and T-bet; Panel 2 assessed 
IL-4 and IL-10 production alongside CCR4, CTLA-4, GATA-3 and Foxp3. These 
panels were assessed after both 24 and 48 hours stimulation. A third panel assessed 
all four cytokines simultaneously (IFNγ, IL-17, IL-4 and IL-10) and was performed 
after 48 hours stimulation (please see Appendices for details of the panels).  
 
4.2.1.1 Intracellular cytokine staining reveals a decrease in cytokine expression 
after 48 hours at constant 1% oxygen and confirms the pro-inflammatory effect 
of hypoxia 
Initially intracellular cytokine staining was investigated at 48 hours stimulation by 
using the cytokine-only staining panel. This revealed an upregulation in IFNγ and IL-
17A at 3% oxygen (figure 4.7B) after 48 hours stimulation, and an upregulation in 
IFNγ production at 21% oxygen (figure 4.7C). However, both of these pro-
inflammatory cytokines were reduced at constant 1% oxygen, with reperfusion injury 
resulting in a slight elevation in cytokine production in comparison. T lymphocytes 
stimulated at 8.5% oxygen did not show a high production of either pro-inflammatory 
cytokine, but showed a reasonable production of IL-10. The highest production of IL-
10 was observed at 21% oxygen, but again constant 1% oxygen again showed a 
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depression in production. This was in agreement with previous analysis of 
supernatants (figure 4.7B). IL-4 did not show any significant patterns, but a slight 
increase in production was observed at 3% oxygen. High background was detected 
during IL-4 staining and additional blocking steps were employed to improve 
resolution.  
Therefore, cytokine production at constant 1% oxygen was generally depressed by 
48 hours staining which was not in agreement with the basic ELISA data. We 
therefore used the other two panels to assess cytokine production at both 24 and 48 
hours alongside other markers of T helper cell subsets. Similar patterns of cytokine 
production were observed at 48 hours compared to the cytokine-only staining panel 
(figure 4.7C) with only minor changes probably resulting from natural experimental 
deviation and differences in donors between experiments. IL-10 production showed 
the greatest difference between the two. IL-4 staining could not be detected after 24 
hours and this data was therefore excluded from analysis.  
IFNγ production after 24 hours stimulation was highest at 21% oxygen, constant 1% 
oxygen and reperfusion injury treatments. However, IFNγ production at constant 1% 
oxygen and reperfusion injury treatments decreased over time, and 21% oxygen 
resulted in a more static percentage of IFNγ positive cells at both time points (figure 
4.7C). In contrast, at 3% and 8.5% oxygen, there was a much bigger increase in the 
percentage of cytokine-positive cells from 24 to 48 hours. 
In general, all cytokines appeared to be delayed in their production at 8.5% oxygen. 
IL-10 production was reduced at 8.5% oxygen at 24 hours but increased to 48 hours. 
Therefore, there may be a slight reduction in some cytokine production at 8.5% 
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oxygen, but IL-10 may be less affected by this over time compared to the other 
cytokines investigated.  
In contrast, at 3% oxygen, IFNγ and IL-17A production at 24 hours was low 
compared to other oxygen levels, but expression increased to 48 hours stimulation. 
IL-17A production at constant 1% oxygen appeared to be depressed compared to 
other oxygen levels at both time points.  
Intracellular staining revealed a similar ratio of IFNγ/IL-17A (figure 4.8) to the ratios 
attained from supernatants, further supporting the downregulation in IL-17A 
production at constant 1% oxygen (figure 4.8). However, the IFNγ/ IL-10 ratio was 
slightly altered, with a downregulation in IFNγ compared to IL-10 at constant 1% 
oxygen (figure 4.8). This may have been due to differences when comparing ELISA 
data to intracellular staining. ELISA reveals the amount of free cytokine within the 
supernatant that has been released over time, whereas intracellular staining reveals 
a snapshot of what cytokine preference a cell has at a specific time-point, therefore 
















Figure 4.7. Intracellular cytokine staining over time. CD4+ CD45RO+ T lymphocytes 
were isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for later 
analysis. 2x105 cells were equilibrated to the stated oxygen level for 24 hours before 
stimulation with 2μg/ml anti-CD3// 5μg/ml anti-CD28.  2μg/ml brefeldin A treatment was given 
for the last three hours of stimulation for cytokine analysis. A) Forward scatter (FS)/ side 
scatter (SS) plots for non-stimulated and stimulated cells show the selected gate on 
stimulated cells (R72). Intracellular cytokine staining for IFNγ, IL-17A, IL-10 and IL-4 was 
employed to determine cytokine production on a per cell basis at the oxygen levels stated. B) 
Using the cytokine staining panel, CD4+ memory T lymphocytes were intracellularly stained 
after 48 hours stimulation and their percentage cytokine positive cells determined. Example 
plots, including isotype controls, from a donor stimulated at 8.5% oxygen are shown, with 
percentages of each cytokine stated. Isotype controls were gated to within 1% of the control 
except for IL-10 where a fixed gate was applied. C) Using the two marker panels, cytokine 
production on a per cell basis was investigated after 24 hours and 48 hours and their 
percentage cytokine positive cells determined. Statistical analysis was performed using 
Mann Whitney test, and median values are shown in the data with range where necessary. 
*=p<0.05 **=p<0.005. # p<0.05 between 21% oxygen with 8.5% and 1%C oxygen at 24 
hours. ## p<0.05 between 3% and 1%C oxygen. ### p< 0.05 between 21% oxygen with 3% 
and 1%C oxygen. 1%C = constant 1% oxygen. 1% IR = 1% oxygen with reperfusion injury. 
Data is representative of at least 2500 cells in the stimulation gate. A minimum of 7 donors 
were investigated at each oxygen level for IFNγ, IL-17A and IL-10 after 48 hours, and a 
minimum of 4 donors for IL-4 after 48 hours. A minimum of 4 donors were investigated at 
each oxygen level for the 24 hour investigations in C). Although initially, pro-inflammatory, 





Figure 4.8. Intracellular cytokine staining revealed similar ratios of cytokines to 
the ELISA assessment of cytokines in supernatant. CD4+ CD45RO+ T 
lymphocytes were isolated using a Miltenyi MACs CD4+ memory isolation kit and 
frozen at -80°C for later analysis. 2x105 cells were equilibrated to the stated oxygen 
level for 24 hours before stimulation with 2μg/ml anti-CD3// 5μg/ml anti-CD28 for 48 
hours.  Intracellular cytokine staining was used to determine cytokine production on a 
per cell basis at the oxygen levels stated. All stimulations were treated for the last 3 
hours with 2μg/ml brefeldin A to inhibit cytokine secretion. A) Ratios of IFNγ % 
positive cells with IL-17 % positive cells were investigated. B) Ratios of IFNγ positive 
cells with IL-10 were investigated. Statistical analysis was performed using Mann 
Whitney test and median values are shown in the data. *=p<0.05. 1%C = constant 
1% oxygen. 1% IR = 1% oxygen with reperfusion injury. Data is representative of at 
least 2500 cells in the stimulation gate. A minimum of 7 donors were investigated at 
each oxygen level. IFNγ plays more of a prominent role at constant 1% oxygen 




4.2.1.2 Increase in the percentage of cytokine double-positive cells at 3% 
oxygen 
The cytokine-only panel allowed for investigation into the presence of cytokine 
double-positive cells within CD45RO+CD4+ cell populations after 48 hours 
stimulation. Double positive cytokines were mainly observed as another cytokine 
being simultaneously expressed alongside IFNγ. Combinations of other cytokines 
were rarely observed (data not shown).  
A significant increase in the number of IFNγ+IL-17A+ cells was observed at 3% 
oxygen, although there was quite a spread of data depending on donor (figure 4.9B). 
Additionally IFNγ+IL-10 cells were increased at 21%, 8.5% and 3% oxygen 
compared to both low oxygen treatments (figure 4.9A). The spread of data at 3% 
oxygen meant that this was not significant, whereas data from 21% and 8.5% oxygen 
cultures were significantly increased compared to constant 1% oxygen. The numbers 
of IFNγ+IL-4+ CD4+ T lymphocytes was consistently low, but were increased at 21% 
and 3% oxygen and reduced at 8.5% oxygen and in cells exposed to reperfusion 
injury (figure 4.9C).  
At constant 1% oxygen, the numbers of IFNγ+IL-17A+ and IFNγ+IL-10+ double-
positive cells were significantly reduced. Reperfusion treatment alleviated this 
reduction slightly. This reflected the overall reduction in IL-17A and IL-10 intracellular 







Figure 4.9. Increased cytokine double positives at 3% oxygen. CD4+ CD45RO+ 
T lymphocytes were isolated using a Miltenyi MACs CD4+ memory isolation kit and 
frozen at -80°C for later analysis. 2x105 cells were equilibrated to the stated oxygen 
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level for 24 hours before stimulation with 2μg/ml anti-CD3// 5μg/ml anti-CD28.  
Intracellular cytokine staining was used to determine cytokine production on a per cell 
basis at the oxygen levels stated. All stimulations were treated for the last 3 hours 
with 2μg/ml brefeldin A to inhibit cytokine secretion. Using the cytokine staining 
panel, CD4+ memory T lymphocytes were stimulated for 48 hours and the 
percentage of cytokine double positive cells was determined. A) An example forward 
scatter (FS)/ side scatter (SS) plot showing gating on stimulated cells. B) IFNγ+IL-
10+ cells C) IFNγ+IL-17+ cells with an example plot. D) IFNγ+IL-4+ cells. Statistical 
analysis was performed using Mann Whitney test and median values are 
shown.*=p<0.05. **=p<0.005. ***=p<0.001. 1%C = constant 1% oxygen. 1% IR = 1% 
oxygen with reperfusion injury. Data is representative of at least 2500 cells in the 
stimulation gate. A minimum of 7 donors was investigated at each oxygen level 
excepting where IL-4 was involved, where a minimum of 4 donors was investigated. 
An increase in IFNγ+IL-17A+ double positive cells was seen at 3% oxygen, whereas 









4.2.2 Markers associated with different subsets are differentially expressed in 
varying oxygen levels 
Historically, cytokine production was the cardinal marker for T lymphocyte 
polarisation. Due to the importance of the cytokines’ role within the immune response 
this output is still considered when evaluating different subsets in contemporary 
science. However, as shown, cells expressing two cytokines associated with different 
subsets are present [145, 154, 358]. Additionally, stimulation methods do not always 
result in detectable cytokine production from every cell at the time point of analysis, 
therefore alternative markers that define T lymphocyte subsets is of additional 
benefit.   
4.2.2.1 Pro-inflammatory markers are upregulated at lower oxygen levels 
4.2.2.1.1 Assessment of surface markers associated with a pro-inflammatory 
phenotype  
In this study, the percentage of CXCR3 positive cells remained similar across the 
different oxygen levels investigated with a large majority of CXCR3+ CD4+ memory T 
lymphocytes (figure 4.10B). When intensity of expression was investigated, using the 
MFI, a pattern emerged of decreased expression at 3% oxygen but an increase at 
constant 1% oxygen (figure 4.10C). However, this pattern correlated with the FS 
values obtained at different oxygen levels (figure 4.10D and fig 3.8) and the 
differences in CXCR3 MFI are therefore most probably due to the differences in cell 
size at different oxygen levels.  
The Th17-associated marker, CCR6, showed no statistical significant increase or 
decrease in expression at any particular oxygen level, and appeared to be quite 
donor-specific in its expression on CD4+ CD45RO+ T lymphocytes (figure 4.10B). 
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Figure 4.10. Surface markers associated with pro-inflammatory CD4+ memory 
T lymphocytes do not differ at varying oxygen levels. CD4+ CD45RO+ T 
lymphocytes were isolated using a Miltenyi MACs CD4+ memory isolation kit and 
frozen at -80°C for later analysis. 2x105 cells were equilibrated to the stated oxygen 
level for 24 hours before stimulation with 2μg/ml anti-CD3// 5μg/ml anti-CD28. All 
stimulations were treated for the last 3 hours with 2μg/ml brefeldin A. Using the pro-
inflammatory marker panel, surface markers associated with Th1 and Th17 
phenotypes were investigated at different oxygen levels using flow cytometry. A) 
Forward scatter (FS)/ side scatter (SS) plots for non-stimulated and stimulated cells 
show the selected gate on stimulated cells (R97). B) Percentage positive CXCR3 and 
CCR6 cells were assessed at different oxygen levels after 48 hours stimulation. An 
example dot plot is shown. C) CXCR3 MFI at the different oxygen levels after 48 
hours stimulation. Mann Whitney statistics were used for analysis and median values 
are shown. **=p< 0.01. D) Correlation between CXCR3 and cell size as assessed by 
Spearman Rank Correlation. R= 0.3249, p= 0.0382. Data is representative of at least 
2500 cells in the stimulation gate. A minimum of 8 donors was investigated at each 
oxygen level. CXCR3 expression appeared to correspond to cell size, but no other 





4.2.2.2 Pro-inflammatory Transcription Factors 
In this study, T-bet expression initially appeared highest in reperfusion injury 
treatments after 24 hours (figure 4.11B). However, after 48 hours stimulation this 
pattern altered, with T-bet expression being highest at 3% oxygen, and a reduction in 
expression in reperfusion treatments occurring (figure 4.11C).  
Furthermore, two of the three oxygen levels thought to expose cells to the most ROS 
– 21% and 1%IR - contained the highest numbers of T-bet+IFNγ+ cells after 24 hours 
stimulation (figure 4.11B), but this was not sustained overtime to 48 hours. The 
reperfusion injury treatment particularly resulted in a drop in double positive cells 
further clarifying the T-bet only data. At 8.5% oxygen, the expression of T-bet+IFNγ 
Th1-associated markers was low at both 24 and 48 hours, suggesting they played 
less of an overall role within the cell population at physiologically healthy oxygen 
levels. 
Flow cytometric data acquired from staining CD4+ CD45RO+ cells for RORγt, the 
master regulator of Th17 cells, was eliminated from analysis due to its variability of 
















Figure 4.11. Alternative pro-inflammatory markers are upregulated in hypoxia. 
CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs CD4+ memory 
isolation kit and frozen at -80°C for later analysis. 2x105 cells were equilibrated to the 
stated oxygen level for 24 hours before stimulation with 2μg/ml anti-CD3// 5μg/ml 
anti-CD28.  2μg/ml brefeldin A treatment was given for the last three hours of 
stimulation for cytokine analysis. A) Forward scatter (FS)/ side scatter (SS) plots for 
non-stimulated and stimulated cells show the selected gate on stimulated cells (R72). 
Using the pro-inflammatory marker panel, T-bet and IFNγ expression were 
investigated at different oxygen levels by intracellular staining and flow cytometry. B) 
The percentage of T-bet positive cells was assessed at the stated oxygen levels after 
24 hours stimulation. C) The percentage of T-bet positive cells was assessed at the 
stated oxygen levels after 48 hours stimulation. D)The percentage of Tbet+IFNγ+ 
cells was assessed at both 24 and 48 hours post-stimulation. Example plots of T-
bet+IFNγ+ staining after 48 hours stimulation. Statistical analysis was performed 
using Mann Whitney test, and median values are shown in the data with range where 
necessary. **=p<0.005. # p<0.05 1%C compared to 8.5% oxygen, and p<0.005 21% 
compared with 8.5% oxygen at 24 hours. ## p<0.05 3% compared to 8.5% oxygen at 
48 hours.1%C = constant 1% oxygen. 1% IR = 1% oxygen with reperfusion injury. 
Data is representative of at least 2500 cells in the stimulation gate. A minimum of 4 
donors was investigated at each oxygen level. The percentage of T-bet+IFNγ+ cells 
at 3% oxygen increased over time.  
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4.2.2.3 Th2 associated markers are increased at physiologically healthy oxygen 
levels 
The highest percentage of CCR4 positive cells and the highest CCR4 MFI was 
observed at 8.5% oxygen (figure 4.12B and C).  A stepwise decrease in MFI values 
to 1% oxygen treatments was observed with stimulation at constant 1% oxygen 
resulting in the lowest CCR4 expression intensity. As constant 1% oxygen contained 
the largest cells (figure 3.8) it can be assumed that the upregulation in CCR4 
expression was a more direct response to the environmental oxygen levels 
experienced by the cells and not due to cell size as observed for CXCR3 expression.  
The transcription factor GATA-3 has been labelled the ‘master-regulator’ of Th2 cells 
after it was discovered that its deletion can inhibit the generation of this particular 
subset in CD4+ cells [47, 117]. Similar to the increase in CCR4 expression, the 
highest GATA-3 expression was also observed at 8.5% oxygen. However, high 
GATA-3 expression was also observed at constant 1% oxygen after 48 hours 
stimulation contrary to what would be expected from the CCR4 data. Nonetheless, 
GATA-3 was again reduced in reperfusion injury (figure 4.12D).  
The combination of these markers, at the two different time points being investigated, 
provided a clearer picture of what was occurring at different oxygen levels (figure 
4.12E). At 8.5% oxygen, the percentage of CCR4+GATA3+ positive cells was highest 
at both time points compared to all other oxygen levels. After 24 hours this was 
significant when compared to 3% and constant 1% oxygen. A Th2-like response may 
therefore be promoted at 8.5% oxygen. However, at 48 hours cells stimulated at 
constant 1% oxygen increased their combined expression of CCR4 and GATA3, 
suggesting a Th2-like response was favoured, but delayed, at this oxygen level. 
149 
 
CD4+ memory T lymphocytes stimulated at 3% oxygen also increased 
CCR4+GATA3+ combined expression over time, but not to the extent observed at 









Figure 4.12. Markers associated with a Th2 phenotype are upregulated at 
physiologically healthy oxygen levels. CD4+ CD45RO+ T lymphocytes were 
isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for 
later analysis. 2x105 cells were equilibrated to the stated oxygen level for 24 hours 
before stimulation with 2μg/ml anti-CD3// 5μg/ml anti-CD28.  2μg/ml brefeldin A 
treatment was given for the last three hours of stimulation for additional cytokine 
analysis. A) Forward scatter (FS)/ side scatter (SS) plots for non-stimulated and 
stimulated cells show the selected gate on stimulated cells (R72). Using the anti-
inflammatory marker panel, surface markers and transcription factors associated with 
a Th2 phenotype were investigated at different oxygen levels by both surface and 
intracellular staining, and assessed by flow cytometry. CCR4 surface marker staining 
was assessed and the B) percentage of positive  cells and C) MFI were assessed 
after 48 hours stimulation. D) GATA-3 intracellular staining was performed and 
assessed after stimulation at varying oxygen levels. E) The percentage of 
CCR4+GATA3+ cells at both 24 (turquoise) and 48 (blue) hours was assessed. 
Statistical analysis was performed using the Mann Whitney test and median values 
are shown in the data. *=p<0.05. **=p<0.005. ***=p<0.001. 1%C = constant 1% 
oxygen. 1% IR = 1% oxygen with reperfusion injury. Data is representative of at least 
2500 cells in the stimulation gate. A minimum of 4 donors was investigated at each 
oxygen level. CCR4 and GATA-3 expression were highest at 8.5% oxygen.  
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4.2.2.4 Markers associated with a regulatory phenotype are increased at 3% 
oxygen after 48 hours stimulation 
Foxp3 is a transcription factor integral for the maintenance and functioning of most 
Treg cells, and is thought of as the ‘master regulator’ of nTregs and some iTregs 
[353, 359, 360]. After 48 hours stimulation, Foxp3 expression was highest at 3% and 
constant 1% oxygen, and was significantly reduced in reperfusion injury (figure 
4.13C). CTLA-4, a surface marker associated with Treg function, did not reveal any 
significant patterns, but appeared to have reasonable expression at 21%, 3% oxygen 
and reperfusion injury treatments (figure 4.13B). The combination of these surface 
markers showed the percentage of CTLA-4+Foxp3+ cells was slightly increased at 
3% oxygen at 48 hours, indicating an increase in regulatory functions may occur in 
physiologically low-oxygen environments such as the RA joint and the lymph node 
(figure 4.13D). However, at 24 hours reperfusion treatments contained the most 
CTLA-4+Foxp3+ cells, suggesting a regulatory phenotype may be a rapid response 
to re-exposure to oxygen. However, this regulatory-like phenotype severely dropped 
to 48 hours compared to the other oxygen treatments suggesting that it was not 
maintained when oxygen levels fluctuated drastically. The percentage of CTLA-
4+Foxp3+ cells at 8.5% oxygen remained low compared to 3% oxygen at both time 
points, highlighting further the role that different environmental oxygen levels can 























Figure 4.13. Markers associated with regulatory functions are increased at 3% 
oxygen. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs CD4+ 
memory isolation kit and frozen at -80°C for later analysis. 2x105 cells were 
equilibrated to the stated oxygen level for 24 hours before stimulation with 2μg/ml 
anti-CD3// 5μg/ml anti-CD28.  2μg/ml brefeldin A treatment was given for the last 
three hours of stimulation for additional cytokine analysis. A) Forward scatter (FS)/ 
side scatter (SS) plots for non-stimulated and stimulated cells show the selected gate 
on stimulated cells (R72). Using the anti-inflammatory marker panel, surface markers 
and transcription factors associated with a regulatory phenotype were investigated at 
different oxygen levels by both surface and intracellular staining, and assessed by 
flow cytometry. The percentage of B) CTLA-4+ and C) Foxp3+ cells was assessed 
after 48 hours stimulation. D) The combination of these markers was assessed by 
determining the percentage of CTLA-4+ Foxp3+ cells at both 24 and 48 hours, with 
example staining plots given in E). Statistical analysis was performed using the Mann 
Whitney test and median values are shown in the data. *=p<0.05. ***=p<0.001. #= 
p<0.005 between 3% oxygen and reperfusion injury treatments at 48 hour 
stimulations. 1%C = constant 1% oxygen. 1% IR = 1% oxygen with reperfusion injury. 
Data is representative of at least 2500 cells in the stimulation gate. A minimum of 4 
donors was investigated at each oxygen level. 3% oxygen upregulated expression of 





4.2.2.5 IL-10 production is associated with different T helper cell subsets at 
different oxygen levels.  
The marker staining panels also allowed assessment of whether IL-10 was being 
produced by Th2 or Treg cells by assessing its expression in either CCR4+GATA3+ 
or CTLA-4+Foxp3+ cells. IL-10 positive cells were gated upon, as seen in the gating 
plan in figure 4.14, and assessed for the expression of the indicated markers. A 
greater majority (averages > 40% vs < 30%) of IL-10 was expressed in the 
CCR4+GATA3+ cells compared to the CTLA-4+Foxp3+ cells highlighting that it was 
mainly Th2-like cells producing IL-10 in these culture conditions. Furthermore, the 
patterns of CCR4+GATA3+ and CTLA-4+Foxp3+ expression in the IL-10 gates 
reflected the patterns observed for the overall stimulated population (figures 4.12 and 
4.13) suggesting that IL-10 production in CD4+ memory T lymphocytes may be 
associated with multiple T helper subsets and that oxygen may not influence which T 




















Figure 4.14. The production of IL-10 varies between different subsets at 
different oxygen levels. CD4+ CD45RO+ T lymphocytes were isolated using a 
Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for later analysis. 
2x105 cells were equilibrated to the stated oxygen level for 24 hours before 
stimulation with 2μg/ml anti-CD3// 5μg/ml anti-CD28.  2μg/ml brefeldin A treatment 
was given for the last three hours of stimulation for cytokine analysis. A) Forward 
scatter (FS)/ side scatter (SS) plots for non-stimulated and stimulated cells show the 
selected gate on stimulated cells (R64). Using the anti-inflammatory marker panel, IL-
10 production was assessed in conjunction with surface markers and transcription 
factors associated with a Th2 and a regulatory phenotype by flow cytometry after 
stimulation for 48 hours at different oxygen levels. A) shows the gating used for 
analysis of the flow cytometry data. Stimulated cells were selected for analysis and 
the IL-10+ cells gated upon. This gate was applied to the B) CCR4+GATA3+ and C) 
CTLA-4+Foxp3+ graphs and the percentage of positive cells assessed. Mann 
Whitney test was used for statistical analysis and median values are shown. 
*=p<0.05. Data is representative of at least 2500 cells in the stimulation gate. A 
minimum of 5 donors was investigated at each oxygen level. When considering 
overall expression Th2 and regulatory marker expression, IL-10 expression does not 
seem to be preferentially associated with either subset.  
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4.2.3 A limited microarray analysis gives clues as regulatory mechanisms 
instigated in hypoxia 
Given the differences in protein and transcription factor expression observed it was 
decided to undertake  a preliminary examination of mRNA associated with the 
different T helper subsets (for details please see Appendices). cDNA was generated 
from mRNA isolated from stimulations for 48 hours at 8.5% (treated as a control) and 
constant 1% oxygen. Along with the limited numbers of samples being investigated, 
the 8.5% oxygen RNA isolation was apparently contaminated with human genomic 
DNA according to in-built quality control checks in the plate. Therefore no 
conclusions can be drawn from this data but it gives an interesting indication of 
further trends that may be occurring in physiologically healthy oxygen levels 
compared to hypoxia.  
Despite the limitations of these data, the results obtained did reflect some of the 
results gained thus far. Firstly, the microarray showed that GATA-3 expression was 
upregulated at constant 1% oxygen compared to 8.5% oxygen. Our flow cytometry 
data suggested that GATA-3 expression increased at 1% oxygen over time whereas 
at 8.5% oxygen the increase observed from 24 to 48 hours was more limited. It is 
therefore possible that the increase in GATA-3 mRNA observed in hypoxia may 
reflect the delayed upregulation in Th2-associated markers as implied previously. 














GATA3 GATA binding protein 3 153.4311   
IL23A Interleukin 23, alpha subunit p19 95.1049   
CCL7 Chemokine (C-C motif) ligand 7   -65.7333 
IL17RD Interleukin 17 receptor D   -44.8972 
IL17C Interleukin 17C   -44.5871 
IL4 Interleukin 4   -24.9083 
HGDC 
Human Genomic DNA 
Contamination   -52.657 
Table 4.1. Genes upregulated (red) and downregulated (blue) after 48 hours 
stimulation at constant 1% oxygen compared to control oxygen level of 8.5%.  
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4.2.4 Naïve T lymphocyte polarisation reveals a similar pattern to memory cells 
While the focus of the project is on CD4+ CD45RO+ cells, given their role in 
regulating process in inflammatory issues, limited experiments on naïve T 
lymphocytes polarised to Th1, Th2 or Th0 phenotype at different oxygen levels were 
also undertaken. CCR4 and CXCR3 expression were examined to assess the 
success of polarisation at different oxygen levels. At 8.5% oxygen the highest CCR4 
expression was observed for all polarisations whereas at 3% and constant 1% 
oxygen CCR4 expression was reduced even in Th2 polarisations (figure 4.15). 
Conversely, CXCR3 expression was the most increased at constant 1% oxygen. 
Interestingly 3% oxygen did not upregulate CXCR3 as much as may be expected 
from the previous memory cytokine data (figure 4.10). The Th1/Th2 polarisations 
appeared particularly distinct in the 21% cultures, with high CCR4 expression in Th2-
polarised cells and high CXCR3 expression in Th1-polarised cells. As the in vitro 
protocols used for polarisation in many laboratories were generated in 21% oxygen, it 
may be of no surprise that these observations were made. Th0 cells (no polarisation) 
appeared to favour CXCR3 expression over CCR4 expression at all the oxygen 
levels investigated, indicating that our environmental conditions may favour a Th1 
phenotype, or that Th1 differentiation is generally more favoured in the naïve T 
lymphocyte differentiation process. At 8.5% oxygen both CXCR3 and CCR4 was 
reduced in the Th1-polarised cells. This may have been due to their inhibition of 
forming a Th2-like phenotype due to the factors added to their environment, but 
inhibition of a Th1-like phenotype due to the oxygen conditions. Due to time 





Figure 4.15. Naïve CD45RA+T lymphocytes CCR4 and CXCR3 expression at 
different oxygen levels. CD45RA+CD4+ T lymphocytes were isolated using a 
Miltenyi naïve T lymphocyte isolation kit and frozen at -80°C until required. Cells 
were then defrosted and  5x 104 cells were equilibrated to the stated oxygen level for 
24 hours and then stimulated using plate-bound anti-CD3/ anti-CD28 under Th0, Th1 
or Th2 differentiating conditions. A) shows the gate applied to stimulated cells for 
analysis by flow cytometry (R1). B) CCR4 and C) CXCR3 MFI were assessed by flow 
cytometry after 72 hours stimulation. 3-4 donors were run at each oxygen level for 
each treatment in one experiment. Statistical analysis was performed using Mann 
Whitney test but no results were significant. Median values are shown with the range. 





In this chapter the phenotype of CD4+ memory T lymphocytes at different oxygen 
levels has been assessed. An array of different cytokines can be observed in chronic 
inflammatory environments such as the rheumatoid joint [29, 33, 35], and the 
effectiveness of anti-TNFα in RA treatment [35] has shown that depleting a certain 
cytokine within a tissue, which will alter the overall balance of cytokines, can be of 
benefit. Therefore, the balance of cytokine production was investigated at different 
oxygen levels by both ELISA and intracellular cytokine staining. 
The data presented in this chapter suggest that cytokine production can vary 
depending on environmental oxygen levels. ELISA assessment of stimulated CD4+ 
CD45RO+ T lymphocytes supernatants revealed that IFNγ and TNFα were the most 
prominent cytokines produced at every oxygen condition, contributing to between 87-
97% of the overall cytokines produced over 45 hours. This is the expected trend in in 
vitro stimulated peripheral blood CD4+ memory T lymphocytes [58, 62, 361]. 
However, at constant 1% oxygen these more pro-inflammatory cytokines were in 
greater proportion when compared to higher oxygen levels. In contrast, cytokines 
deemed to be more Th2-associated or anti-inflammatory (IL-4, IL-5 and IL-10) were 
greatest in the overall cytokine population at higher oxygen levels.   
 
4.3.1 CD4+ CD45RO+ T lymphocyte cytokine production and polarisation at 
constant 1% oxygen  
Intracellular cytokine staining further confirmed the previous results that low 
environmental oxygen promotes a pro-inflammatory phenotype. After 24 hours 
stimulation a high percentage of IFNγ-positive cells was detected at constant 1% 
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oxygen. This suggested that low environmental oxygen may promote a more pro-
inflammatory T helper cell phenotype in CD4+ CD45RO+ T lymphocyte populations. 
As pro-inflammatory cytokines may play a greater role in chronic inflammatory 
tissues [29, 35], it is possible that the oxygen environment contributes to a more 
aggressive immune response. However, highest IFNγ production was also detected 
at 21% oxygen at this time point, suggesting that it is not only lack of oxygen that 
results in an initial pro-inflammatory response.  
Despite good IFNγ intracellular cytokine staining at 24 hours in constant 1% oxygen, 
the percentage of cytokine-positive cells dropped to 48 hours stimulation compared 
to 21%, 8.5% and 3% oxygen treatments, suggesting that sustained hypoxia may 
result in a reduction in cytokine production over time. As supernatants were only 
assessed by ELISA from 48 hour stimulations (with 3 hours treatment with brefeldin 
A)  this may not have been fully reflected in the ELISA data, due to the detection of 
cytokines produced in the earlier stages of stimulation. Alongside this, T-bet 
expression also dropped overtime, and this may provide one mechanism for the drop 
in IFNγ production overtime in constant 1% oxygen.  
Whereas T-bet expression appeared to drop in constant 1% oxygen over time, 
GATA-3 expression appeared to increase overtime compared to other oxygen levels 
(as indicated by both intracellular staining and the limited microarray). It is possible 
that the later increase in GATA-3 expression observed at 48 hours stimulation may 
be due to a delayed promotion of humoral immunity, or may be result of the lack of T-
bet expression which normally antagonises GATA-3 function [110]. Despite the 
increase in GATA-3 expression after 48 hours, IL-4 cytokine production did not 
increase alongside it. 
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In contrast to IFNγ, IL-17A and IL-10 cytokine production was slightly increased over 
time at constant 1% oxygen. However, this increase was not as pronounced as those 
observed at higher oxygen conditions. With regards to these two cytokines, 
examinations of RORγt expression were fraught with problems, and MAF, a possible 
transcriptional regulator of IL-10 [362], was not assessed. The data regarding IL-17A 
is somewhat contradictory to that described in the literature. The stabilisation of HIF-
1α in low environmental oxygen levels is thought to promote a Th17-like phenotype 
as already discussed [120, 236, 276, 298], and therefore it was hypothesised that an 
increase in IL-17 production may be observed. However, less IL-17 production was 
observed at constant 1% oxygen compared to other oxygen levels. This was 
observed in both analyses of supernatants and from intracellular cytokine staining. IL-
17A was also reduced when assessing double-cytokine expressing cells, as the 
IFNγ+IL-17A+ population was reduced at constant 1% oxygen compared to other 
oxygen levels. As the cytokine production observed was produced by CD4+ memory 
T lymphocytes in the cell population, it may be that the response of this specific cell 
type to hypoxia is altered compared to naïve T lymphocytes with respect to IL-17 
production. As the literature on hypoxia and Th17 differentiation mainly employs 
naïve CD4+ T lymphocyte populations [120, 236, 276], the observation that CD4+ 
CD45RO+ T lymphocytes depress IL-17 production is novel.  
4.3.2 Constant 1% oxygen with 3% oxygen differ in their effect on CD4+ T 
CD45RO+ lymphocytes 
In assessing the effect of environmental oxygen levels on memory T lymphocyte IL-
17A production, it is interesting to compare the results from constant 1% oxygen to 
those from 3% oxygen. The differences between the effect of 1% and 3% oxygen 
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environmental oxygen on CD4+ memory T lymphocytes appeared quite profound, 
especially when considering that it is possible for a tissue to fluctuate between these 
oxygen levels. At 3% oxygen cytokine production appeared much more maintained 
over time, with both IFNγ and IL-17A production increasing over time more than at 
other oxygen levels. As HIF-1α is stabilised at 3% oxygen [230], it is possible the 
expected effect of HIF-1α stabilisation on IL-17A expression occurs at 3% oxygen, 
but that 1% oxygen depresses IL-17A production due to additional influences on 
cellular processes.  
IFNγ+IL-17A+ double positive cells have been detected in inflamed joints [145, 358] , 
and are associated with worse pathology in EAE compared to IL-17A-only producing 
cells [349]. An increase in IFNγ+IL-17A+ double positive cells was detected at 3% 
oxygen compared to all the other oxygen levels. This suggests that cytokine 
expression is favoured at this oxygen level, but also promotes the notion that Th17 
plasticity is upregulated at this oxygen level compared to other oxygen levels, 
including constant 1% oxygen.  As T-bet expression was also observed to be 
increased at this oxygen level, it is possible that the Th17 cells present within the 
original population favour this oxygen level, and also undergo a phenotypic switch to 
a more Th1-like phenotype. However, IL-17A was more regularly found in T-bet 
negative cells than T–bet positive (data not shown).  
Despite the observation of IFNγ+IL-17+ cells in the rheumatoid joint, T lymphocyte 
cytokine production has been reported to be limited in this environment [175, 176]. 
As 3% oxygen is the average oxygen level detected in the rheumatoid joint, the 
results obtained in this chapter contradict what may be hypothesised as cytokine 
production appears to be more supported at this oxygen level. As this study only 
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examined cytokine production over 48 hours, it is possible the data is limited, and 
more longitudinal studies may be of benefit in the future. Previous studies 
investigating CD4+ T lymphocyte cytokine production in the joint provide only a snap-
shot view of lymphocyte behaviour in the joint, and it is not known how long the 
lymphocytes examined actually have existed within the joint environment. As RA T 
lymphocytes express CD45RB only at low levels, it is possible that they get ‘stuck’ in 
the joint [306]. Therefore, it is difficult to decipher how they behave when they initially 
migrate into the synovial tissue, and it would be interesting to investigate whether 
long-term culture at 3% oxygen eventually results in a depression in cytokine 
production. There are also many other environmental factors in the RA joint that may 
place additional pressures on the cytokine production of T lymphocytes. These 
include cytokine production from non-lymphoid cells, ROS production from 
neutrophils, lack of other nutrients, and a potential lack of other supporting structures/ 
factors that lymphocytes will find in other environments such as the lymph node for 
long-term cytokine production. This may provide some explanation for the increased 
cytokine production observed in this study at 3% oxygen compared to the chronic 
inflammatory environment of the joint.  
 
4.3.3 Further cytokine plasticity at 3% and 21% oxygen 
Not only Th17-Th1 plasticity was observed increased at 3% oxygen, as an increase 
in IFNγ+IL-10+ and IFNγ+IL-4+ double positive cells was also observed at both 3% 
and 21% oxygen. In vitro investigations of mouse T lymphocyte polarisation often 
provides very distinct populations of Th1 and Th2 T lymphocytes in response to 
stimuli [63, 142] although in vivo studies suggest that murine Th2-to-Th1 plasticity is 
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possible in previously antigen-exposed CD4+ T lymphocytes [154]. In humans, T 
lymphocyte plasticity is possibly more prevalent and re-expression of silenced genes 
may occur with respect to cytokines of opposing subsets [98]. Additionally, IL-4 
production in effector memory T lymphocytes has previously been shown to fall into 
the IFNγ+ fraction after ten days stimulation [64]. Therefore, it is possible that these 
two oxygen levels promote increasing plasticity between the different Th1 subtypes.  
As already alluded to, the data obtained from stimulation at 3% oxygen is interesting 
when considering physiological environments where this oxygen level will be 
experienced. Cytokine production needs to be maintained in the lymph node in 
response to antigen and the data obtained from stimulations at 3% oxygen suggest 
that this environmental oxygen level may promote the generation of pro-inflammatory 
T lymphocytes. CD4+ central memory  lymphocytes, which are activated in the lymph 
node [63],  do not maintain epigenetic regulation of their cytokine genes like effector 
memory T lymphocytes [98], and therefore may be easier to manipulate with regards 
to subsequent phenotype. As oxygen levels appear to have some regulation over 
phenotype and cytokine production, it would be interesting to take a closer look at the 
effects of environmental oxygen levels on this specific subset of memory T 
lymphocyte by investigating cytokine production either over a longer time period, or in 
response to specific antigenic stimulation.  
 
4.3.4 Observations in reperfusion injury treatments 
Observations made from reperfusion injury treatments gave an interesting insight into 
what may occur when oxygen levels fluctuate. The data still needs to be treated with 
some caution as the oxygen fluctuations were extreme and would not be experienced 
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by cells physiologically. That said, the data from this model reveals some subtle 
differences between the behaviour of cells stimulated at constant 1% oxygen and 
those that went on to experience reperfusion injury. Compared to constant 1% 
oxygen, increases in intracellular cytokine production of IFNγ, IL-17A and IL-10 were 
observed occurring alongside reductions in transcription factor expression. However, 
IL-4 intracellular cytokine staining was the lowest in reperfusion injury samples. As 
the number of replicates was low, further exploration of this would be beneficial.  
 
4.3.5 A more resolving phenotype at 8.5% oxygen 
Physiologically healthy oxygen levels of 8.5% oxygen revealed some differences 
compared to the other oxygen levels examined. In general, cytokine production was 
not as upregulated compared to stimulation at other oxygen levels. When closely 
examining the balance of cytokines in supernatants, IL-4, IL-5, IL-10 and IL-17A 
played a greater role at 8.5% oxygen than compared to the other oxygen levels, and 
that this may have been due to the down regulation of pro-inflammatory cytokines. 
Intracellular cytokine staining for IL-10 production stained the highest percentage of 
cells after 48 hours stimulation at 8.5% oxygen, despite initial expression being lower 
at 24 hours. This suggested that CD4+ CD45RO+ T lymphocytes at 8.5% might have 
increased anti-inflammatory or regulatory capabilities. However, the percentage of 
CTLA-4+Foxp3+ cells was not the highest at 8.5% oxygen. IL-10 is commonly listed 
as one of the Th2-associated cytokines [47], and a reasonable percentage of  the IL-
10 observed at 8.5% may be associated with this subset. In addition, the percentage 
of CCR4+GATA3+ cells was high in 8.5% oxygen treatments after both 24 and 48 
hours stimulation. Due to our initial population of CD4+ memory T lymphocytes, there 
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are several possibilities that could have caused this upregulation; either the resident 
Th2-like cells were preferably expanded at this oxygen level; or other non-Th2 cells 
(potentially including central memory) were converting to a more Th2-like phenotype. 
As IL-4 - a cytokine associated with Th2 immune responses - was not highly 
detected, confirmation of the presence of this subset would need further clarification. 
The increase in Th2-like phenotype was further suggested in experiments performed 
on naïve T lymphocytes, where stimulation at 8.5% resulted in the highest CCR4 MFI 
values, even in Th1 and Th0-polarising conditions.  However, this work was limited 
by the lack of experimental repeats, and warrants future confirmation.  
It is therefore possible that physiologically healthy oxygen levels of 8.5% oxygen 
result in more Th2-skewed phenotype. This may be a result of the environment 
lacking certain factors that cells normally respond to in inflammatory stimuli that may 
promote their pro-inflammatory phenotype. These factors could include ROS and the 
stabilisation of HIF-1α. HIF-1α is not expected to be stabilised in 8.5% oxygen [230], 
and physiologically healthy oxygen levels have previously been observed to limit the 
production of ROS [235, 244]. The increase in IL-10 as part of the cytokine 
population at this oxygen level will also promote the dampening down of the immune 
response, and promotion of a Th2-like inflammatory response will aid wound healing 
[113, 114]. 
 
4.3.6 IL-10 production  
High IL-10 production was observed in 21% oxygen cultures. This was unexpected 
and highlights how in vitro work may detect more IL-10 than actually plays a role 
physiologically. As IL-10 is associated with anti-inflammatory and regulatory 
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processes, this is an important finding for in vitro research. For example, it will be 
important in the study of tumour immunology where regulatory cells are thought to 
play a role in dampening anti-tumour immune responses [363]. If IL-10 is over-
represented in in vitro work, it may delay full understanding of the regulatory 
response occurring in the tumour environment. As tumour micro-environments are 
often severely hypoxic [206], the contrast in IL-10 production at 21% and 1% oxygen 
treatments revealed in this study highlights the importance of performing in vitro work 
at tissue-relevant oxygen levels.  
Interestingly, IL-10 production did not appear to be more associated with either a 
more regulatory or Th2 phenotype. However, the double-positive gates applied did 
not allow for examination of IL-10 production in cells expressing a single marker. For 
example, there was a population of Foxp3 negative cells expressing both IL-10 and 
CTLA-4, and these cells could be Tr1s (as discussed in the main introduction) [139, 
141, 364]. This further analysis was not performed as the number of IL-10 cells was 
low and it was difficult to draw any conclusions from this data. It may be of benefit to 
examine IL-10 production with respect to all different T helper subsets simultaneously 
in the future due, as IL-10 production has been observed from all subsets [47, 95, 





5. RESULTS: POTENTIAL MECHANISMS OF HYPOXIC ALTERNATION OF 
MEMORY CD4+ T LYMPHOCYTE RESPONSE TO STIMULATION 
5.1 Introduction 
As we have shown already, hypoxia appears to have significant effects on the 
functions of CD4+ memory T lymphocytes. Dioxygen is a reactive molecule that plays 
a large role in cellular biochemistry, and its depletion therefore disrupts many cellular 
biochemical processes. On top of the basic biochemical changes that occur when a 
reactive molecule is depleted, regulatory mechanisms kick in due to the necessity of 
maintaining good oxygen levels. These processes are linked through the 
upregulation of hypoxia sensitive genes. Moreover hypoxia has been shown to affect 
biogenesis in T lymphocytes by altering membrane potential via the inhibition of 
Kv1.3 channels, resulting in a reduced calcium signal in response to TCR ligation 
[273, 275].  
In this chapter two downstream effects of hypoxia on CD4+ memory T lymphocyte 
function have been investigated: 
HIF-1α stabilisation. The stabilisation of HIF-1α is both a well-documented and 
well established response to hypoxia [224] and a full description of its regulation 
can be found in chapter 1. Once stabilised, HIF-1α subunits translocate to the 
nucleus, dimerise with HIF-β subunits, and initiate downstream transcription of 
hypoxia-responsive genes [224] which are able to regulate immune responses.  
 
Intracellular reactive oxygen species (ROS) production increases in responses to 
lack of oxygen. As discussed in the main introduction, lack of oxygen can result in 
an increase in superoxide production from the mitochondrion [254-256], which 
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can act as a signalling molecule and result in an increased oxidative cellular 
environment  [257]. 
Observations from these studies led to further study of proximal T lymphocyte 
signalling at different oxygen levels.  
 
5.1.1 This chapter’s aims 
The aim of this chapter is to establish whether HIF-1α stabilisation and ROS provide 
a mechanism for the previous results observed at different oxygen levels. CD4+ 
CD45RO+ T lymphocytes were again isolated and frozen at -80˚C until required 
experimentally. HIF-1α was stabilised by the use of defoxamine, and the ROS 
environment of the joint mimicked using hydrogen peroxide. In contrast, the effects of 
the anti-oxidant N-acetyl cysteine were also examined. Flow cytometry was used to 




In chapter 3 an upregulation in CD69 expression at constant 1% oxygen was 
described. In this current chapter the effects of aspects of the low-oxygen 
environment on CD69 expression were initially investigated in more detail by 
examining the effects of ROS and HIF-1α stabilisation on CD4+ CD45RO+ T 
lymphocytes isolated and stored as in previous chapters. These effects were 
investigated at physiologically healthy oxygen levels of 8.5%, as investigation at 21% 
oxygen may have resulted in intrinsic increases in ROS production that would not 
have been controlled for, as previously culture at 21% oxygen was shown to 
decrease cellular levels of the anti-oxidant glutathione compared to the 
physiologically healthy oxygen level of 5% [244]. Furthermore, 21% oxygen has also 
been associated with increase oxidative damage [271].  
Due to the nature of its regulation by Fe2+ dependent PHDs, HIF-1α can be 
stabilised using DFX treatment in higher oxygen levels  by its action as an iron 
chelator [224, 225, 366]. DFX treatment was optimised in stimulated CD4+ memory T 
lymphocytes and 2.5μM DFX was found to be best in the stabilisation of HIF-1α 
treatment, as observed by brighter HIF-1α nuclear staining of CD4+ memory T 
lymphocytes compared to control (figure 5.1). Higher concentrations of DFX resulted 
in reduced HIF-1α stabilisation compared to 2.5μM treatments.  
To investigate the role of redox at different oxygen levels, H2O2 was used at 8.5% 
oxygen, whereas NAC was used at 1% oxygen. The superoxide formed from 
mitochondrial ROS production is rapidly converted to H2O2 by MnSOD [211, 256]. 
H2O2 therefore is the most physiologically relevant ROS with respect to hypoxia, as it 
will be H2O2 that diffuses out of the mitochondria resulting in downstream signalling 
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and protein damage. Therefore, its effects in physiologically healthy oxygen levels 
were investigated. Contrasting experiments were conducted at 1% oxygen to 
determine the effects of antioxidants when oxygen is deficient. Glutathione is a major 
cellular anti-oxidant that scavenges ROS. NAC provides a cysteine for the generation 




























Figure 5.1. 2.5μM DFX is optimum for HIF-1α stabilisation by DFX treatment. 
CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs CD4+ memory 
isolation kit and frozen at -80°C for later analysis. CD4+ CD45RO+ T lymphocytes 
were stimulated with 2μg/ml anti-CD3// 5μg/ml anti-CD28 at 21% oxygen and 
simultaneously treated with the stated concentrations of deferoxamine mesylate 
(DFX) in PBS for 18 hours. A) Cells were assessed by confocal microscopy for their 
expression of HIF-1α. B) Arbitrary analysis of HIF-1α pixel values in lines across 
nuclei revealed a significant increase in HIF-1α expression at 2.5μM DFX. Statistical 
analysis was performed using Paired T test and mean values are shown. ***= 
P>0.001. A minimum of ten cells were assessed across several slides. 2.5μM DFX 
resulted in a higher nuclear HIF-1a signal.  
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5.2.1 Investigating the effects of ROS and HIF-1α stabilisation on CD69 
expression 
CD69 expression was examined at 8.5% oxygen in response to HIF-1α stabilisation 
and ROS treatment, or a combination. CD4+ memory T lymphocytes were treated for 
only 18 hours after equilibration for 24 hours at 8.5% oxygen. Previous studies have 
shown that longer treatment with DFX and H2O2 leads to cells death [[369]; Dr Steve 
Young, personal communication]. As a control, oxygen levels within the incubator 
were changed to 1% oxygen at the time of stimulation after equilibration to 8.5% 
oxygen.  
The data presented in chapter 3 suggested an increase in CD69 expression occurred 
in low environmental oxygen. Therefore, it was hypothesised that an increase in 
CD69 would occur in response to DFX and H2O2 treatment alongside an increase in 
the 1% oxygen control. However, the opposite was observed, with the individual 
treatments, combination treatment and 1% oxygen control all reducing CD69 
expression compared to untreated cells maintained at 8.5% oxygen. Therefore, DFX 
treatment and H2O2 did mimic 1% oxygen treatment in these experiments, but in a 
different manner than hypothesised (figure 5.2). The disparity in these observations 
suggested that the oxygen level during the non-stimulated equilibration period may 
influence later cellular responses to stimulation, such as CD69 expression (figure 
5.2). 
NAC treatment, given for the whole duration of the experiment including the 
equilibration period, did have the expected effect on CD69 expression. 1mM NAC 
treatment significantly reduced CD69 expression at constant 1% oxygen (figure 5.3). 
This reduction was on a par to CD69 expression seen at 8.5% oxygen in (figures 3.3 
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and 3.4). This suggested that redox played a role in the response of CD4+ memory T 













Figure 5.2. HIF-1α and ROS treatment mimic hypoxic treatment on the 
expression of CD69, and reveal the importance of hypoxic pre-exposure before 
stimulation. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs 
CD4+ memory isolation kit and frozen at -80°C for later analysis. CD4+ CD45RO+ T 
lymphocytes were equilibrated for 24 hours to 8.5% oxygen before being treated with 
2.5μM deferoxamine mesylate (DFX), 10μM hydrogen peroxide (H2O2) or both 
simultaneously with stimulation with anti-CD3//anti-CD28. After 18 hours stimulation, 
cells were stained for expression of CD69 and assessed by flow cytometry. A) show 
the gate applied to stimulated cells. B) CD69 expression was determined by 
investigating the mean fluorescence intensity (MFI) at the various treatments. Data is 
representative of at least 2500 cells in the stimulation gate. Statistical analysis was 
performed using Paired T test and mean values are shown in the data. Three 




Figure 5.3. NAC treatment in hypoxia decreases CD69 expression on a par with 
physiologically healthy oxygen levels. CD4+ CD45RO+ T lymphocytes were 
isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for 
later analysis. CD4+ CD45RO+ T lymphocytes were treated with 1mM N-acetyl-L-
cysteine (NAC) and simultaneously equilibrated to 1% oxygen for 24 hours. As a 
control, cells were equilibrated to 1% or 8.5% oxygen without NAC treatment. Cells 
were stimulated for 48 hours and then stained for expression of CD69 and assessed 
by flow cytometry. CD69 expression was determined by investigating the mean 
fluorescence intensity (MFI) at the various treatments. Statistical analysis was 
performed using the Paired Test and mean values are shown. * p< 0.05. **p< 0.005. 
NS non-significant. Data is representative of at least 2500 cells in the stimulation 
gate. Five donors were run at each treatment. NAC treatment resulted in a drop in 





5.2.2 Proximal T lymphocyte signalling is altered in hypoxia 
The disparity in the results described above, compared to Chapter 3, suggested 
equilibration of resting cells at different oxygen levels may influence subsequent 
phenotype post-stimulation. Therefore, the effect of various oxygen levels on 
proximal T lymphocyte signalling machinery in resting cells was examined. The 
phosphorylation of the activatory residue – tyrosine 394 (Y394) - of Lck was chosen 
for investigation, as this is thought to be dominant over the inhibitory residue.  
CD4+ memory T lymphocytes were equilibrated, resting, at a designated oxygen 
level for 24 hours. Paraformaldehyde solution was added to the cultures to a final 
concentration of 4% to fix them at the oxygen level they were maintained at to retain 
the level of Lck phosphorylation established over the equilibration period. Lck 
phosphorylation was then assessed in the fixed cells by staining and flow cytometry. 
A significant reduction in the percentage of positive Lck phosphorylated at Y394 in 
resting CD4+ memory T lymphocytes in 1% oxygen was observed compared to 8.5% 










Figure 5.4. Lck phosphorylation at the activatory tyrosine residue 394 is 
reduced in hypoxia. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi 
MACs CD4+ memory isolation kit and frozen at -80°C for later analysis. CD4+ 
CD45RO+ T lymphocytes were equilibrated at 21%, 8.5%, 3% and 1% oxygen for 24 
hours before being fixed with 4% paraformaldehyde directly in the hypoxystation or 
immediately after removal from 21% incubator. Cells were stained for 
phosphorylation at Tyr 394 on Lck and assessed by flow cytometry. Percentage 
positive cells were determined by comparison with isotype controls. A) Gating 
strategy for Lck Tyr Y394 phosphorylation assessment. B) Lck Tyr 394 
phosphorylation at the oxygen levels stated. Mann Whitney statistical test was used 
for analysis and median values are shown in the data. **p< 0.005. 1%C = constant 
1% oxygen. Data is representative of at least 2500 cells in the R1 gate. A minimum of 
8 donors were investigated at each oxygen level.   
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5.2.3 The effect of ROS and HIF-1α stabilisation on proximal T lymphocyte 
signalling 
As DFX and H2O2 treatment had to some extent mimicked the effects of switching to 
1% oxygen after equilibration at 8.5% oxygen on CD69 expression, the effect of 
these treatments on Lck activation was also assessed at 8.5% oxygen. Treatments 
were given from the beginning of the experiment for 18 hours, and cells were again 
resting. The pool of active Lck decreased in response to both treatments, albeit non-
significantly (figure 5.5). H2O2 treatment again had the largest effect, but a 
combination of the treatments restored the level of active Lck within the cells. 
Interestingly, the pool of active Lck was reduced in this experiment at 8.5% oxygen 
controls compared to the 24 hour observations (figure 5.4), suggesting duration of 














































Figure 5.5. The effect of HIF-1α and ROS treatment on proximal T lymphocyte 
signalling. CD4+ CD45RO+ T lymphocytes were isolated using a Miltenyi MACs 
CD4+ memory isolation kit and frozen at -80°C for later analysis. CD4+ CD45RO+ T 
lymphocytes were treated with 2.5μM deferoxamine mesylate (DFX), 10μM hydrogen 
peroxide (H2O2), or both, and equilibrated to 8.5% oxygen for 18 hours. As a control, 
no treatment was given. Cells were stained for phosphorylation at Tyr 394 on Lck and 
assessed by flow cytometry. Percentage positive cells were determined by 
comparison with isotype controls. Mann whitney statistical test was used for analysis 
but no statistical differences were found. Medians are shown in the data. Data is 
representative of at least 2500 cells in the stimulation gate. Five donors were 







The effect of NAC on CD69 expression suggested cellular redox may play a role in 
the response of CD4+ memory T lymphocytes to hypoxia. As Lck had revealed 
differences in the level of activation at different oxygen levels and in response to 
H2O2/ DFX treatments, levels of the activatory phosphorylation at Y394 were 
determined in resting CD4+ memory T lymphocytes after 24 hours treatment with 
NAC at 1% oxygen. NAC treatment resulted in the significant increase in Lck Y394 
phosphorylation at 1% oxygen compared to non-treated cells (figure 5.6). This 
mimics the effect of increasing oxygen levels, as at 8.5% oxygen a significant 













































Figure 5.6. NAC treatment in hypoxia reveals the redox regulation of proximal T 
lymphocyte regulation. CD4+ CD45RO+ T lymphocytes were isolated using a 
Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for later analysis. 
CD4+ CD45RO+ T lymphocytes were treated with 1mM N-acetyl-L-cysteine (NAC), 
or no treatment, and equilibrated for 24 hours to 1% oxygen. Cells were stained for 
phosphorylation at Tyr 394 on Lck and assessed by flow cytometry. Percentage 
positive cells were determined by comparison with isotype controls. Mann Whitney 
test was used for statistical analysis and median values are shown in the data. * 
p<0.05. Data is representative of at least 2500 cells in the T lymphocyte gate. A 
minimum of nine donors were investigated for each treatment. NAC treatment 
resulted in an increase in Lck Tyr 394 phosphorylation at 1% oxygen. The same 





5.2.4 The influence of HIF-1α stabilisation and ROS on T helper cell subset 
cytokines and markers 
In addition to investigating the effect of DFX and H2O2 treatment on CD69 and Lck 
expression, an experiment was performed to examine their effects on the phenotypic 
markers investigated in chapter 4. Surface and intracellular staining was performed 
after 18 hours stimulation with the different treatments.  
The combination of DFX and H2O2 treatment resulted in similar patterns in cytokine, 
transcription factor and surface marker expression compared to the patterns 
observed between 8.5% and constant 1% oxygen culture after 48 hours stimulation 
(as described in chapter 4). With regards to pro-inflammatory cytokines and markers, 
Tbet+ and IL-17A intracellular cytokine staining revealed reductions when cells were 
exposed to both DFX and H2O2, similar to what is see at constant 1% oxygen. CCR6 
expression also appeared to be increased after exposure to H2O2. However, n 
numbers and experimental repeats were limited, and would require increasing in 
future.  
With regards to the other panel investigated, CCR4 and CTLA-4 expression was 
reduced when H2O2 treatment was given alone or in combination with DFX, as did 
the percentage of CTLA-4+ Foxp3+ cells. IL-4 and IL-10 were barely detectable by 
intracellular cytokine staining after 18 hours stimulation, and therefore were not 










Figure 5.7. The effect of DFX and H2O2 treatment on markers associated with 
Th1 and Th17 pro-inflammatory T helper cells. CD4+ CD45RO+ T lymphocytes 
were isolated using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C 
for later analysis. A) shows the FS/SS plot with the selected gate on stimulated cells. 
B) Markers associated with pro-inflammatory T helper subsets were assessed by 
intracellular staining and flow cytometry at 8.5% oxygen. 2x105 cells were 
equilibrated to 8.5% oxygen for 24 hours, before being treated with 2.5μM 
deferoxamine mesylate (DFX) and/or 10μM hydrogen peroxide (H2O2) at the same 
193 
 
time as being stimulated with 2μg/ml anti-CD3/ 5μg/ml anti-CD28 for 18 hours.  
2μg/ml brefeldin A treatment was given for the last three hours of stimulation. Three 
donors were investigated for each treatment except for 8.5%-8.5% IL-17 where n=2. 
Experiments were performed on two different occasions. Example dot plots for T-bet 
vs IFNg are shown. Statistical analysis was performed using Mann Whitney test, but 






Figure 5.8. The effect of DFX and H2O2 treatment on markers associated with 
Th2 and regulatory T helper cells. CD4+ CD45RO+ T lymphocytes were isolated 
using a Miltenyi MACs CD4+ memory isolation kit and frozen at -80°C for later 
analysis. A) shows the FS/SS plot with the selected gate on stimulated cells. B) 
Markers associated with anti-inflammatory T helper subsets were assessed by 
intracellular staining and flow cytometry at 8.5% oxygen. 2x105 cells were 
equilibrated to 8.5% oxygen for 24 hours, before being treated with 2.5μM 
deferoxamine mesylate (DFX) and/or 10μM hydrogen peroxide (H2O2) at the same 
time as being stimulated with 2μg/ml anti-CD3/ 5μg/ml anti-CD28 for 18 hours.  
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2μg/ml brefeldin A treatment was given for the last three hours of stimulation. Three 
donors were investigated for each treatment. Example CTLA-4 vs Foxp3 dot plots are 
shown. Experiments were performed on two difference occasions. Statistical analysis 
was performed using Mann Whitney test, but no significant differences were 
observed. Median values are shown in the data. 
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5.3 Discussion  
In this chapter the mechanisms behind the effects of hypoxia on CD4+ memory T 
lymphocytes have been explored by investigating both ROS exposure and the 
stabilisation of HIF-1α, two outcomes of cellular exposure to hypoxia reported in the 
literature [204, 224, 238, 255, 256].  ROS exposure was examined by treating cells 
with 10μM H2O2, and HIF-1α stabilisation was assessed by treating cells with 2.5μM 
DFX. DFX stabilises HIF-1α via its action as an iron chelator, as the PHDs that 
normally regulate HIF-1α protein stability are dependent on both dioxygen and iron 
as a co-factor [224, 225, 366]. H2O2 was found to have a slightly greater effect than 
HIF-1α stabilisation, suggesting that redox may influence CD4+ CD45RO+ T 
lymphocyte behaviour.  In support of this, the addition of the anti-oxidant NAC in 
hypoxia reversed the pattern observed in hypoxia and with H2O2 treatment, 
confirming that this may be the case.  
Initially, CD69 expression was assessed in response to different treatments due to 
the strong upregulation observed in response to constant 1% oxygen in Chapter 3 
(figures 3.3 and 3.4). Responses, however, depended on when the treatments were 
given. Both H2O2 and DFX were given to cells at the time of stimulation, after a 
period of equilibration at 8.5% oxygen. A switch to 1% oxygen at stimulation was 
used as a control in these experiments. H2O2 and DFX mimicked 1% oxygen in their 
effect on CD69 with decreased expression. However, this was contrary to what 
shown in Chapter 3, where CD69 expression was increased at constant 1% oxygen. 
Two factors (other than the treatments) were altered in these experiments compared 
to those performed in previous chapters. Firstly, cells were equilibrated for 24 hours 
at 8.5% oxygen, but a switch in oxygen level to 1% oxygen at the time of stimulation 
was used as a control. Secondly, cells were only stimulated for 18 hours when 
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treated with H2O2 and DFX due to their toxicity, whereas CD69 expression was 
previously assessed after 24 hours stimulation. As only an additional 6 hours 
stimulation would be needed for the cells to upregulate CD69 at 1% oxygen, it was 
assumed that the latter difference in experimental procedure was not the cause for 
the difference in results observed. Instead, it is probable that the oxygen level during 
the equilibration period influenced subsequent cellular responses to stimulation. 
These results did show that under these equilibration conditions, H2O2 and DFX 
treatment mimicked the effect of oxygen levels of 1% oxygen, but also show that 
environmental oxygen levels have an effect even on resting cells. In contrast, cells 
treated with NAC were treated from the start of the experiment, as NAC is not toxic to 
the cells over time. The effect of NAC treatment on CD69 expression at 1% oxygen 
also highlight the potential role redox plays in determining T lymphocyte cell biology 
as it reduced the effect of 1% oxygen on CD69 to a level on a par with 8.5% oxygen. 
Due to the observation that equilibration appeared to influence subsequent 
responses to hypoxia, proximal T lymphocyte signalling was investigated via the 
determination of phosphorylation of the activatory tyrosine residue on the kinase Lck. 
Phosphorylation at this residue is thought to be dominant over an alternative 
inhibitory residue [75, 84], and allows the kinase to phosphorylate downstream 
targets such as ITAMs in the TCR:CD3 complex, thus promoting downstream 
signalling [79]. Regulation of T lymphocyte signalling in response to hypoxia has 
already been touched upon within this thesis with the observation of differences in 
expression of CD3 and CD45RO at different oxygen levels in stimulated cells 
(chapter 3).  
198 
 
In this chapter, the population of active Lck in resting cells in 1% oxygen was 
decreased when compared to 8.5% oxygen. As the population of active Lck in resting 
cells is thought to determine TCR:CD3 ITAM phosphorylation post-stimulation and 
therefore subsequent signalling strength [75], this is a key finding. A smaller pool of 
active Lck may result in a lower signal being delivered to the lymphocyte [75]. Within 
a population of lymphocytes, this may result in a smaller number of cells passing the 
threshold for activation. Conversely, it may also protect cells from an overtly large 
activatory signal that could result in cellular apoptosis, and therefore may protect 
autoreactive cells from peripheral deletion [50, 52]. In environmental oxygen levels of 
around 1%, cells that are activated may be less activated than their 8.5%-cultured 
counterparts. This may have downstream effects on the lymphocytes function, such 
as reduced proliferation [81, 370].  
The effect of the different treatments on Lck activatory phosphorylation were 
examined to see whether the redox environment and/ or HIF-1α stabilisation 
influenced proximal T lymphocyte signalling. As cells were resting in these 
experiments, all treatments were given from the start. Both H2O2 and DFX were 
again assessed at 8.5% oxygen culture conditions, and NAC at 1% oxygen. In these 
experiments, H2O2 and DFX resulted in a drop in Lck-394 phosphorylation when 
compared to 8.5% oxygen, which mimicked 1% oxygen treatments in earlier 
experiments (figure 5.4). H2O2 treatment had a greater influence than DFX, and NAC 
reversed the pattern observed at 1% oxygen. Therefore, redox appears to be an 
aspect of the hypoxic environment that can influence both proximal T lymphocyte 
signalling molecules, and the cellular response that occurs after stimulation has 
occurred. DFX can behave as an anti-oxidant [371], and therefore may have 
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alleviated some of the oxidative stress experienced by the cells in DFX plus H2O2 
treatments. This may have reduced the effects of HIF-1α stabilisation on the cells. 
ROS has been suggested to be able to stabilise HIF-1α expression [256], and 
therefore, conversely, in the combination treatments DFX may have reduced any 
HIF-1α stabilisation induced by H2O2. Future work would need to be done to decipher 
the exact mechanism by which ROS influences both CD69 expression and proximal 
T lymphocyte signalling.  
T helper subset-associated cytokines and markers were also assessed in response 
to DFX and H2O2 treatment, and to some extent mimicked the patterns of cytokine, 
transcription factor and surface marker expression observed at constant 1% oxygen 
compared 8.5% oxygen culture after 48 hours stimulation (as described in chapter 4). 
The combination of DFX and H2O2 induced subtle changes in T helper subset 
phenotypic markers, suggesting that both HIF-1α and ROS treatment in hypoxic 
conditions may be required to fully influence CD4+ T lymphocyte phenotypic 
preferences.  
However, in this chapter all of the experiments performed with DFX and H2O2 
revealed only trends, partly due to low numbers of repeats, and future work would 
need to be done for better understanding. The cytokines and marker data was similar 
to CD69 data in that not all the data agreed with previous results. For example, 
CTLA-4 expression was reduced when H2O2 was present. Therefore, there may be 
additional influences of these treatments occurring that need to be further 
investigated. Furthermore, DFX and H2O2 treatments had the greatest similarities to 
the 48 hour stimulations from chapter 4, not the 24 hour stimulations, but were only 
given for 18 hours. It is possible that HIF-1α stabilisation and ROS treatment 
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accumulate gradually in hypoxic cultures, in contrast to the DFX and H2O2 treatments 
which were administered that would have resulted in a more acute response, and 





6. GENERAL DISCUSSION 
6.1 Introduction 
CD4+ T lymphocytes are thought to play a role in the pathology of many chronic 
inflammatory environments [165], and therefore understanding their behaviour in 
response to the stresses present in these environments is important for successful 
future therapeutic intervention. CD4+ T lymphocytes experience many different 
oxygen levels physiologically, from the hypoxic thymus [245, 246] and lymph nodes 
[239, 245], to more oxygen-perfused blood [241]. With regards to CD4+ memory T 
lymphocytes; central memory are much more likely to experience antigen in the 
relatively low-oxygen environment of the lymph node; whereas effector memory will 
directly enter - and be stimulated in - affected tissues which may already be deprived 
of their normal oxygen levels. Therefore, both types of CD4+ memory T lymphocyte 
may normally function in physiologically low-oxygen environments.  
Chronic inflammatory environment such as the rheumatoid joint are known to be 
lower in oxygen than their healthy-tissue counterparts, and this hypoxia is thought to 
persist [199]. Therefore, the infiltrating cells entering a chronic inflammatory 
environment may experience potentially very low oxygen levels. Evidence suggests 
that T lymphocytes in these environments behave differently than expected in acute 
inflammatory situations. In the rheumatoid joint, T lymphocytes appear to be in a 
‘stuck’ phenotype, with delayed apoptosis [372], and depressed  cytokine production 
[155, 156, 176, 180, 373] and proliferation [172, 173]. In this thesis the influence that 




6.2 Alterations in proliferation and proximal T lymphocyte signalling reveal 
fundamental influence of environmental oxygen on effector memory CD4+ T 
lymphocyte biology  
In this study, at the physiologically healthy oxygen level of 8.5% oxygen, CD4+ 
CD45RO+ T lymphocyte proliferation was greatest compared to the other oxygen 
levels examined. This agrees with previous studies that observed increases in long-
term proliferation at 5% oxygen, an oxygen level also deemed as physiologically 
healthy [235, 284, 285, 288]. Investigation at the slightly higher oxygen level of 8.5% 
is novel, and may further reflect the CD4+ T lymphocyte response to being stimulated 
at a reasonably perfused tissue. However, anatomic sites in which T lymphocytes are 
presented antigen are often more hypoxic in nature [9, 239, 245, 246], and therefore 
T lymphocytes may only be rarely stimulated in oxygen levels of around 8.5% 
oxygen. Proliferative responses were expected to be most robust in central memory 
T lymphocytes. Specifically, this particular memory subset would probably not be 
exposed to oxygen levels higher than 5% when presented with antigen, as revealed 
by studies detailing oxygen levels of between 0.5-4.5% [239], and 1.3-3.3% [245] in 
the spleen. Therefore, the physiological relevance of this result needs to be better 
assessed in the future by prior separation of central and effector memory T 
lymphocytes before exposure to antigenic stimulation at different oxygen levels.  
Regarding the lower oxygen levels observed in lymph nodes; a reduction in 
proliferation was observed at 3% oxygen and constant 1% oxygen, and was also 
observed in 21% oxygen cultures, and suggests that the oxygen environment of the 
lymph node may limit T lymphocyte responses to antigen.  A reduction in proliferation 
in hypoxia (1-3% oxygen) has been observed previously, although a comparison of 
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1% oxygen with 3% and 8.5% oxygen is novel [235, 240, 275, 289, 290]. 
Furthermore, RA T lymphocytes directly stimulated from the RA joint had reduced 72 
hour proliferation in comparison to those rested at 21% oxygen levels for 5 days 
[316]. As we observed better proliferation in the reperfusion injury group compared to 
constant 1% oxygen treatments, it is possible the later addition of oxygen may 
enhance proliferation, despite the oxidative environment, through mechanisms as of 
yet unknown.  
The lack of proliferation at 21% oxygen observed is contrary to previous published 
results with mixed T lymphocyte populations [235, 244, 281]. In the current study 
using CD4+ memory T lymphocytes, there was an increase in the number of cells 
that did not undergo any rounds of proliferation at 21% oxygen. Due to their exposure 
to previous inflammatory responses, it is possible that CD4+ memory T lymphocytes 
are more adapted to hypoxic environments, and that the hyper-oxic environment of 
21% oxygen levels is inappropriate for their culture. In support of this concept, CD4+ 
T lymphocytes lose mitochondrial mass as they differentiate [374]. Exposure to 
higher oxygen levels would result in overloading of memory T lymphocyte 
mitochondria, and may result in the production of ROS as previously observed after 
culture at 21% oxygen [244, 271]. Mixed T lymphocyte populations cultured at 21% 
oxygen have been shown to have reduced glutathione compared to physiologically 
healthy oxygen levels (5%) [244] and have increased ROS damage [240, 271].  
Hypoxia also results in the increased release of ROS from both the mitochondrial 
electron transport chain [254-256] and extra-mitochondrial sources [375]. Hypoxia 
has therefore been associated with an increase in oxidative damage in cell culture 
specifically in stimulated CD4+ T lymphocytes [235, 240]. This phenomenon of ROS 
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production at both extremes of oxygen availability has also been described for 
skeletal muscle [376]. The redox environment has been previously implicated in 
negatively regulating T lymphocyte proliferation [173, 235, 377]. Therefore when a 
redox imbalance occurs in both hyper- or hypo- oxic conditions, it may result in an 
oxidative intracellular environment that leads to reduced long-term proliferation, and it 
is possible that the redox environment resulting from culture at these oxygen levels 
may play a role in inhibiting long term proliferation in CD4+ memory T lymphocytes. 
Furthermore, hypoxia has been previously found to inhibit membrane potential by 
acutely inhibiting Kv1.3 channel function and lowering its membrane expression over 
24 hours exposure to 1% oxygen [275] and this additional mechanism may have 
resulted in the inhibition in proliferation observed in this study.  
There could be alternative explanations for the differences in proliferative responses 
observed at different oxygen levels. The observation that the population of Lck in 
resting memory T lymphocytes differs in its activation status depending on which 
oxygen environment it has been exposed to for the last 24 hours suggests that 
proximal T cell signalling may be involved in the T lymphocyte response to 
environmental oxygen. T lymphocyte proliferation is dependent on a high number of  
TCR:CD3 ITAMs being phosphorylated post ligation [321], and it is therefore possible 
that the higher population of active Lck that would have been present after 24 hours 
equilibration at 8.5% oxygen would have allowed for better initiation of proliferative 
responses, whereas the lower population of active Lck at 1% oxygen may have 
reduced any subsequent proliferation. The decrease in the population of active Lck 
contradicts current literature as previously Lck Tyr 394 phosphorylation was found to 
be unaltered after 3 minutes exposure to 1% oxygen compared to 21% oxygen [233]. 
205 
 
As 24 hours elapsed before Lck phosphorylation status was assessed in this study, it 
is possible that Lck activation status changes over time (and this was seen from 
comparisons of 18 hours and 24 hours equilibration). The reason for the decrease 
observed could be greater auto-phosphorylation, or decreased dephosphorylation by 
phosphatases such as LYP. The difference in Lck activation in resting cells at 
different oxygen levels also highlights how the physiological oxygen environment may 
influence T lymphocyte biology before stimulation. Hence, T lymphocytes stimulated 
rapidly upon entering a hypoxic tissue from a well-perfused blood vessel may 
respond differently than if a delay in stimulation occurs once the cell has entered the 
tissue.  
As RA synovial T lymphocytes also have lowered phosphorylation of the TCR:CD3 
complex [156, 172] it is possible that the effect of low oxygen levels on proximal T 
lymphocyte signalling observed in this in vitro study has some physiological 
relevance. Furthermore, a genetic alteration in the gene for LYP, ptpn22, is the 
second highest ranking single nucleotide polymorphism (SNP) associated with risk 
for RA, further suggesting that TCR proximal signalling machinery may be important 
in the development of the disease [157, 378, 379]. The outcome of this SNP is 
thought to be gain-of-function protein [159, 161, 162].  In this instance, the LYP 
molecule will be over-active, dephosphorylating the activatory residues of the Lck 
molecule more readily, thus mimicking what was observed in hypoxia. Many patients 
do not carry the PTPN22 polymorphism, and hence it is interesting that 
environmental oxygen levels can mimic its outcome.  
Potential mechanisms behind differences in the population of active Lck at different 
oxygen levels may also be due to the redox environment present. H2O2 was found to 
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non-significantly decrease Lck activatory residue phosphorylation at 8.5% oxygen, 
whereas NAC treatment significantly increased Lck activation at 1% oxygen. As NAC 
is also known to inhibit NFκB [367] it would need to be further confirmed that the 
redox environment was involved in T lymphocyte regulation. The stabilisation of HIF-
1α at 8.5% oxygen via DFX treatment appeared to have less of an effect than H2O2, 
and when the treatments were combined a small increase in activated Lck was 
observed when compared with the H2O2-only treatment. This could be due to the fact 
that DFX has the ability to act as an antioxidant [371], and could therefore counteract 
the effects of ROS treatment. However, these data need repeating before more solid 
conclusions are made from them. Alternative hypoxia mimetics, such as cobalt 
chloride, could be utilised in the future to further assess the effect of HIF-1α on Lck 
activation status. H2O2 treatment may have been able to stabilise some HIF-1α 
expression, as ROS has previously been shown to inhibit PHD activity [196, 224]. 
This would need to be investigated more in the future to delineate the different effects 
that redox can have on hypoxic cell biology. However, as HIF-1α is not necessarily 
stabilised in resting T lymphocytes in hypoxia [204], it may be that it does not play 
much of a regulatory role in this situation.  
Redox is known to influence T lymphocyte biology, and the TCR signalling machinery 
has been shown to be particularly susceptible to this [380]. Lck protein levels have 
been shown to drop in the presence of ROS overtime due to proteosomal targeting, 
and this was linked to a decrease in proliferation [380]. This is also very interesting 
when considering chronic autoimmune environments such as the rheumatoid joint, 
where many ROS-producing neutrophils can be observed. Direct culture with 
activated neutrophils was shown to reduce T lymphocyte proliferation [380], and 
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therefore the oxidative environment generated by neutrophils and low environmental 
oxygen in the RA tissue may give rise to the depressed phenotype associated with 
RA T lymphocytes.  
 
6.3 Expression of surface markers and markers of activation are altered at 
different oxygen levels, implying different effector functions 
The assessment of activation markers is often used to investigate cellular responses 
to particular stimuli or treatments. The expression of CD69, CD3, CD45RO and HLA-
DR at different oxygen levels is discussed below. HLA-DR expression was not found 
to be significantly different in response to different oxygen levels. HLA-DR is a 
molecule normally associated with APCs. However, its expression is also 
upregulated on CD4+ T lymphocytes as a late marker of activation [308, 381]. HLA-
DR expression has been observed in the RA joint associated with T lymphocytes 
[170, 316]. Due to its nature as a ‘late’ activation marker, it is possible HLA-DR 
expression needs to be assessed over a longer timescale.  
 
6.3 1 The activation marker CD69 is upregulated at lower oxygen levels 
The early activation marker CD69 was observed to be upregulated in response to 1% 
oxygen at both 24 and 48 hours compared with 8.5% oxygen. An upregulation in 
CD69 has previously been described at 5% oxygen compared with 21% oxygen 
culture in PBMCs [244, 288] but the description of a specific upregulation in CD4+ 
memory T lymphocytes at lower oxygen levels is novel. CD69 expression is rapid in 
response to stimulation, but can depend on the stimulation method used. After TCR 
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engagement, the method used within this current study, surface expression peaks 
between 18-24 hours [312].  
 
The expression of CD69 on lymphocytes is important in the inhibition of thymic and 
lymph node egress via the internalisation of sphingosine-1-phosphate receptors, 
which normally bind tissue S1P gradients to promote migration [314, 315]. Both 
mature T lymphocytes and thymocytes express CD69 after stimulation [308, 313, 
314], as it plays an important role in inhibiting lymphocyte migration out of lymphoid 
organs before they are fully developed and also allows them to provide support to B 
lymphocytes [314]. CD69 deficiency has previously been associated with a lack of B 
lymphocyte help from CD4+ T lymphocytes [382]. Therefore, the finding that the 
expression of CD69 is increased on the surface of CD4+ memory T lymphocytes in 
low oxygen suggests that environmental oxygen levels can further promote 
lymphocytes residence within a tissue or organ. For example, central memory T 
lymphocytes activated in a lymph node will upregulate CD69 more if environmental 
oxygen levels are low. This will therefore result in their longer duration resident in the 
lymph node, and may aid their effector development and function. On the other hand, 
the upregulation of CD69 in the inflammatory tissue may also have a similar effect. 
S1P is found on the surface of all cells [314], and therefore the upregulation of CD69 
may also influence migration of a lymphocyte through the tissue via S1P receptor 
internalisation [314]. In a chronic inflammatory site, altered migration may be 
reduced, and the cells may spend weeks in the tissue, as determined by T 
lymphocyte CD45RBdull status (a marker that is decreased over several rounds of 
proliferation and stimulation)  [306]. It would be interesting to determine what role 
CD69 plays in this.  
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The upregulation of CD69 in hypoxia suggests it may play an important role in 
immunity. In a murine model of CIA CD69 deficiency alleviated symptoms [317, 320]. 
However, the protection from disease may have been due to a lack of CD69 
expression on neutrophils, although this was not directly shown experimentally [320]. 
In contrast, CD69 deficiency has been suggested to result in a more pro-
inflammatory phenotype [317, 319]. CD69 is readily detected in chronic inflammatory 
environments [170, 383] such as lupoid kidneys, tumours and the rheumatoid joint,  
where around 60% of CD4+ T lymphocytes from RA synovial tissue were CD69 
positive [40, 170, 311, 316, 383, 384].  
 
Despite the lack of an extracellular ligand, CD69 is thought to have signalling 
potential [309, 310, 313]. In T lymphocytes it co-precipitates with a 40kDa protein 
suspected to be involved in signal transduction [169, 310] and CD69 cross-linking 
can result in ERK phosphorylation [319] . CD69 is also constitutively serine 
phosphorylated, suggesting downstream signalling is potential in physiological 
settings [309, 310]. When the crystal structure of CD69 was determined, an 
unexpected electron density was observed at the site where ligand binding was 
predicted. This electron density suggested a carbohydrate may be a potential ligand 
for CD69, such as those on other surface molecules [311]. CD69 crosslinking results 
in a sustained influx of cellular calcium. This can induce proliferation and cytokine 
production alongside PKC activation (such as PMA treatment). CD69 therefore may 
act as a co-stimulatory molecule in immune cell signalling [309-311, 313], and its 
upregulation in low environmental oxygen conditions may result in as-of-yet unknown 
signals being sent into cells expressing it. Futhermore, failure of CD69 expression 
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has been associated with a lack of a specific memory T lymphocyte population in the 
bone marrow that is associated with the production of high affinity antibodies [382].  
 
The higher and sustained expression of CD69 observed at lower oxygen levels may 
also be detrimental. CD69 has been implicated in the T lymphocyte cell-contact 
dependent upregulation of TNFα from macrophages, including synovial T lymphocyte 
mediated TNFα monocyte production  [28, 40, 164, 169, 194, 195] via a yet-to-be 
identified receptor or ligand. This is particularly poignant when investigating chronic 
inflammatory conditions where TNFα is thought to play a pathological role, such as 
the rheumatoid joint. Anti-TNFα therapy has proved to be extremely beneficial in the 
treatment of RA [35, 194]. Macrophages are thought to be the main producers of 
TNFα in the RA joint, but T lymphocytes are thought to be heavily involved in 
promoting its production. Therefore, in hypoxic, chronically inflamed tissues, CD69 
may play a role in perpetuating inflammation. However, it is possible that T 
lymphocytes are not in close proximity with macrophages in the RA joint [175], 
although some argue they are localised [194]. Further ex vivo studies are required to 
confirm whether CD4+ T lymphocyte CD69 upregulation is involved in human 
autoimmune disease.  
 
Interestingly, CD69 expression is associated with a subset of tissue-resident T 
lymphocytes [55, 58, 61, 382]. Unlike CD4+ effector memory T lymphocytes, these T 
lymphocytes do not circulate through the blood and tissue, but remain in tissue after 
the resolution of inflammation, and CD69’s associated suggests that it has a 
functional role in this cell population. The finding that CD69 expression is upregulated 
on CD4+ memory T lymphocytes in hypoxia is therefore interesting, as it suggests 
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that oxygen levels may influence the generation and maintenance of tissue resident 
CD4+ T lymphocytes. More longitudinal studies would have to be performed to 
confirm this. It is also interesting to note that CD69 is abnormally upregulated in the 
rheumatoid joint [40, 170, 316]. This could be linked to the development of TRM in the 
rheumatoid joint. It may be the case that not all T lymphocytes infiltrate into the RA 
synovium, but some could have ‘set up home’ within the joint environment before 
chronic inflammation was initiated. It also suggests that T lymphocytes that have 
migrated into the joint may have differentiated to a TRM -like phenotype. Future work 
in discerning whether this is in fact the case, and the effect this may have on 
pathology, may be of great benefit to the understanding of chronic inflammatory 
diseases. As CD69 expression may be directly involved in the persistence of TRM 
populations [55, 382] it is possible that its upregulated expression also results in the 
maintenance of T lymphocytes in chronic inflammatory sites.  
CD69 upregulation at 1% oxygen may be due to differences in proximal T lymphocyte 
signalling. CD69 expression under both DFX and H2O2 treatment mimicked that of 
the relevant 1% oxygen control, albeit non-significantly. However, the 1% oxygen 
control revealed a different pattern as to that previously obtained at stimulation at 1% 
oxygen, and this was probably due to the fact that before they were stimulated and 
switched to a 1% oxygen environment, they were equilibrated at 8.5% oxygen 
(whereas before they had been equilibrated at 1% oxygen). Therefore, the oxygen 
level resting cells experience may influence their subsequent biology, even if the 
oxygen level subsequently alters. This could have profound implications on cells 
circulating in the blood and then entering tissue and being activated, compared to 
those resident in tissue that are subsequently stimulated. Out of the treatments 
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investigated in this thesis, H2O2 treatment provided the closest parallel to the 1% 
oxygen control. In contrast, the anti-oxidant N-acetyl cysteine (NAC) reduced CD69 
expression at 1% oxygen to levels close to those observed at 8.5% oxygen. 
Therefore, redox may play an important role in determining CD69 expression on 
CD4+ T lymphocytes. As environmental oxygen levels can cause alterations in 
cellular redox status, this may be one way in which differing environmental oxygen 
levels influence CD4+ memory T lymphocyte biology.  
 
6.3.2 The key signalling molecule CD3ε reveals a different pattern of 
expression at different oxygen levels.  
CD3ε surface expression was observed to alter over time depending on 
environmental oxygen level. After 24 hours, there was no significant difference 
between cells stimulated at 8.5% oxygen and those stimulated at constant 1% 
oxygen. However, by 48 hours, the expression of CD3ε in 1% oxygen had 
significantly increased, whereas cells at 8.5% oxygen continued to decrease their 
expression. A decrease in TCR:CD3 complex expression is expected after 
stimulation, and has previously been attributed as an intrinsic regulatory mechanism 
to limit further activation [322-325]. TCR:CD3 complex surface expression is not 
static, and normally cycles through constant recycling via exo- and endo- cytosis 
[323]. There is some disagreement as to whether decreased exocytosis [323] or 
increased endocytosis [325], results in the reduction of TCR:CD3 complexes at the 
surface, and there is some data suggesting they are released from the surface of the 
cell [72].  
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The observed increase in CD3ε expression in constant 1% oxygen over time post-
stimulation suggests that this cycling is altered in different oxygen levels. As cellular 
granularity was also observed to be increased in constant 1% oxygen compared to 
8.5% oxygen, it is possible that CD4+ memory T lymphocytes in 1% oxygen contain 
more intracellular vesicles involved in recycling of several different molecules. The 
TCR:CD3 complex could be one of these molecules and hence its expression may 
be upregulated.  Physiologically, this increased surface TCR:CD3 expression may 
allow T lymphocytes to prolong exposure to antigen in more hypoxic tissues. In the 
inflamed lymph node, as cells proliferate, available antigen is thought to become 
reduced [54]. As cells are proliferating, it can also be presumed that a drop in 
available oxygen may occur within the lymph node. Therefore, if cells that migrate in 
to the lymph node later upregulate CD3ε in response to decreased oxygen levels, 
they stand a greater chance of sustained TCR:CD3 contact with an APC.  Duration of 
exposure to antigen is thought to decide whether naïve T lymphocytes become 
effector or central memory T lymphocytes [54, 62], and reduced duration is also 
associated with the development of an anergic phenotype. Therefore, the hypoxic-
induced surface upregulation of the TCR:CD3 complex may influence CD4+ T 
lymphocyte biology.  
 
6.3.3 The memory T lymphocyte marker, CD45RO, is expressed at different 
levels at different oxygen levels.  
In this thesis an increase in CD45RO expression was observed at 3% oxygen. A 
complete lack of CD45RO inhibits T lymphocyte signalling due to increased inhibitory 
phosphorylation of Lck in resting cells [88, 160]. Conversely, CD45RO 
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overexpression also results in a reduction in signalling [328], whereas intermediate 
expression levels (10-60% of wild-type) result in an overactive T lymphocyte 
response due to a lack of Lck Y394 dephosphorylation [88]. Hence a fine balance in 
CD45RO isotype expression needs to be maintained for proper T lymphocyte 
signalling, and to pass the signalling threshold required for proper activation of the 
cell as set by Lck activation status. Due to the alterations in cellular signalling that 
subtle changes in CD45RO expression can incur, it is difficult to predict what effect 
increase CD45RO expression at 3% oxygen may have on subsequent cellular 
responses and stimulation. 
As the CD4+ T lymphocytes in this study expressed normal levels of CD45RO, it is 
possible that the small increase in CD45RO expression at 3% oxygen may have 
promoted further T lymphocyte signalling via the dephosphorylation of tyrosine 505 
(Y505) on Lck. A correlation between CD45RO expression levels and Lck Y505 
dephosphorylation has been previously observed in resting cells [88]. Indeed, the 
upregulation of CD45RO post-stimulation at 3% oxygen would  probably only have its 
full effect on the Lck pool when cells return to a resting state, as this is when these 
two molecules are again exposed to each other [73, 88]. As the cells used 
experimentally in this study were mainly memory, it is possible that many of them 
would not survive the stimulation process. Future studies into the expression of 
CD45RO on memory cells generated from naïve T lymphocytes stimulated at 
different oxygen levels could be of benefit in further deciphering whether this 
observation has any functional applications.  
In the context of the lymph node, in which 3% oxygen may be the local environmental 
oxygen level [239, 245], increased activation may be beneficial as it will improve the 
215 
 
chances of full activation. However, in the context of autoimmunity, this reduction in 
the signalling threshold required to activate a cell may be detrimental. As the average 
oxygen levels of the RA joint are also 3% [199-201], it is possible that CD45RO 
expression is increased in autoreactive CD4+ T lymphocytes migrating into this 
environment. If they are subsequently stimulated in the RA tissue, the increase in 
CD45RO expression may result in a greater number of T lymphocytes successfully 
becoming re-activated over the course of exposure to several antigen-bearing cells. 
The opposite is also possible, however, as CD45RO is also thought to be able to 
dephosphorylate the activatory residue on Lck, Y394, especially at higher CD45RO 
membrane concentrations [88, 160]. Therefore, as CD45RO levels increase, it is 
possible that the Lck molecules will also be inactivated, and downstream signalling 
will be inhibited.  
 
6.4 Cytokine production at different oxygen levels is altered  
Cytokine production is a cardinal response of CD4+ T lymphocytes to stimulation.  In 
this thesis, differences were observed in the balance of pro- to Th2/anti-inflammatory 
cytokine production at different oxygen levels. An increase in pro-inflammatory 
cytokines was observed at lower oxygen levels, whereas an increase in the ratios of 
IL-4, IL-5 and IL-10 were observed at 8.5% oxygen. Additionally, an upregulation in 
the expression of IL-10 was observed at 21% oxygen. Despite the differences 
observed being subtle, in a chronic inflammatory environment where successive 
cohorts of lymphocytes continually migrate into the tissue, subtle variances may have 
cumulative effects on local inflammatory responses and consequently influence 
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pathology. In an environment where cells are in close contact, the overall balance of 
cytokine production will be important in either an autocrine or paracrine manner.  
 
6.4.1 Constant 1% oxygen is more pro-inflammatory in nature 
Despite the reduction in cytokine production in more severe hypoxia, the results in 
this study do suggest that in lower environmental oxygen levels a more pro-
inflammatory phenotype may be favoured. This agrees with the pro-inflammatory 
nature of the chronically inflamed environment of established RA [30, 35]. Increasing 
ratios of pro-inflammatory cytokines at 1% oxygen compared to 8.5% oxygen were 
observed and intracellular cytokine staining after 24 hours stimulation suggested that 
IFNγ expression was greatest at 21% oxygen, constant 1% oxygen and in 
reperfusion injury treatments, whereas the least was detected at 8.5% oxygen. 
Hypoxia has been found to promote IFNγ production over 72 hours in mixed CD4+ T 
lymphocytes populations compared to 21% oxygen [237], and it is therefore possible 
that the oxygen environment of the joint influences cytokine production from CD4+ T 
lymphocytes. However, this does not explain the upregulation of IFNγ expression in 
21% oxygen cultures. Increased CXCR3 expression was also observed at 1% 
oxygen, although this did correlate with cell size. However, the increase in the 
number of CXCR3 molecules on larger cells could play a functional role 
physiologically. As increased CXCR3 was also observed on naïve T lymphocytes 
polarised to a Th1 phenotype in 1% oxygen, it is possible that lower oxygen levels do 
promote a more Th1-like phenotype in both naïve and memory T lymphocytes. 
The increase in a pro-inflammatory phenotype at constant 1% oxygen was also 
accompanied by a lack of Th2 and Treg-associated cytokines and markers. In 
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supernatants, only low levels of IL-4, IL-5 and IL-10 were detected, and limited IL-10 
was detected by intracellular staining at both 24 and 48 hours post-stimulation. The 
number of CCR4+GATA3+ positive cells was also decreased at constant 1% oxygen 
after 24 hours, but did increase again after 48 hours stimulation. Culturing at 1% 
oxygen has previously been found to result in the upregulation of IL-4 [237]. 
However, the study that reported this also simultaneously investigated IFNγ 
production, and found that the upregulation in the latter cytokine was greatly 
increased compared to IL-4 in 1% oxygen [237]. However, the data from this thesis 
needs to be treated with some caution, as IFNγ (and IL-5 to some extent) appeared 
to be less affected by freezing than the other cytokines investigated, and therefore 
using cells that had been frozen may have skewed the response to appear more pro-
inflammatory than it was. Future work using fresh cells would be of benefit to confirm 
the patterns observed.  
 
6.4.2 Changes from 24 to 48 hours reveal the unsustainable nature of hypoxia 
Despite the pro-inflammatory phenotype of CD4+ memory T lymphocytes after 24 
hours stimulation at constant 1% oxygen, intracellular cytokine staining suggested 
that this phenotype was not maintained to 48 hours stimulation compared to 21%, 
8.5% and 3% oxygen treatments. However, according to the cell viability data in 
Chapter 3, this is not due to increased cell death. This may not have been fully 
reflected in the analysis of supernatants from 48 hour stimulation due to the detection 
of cytokines produced in the earlier stages of stimulation. The percentage of T-
bet+IFNγ+ cells decreased over time at constant 1% oxygen and reperfusion injury, 
whereas it increased in every other oxygen level assessed. In addition, the 
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percentage of both IL-17A and IL-10 positive cells at constant 1% oxygen did not 
increase to similar levels compared to other oxygen treatments (excepting IL-10 at 
3% oxygen), further suggesting a general depression in cytokine production in 
constant hypoxia.  
Previously the deletion of HIF-1α has been observed to result in the upregulation of 
cytokine production [234]. This may explain the drop in cytokines observed at 1% 
oxygen, when HIF-1α is expected to be stabilised. However, at 3% oxygen HIF-1α is 
also thought to be stabilised [230], and yet IFNγ and IL-17A production appeared to 
be well maintained to 48 hours stimulation. Therefore, factors other than HIF-1α 
stabilisation may cause the depression in cytokine production at 1% oxygen. 
Specifically focussing on IFNγ production over time, the three oxygen levels thought 
to be associated with the most ROS production - 21% oxygen, constant1% oxygen 
and reperfusion injury treatments [235, 244, 254-256, 271] - revealed the worst 
maintenance in this cytokine’s production. Therefore, the oxidative environment in 
which CD4+ memory T lymphocytes are present may influence their ability to 
produce cytokines over time. The observation that the combination of DFX and H2O2 
treatment slightly reduced the percentage of T-bet+IFNγ+ cells suggests that the 
combination of HIF-1α stabilisation and ROS may be responsible for the 
unsustainability of the hypoxic environment with regards to T helper cell function. T-
bet is known to be able to bind the ifnγ locus and initiate transcription [99], although 
some redundancy in its action is possible [110]. Even if it does not initiate IFNγ 
transcription itself, its downstream effects result in this outcome [98, 345, 348]. 
Therefore, the drop in T-bet expression at constant 1% oxygen over time may be 
associated with the simultaneous drop in IFNγ production. Furthermore, cytokine 
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production is a cellular process that, like many other cellular processes, utilises 
cellular energy. Hypoxia results in the reduction of cellular ATP levels [262], and it is 
possible that the observed limit of cytokine production over time in hypoxia was a 
simple result of lack of cellular energy. 
The reduction in cytokine production at constant 1% oxygen may be due to STAT 
signalling. STATs are phosphorylated by cytokine receptor-associated JAKs, and 
then dimerise and translocate to the nucleus where they promote the expression of 
cytokine genes. However in addition to cytokine binding, cellular stress is also able to 
activate some STAT transcription factors, and this has been especially reported in 
response to reperfusion injury [385]. Hypoxia mimetics were found to downregulate 
the expression of STAT1 protein [386] and STAT1 and STAT4 mRNA was reduced in 
1% oxygen compared to 21% oxygen [237]. STAT1 is the immediate signal mediator 
for IFNγ signalling during Th1 differentiation, and therefore its downregulation may 
inhibit further Th1 processes [47]. In effector memory cells the downregulation of 
STAT1 may decrease the autocrine effect of initial IFNγ production, and therefore 
may explain the subsequent drop in cytokine production and lack of Th1-associated 
markers such as T-bet.  Hypoxia mimetics were found to downregulate the 
expression of IFNγR, potentially resulting in a lack of autocrine positive feedback 
(which again would involve STAT signalling) and a subsequent lack of cytokine 
production over time [386]. Phosphorylation of STAT5a, which is associated with the 
promotion of a Th2-like phenotype, was found to  increase in 1% oxygen compared 
to 5% oxygen [235], which may provide an explanation for the increase in GATA-3 
expression observed over time. However, it still does not fully explain the lack of IL-4 
expression. Therefore, it is possible environmental lack of oxygen influences the 
220 
 
expression of various STAT proteins, and this may result in the observed drop in pro-
inflammatory cytokine production over time. The effect hypoxia has on STAT 
transcription factors’ expression, phosphorylation and function in memory T 
lymphocytes would be a useful avenue for future research. 
GATA-3 expression, however, increased over time in constant 1% oxygen (as 
indicated by both intracellular staining and the limited microarray) suggesting a 
phenotypic switch may occur albeit delayed. T-bet and GATA-3 mRNA expression 
has previously shown to be reduced in CD4+ T lymphocytes after 18 hours 
stimulation compared to 21% oxygen [237]. It was also interesting to observe a slight 
trend in increased GATA-3 expression after treatment with H2O2 at 8.5% oxygen 
(figure 5.8). It would be of benefit in the future to try to extend these observations 
over time to see whether this effect was amplified. GATA-3 is important in the 
maintenance of the CD4+ single positive phenotype in thymocytes [351], and GATA-
3 expression has been observed in Th1 cells [99]. It therefore may be expressed at a 
basal level in CD4+ T lymphocytes, and thus the increase in its protein and mRNA 
levels may be due to a lack of regulatory proteins that normally suppress its 
expression in non-Th2 cells. As T-bet itself antagonises the activity of GATA-3 [110], 
the lower level of T-bet expression observed over time in constant 1% oxygen may 
have resulted in the upregulation of GATA-3 expression. Alternatively, a delayed 
promotion of anti-inflammatory mechanisms may occur in constant 1% oxygen, 
resulting in a depression in Th1-associated cytokines and markers, and instead an 
increase in GATA-3 expression.  
Despite the increase in GATA-3 expression over time, IL-4 production did not appear 
to increase compared to other oxygen levels after 48 hours stimulation. As IL-4 could 
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not be detected at 24 hours, future investigations of IL-4 mRNA expression may be of 
benefit to fully elucidate what is occurring with this cytokine in hypoxia. As GATA-3 
does not bind directly to the il4 promoter [47, 117, 387], it is possible that other 
factors, such as c-MAF and STAT5, are more important in the regulation of this Th2 
associated cytokine in low oxygen  [47, 111, 112]. IL-5 levels were also somewhat 
diminished in supernatants from constant 1% oxygen stimulations (but not as 
diminished as at 3% oxygen). GATA-3 does bind this cytokine’s gene locus directly, 
and therefore some questions do arise as to whether its expression determines the 
expression of downstream cytokines. As GATA-3 expression was initially depressed 
in constant 1% oxygen, it is possible that the upregulation of GATA-3 at 48 hours had 
not yet resulted in increased IL-4 and IL-5 expression. Intracellular cytokine staining 
of IL-5, and perhaps IL-13 (another Th2-associated cytokine), at various time points 
may provide more clarity with respect to this.  
These results suggest that in hypoxic inflammatory settings CD4+ memory T 
lymphocytes provide a rapid Th1 response, but that this response does not last as it 
may do in higher oxygen levels, even when compared to a modest increase to 3% 
oxygen. In tissues where an inflammatory response is required due to a new 
pathogenic insult, oxygen levels may initially be quite reasonable and physiologically 
healthier. Therefore the maintenance of cytokine production over time at higher 
oxygen levels allows for the full initiation of an immune response. Later in the 
inflammatory process, low environmental oxygen may have taken precedence due to 
the infiltration of inflammatory cells. The culling of cytokine production in this situation 
may alleviate further cell infiltration and detrimental inflammatory processes, and 
therefore may be a regulatory response to inhibit ongoing pro-inflammatory 
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processes that can cause tissue damage. The results presented in this thesis are 
also suggestive as to why there is a lack of T lymphocyte-associated cytokines in the 
rheumatoid joint [175-177, 180].  
 
6.4.3 Cytokine production at 3% is both pro-inflammatory and maintained 
overtime 
In contrast to stimulation at constant 1% oxygen, 3% oxygen cytokine production 
appeared to be more sustained over time and an increase in the number of double 
positive cells was observed.  Both IFNγ and IL-17A expression increased over time in 
response to stimulation at 3% oxygen, becoming the most prominent cytokines after 
48 hours stimulation at this oxygen level. An increase in T-bet expression was 
observed alongside this, suggesting that pro-inflammatory processes may be more 
promoted at this oxygen level. Furthermore, a greater percentage of cells co-
expressed T-bet with IFNγ at 3% oxygen, suggesting the T-bet expression observed 
was functional. As previously mentioned, T-bet antagonises GATA-3 expression and 
function [110], and therefore the increase in T-bet expression observed at 3% may 
functionally suppress Th2-associated markers. However, intracellular cytokine 
staining also revealed the highest IL-4 cytokine production at 3% oxygen, which does 
question this assumption. As GATA-3 does not directly bind the il4 locus [112, 117, 
352, 387], the increase in IL-4 may be because 3% oxygen provides a better 
environment for general cytokine production than more hypoxic oxygen levels.  
The data obtained from stimulations at 3% oxygen is interesting when considering 
physiological environments where this oxygen level will be relevant. An 
environmental oxygen level of 3% is regularly defined as hypoxic, partly because at 
223 
 
around this oxygen level many cell types will stabilise the expression of HIF-α 
subunits [230], therefore suggesting that the cells deem this environmental oxygen 
level as deficient. Despite this, several physiologically normal tissues that are 
regularly frequented by lymphocytes contain oxygen levels of around 3% oxygen, 
including the lymph nodes [239]. Additionally, 3% oxygen is the average oxygen level 
of the rheumatoid joint [199-201], and therefore this environmental oxygen level may 
be an important influence in not only healthy immune responses, but also aberrant 
ones. The sustained cytokine production in 3% oxygen observed in this study is 
somewhat contradictory to what would be expected of CD4+ T lymphocytes in the 
rheumatoid joint, as CD4+ T lymphocyte cytokine production is normally depressed in 
this environment [175-177, 180].  However, maximal cytokine production at 3% 
oxygen in the lymph node may be of benefit.  
It is possible that gradients of oxygen may exist within the rheumatoid joint, as 
observed in the spleen. T lymphocytes found in more avascular synovial tissue may 
experience more severe hypoxia and diminish cytokine production over time in these 
niches. In contrast, cells experiencing slightly higher oxygen perfused tissue may 
acquire the ability to express other cytokines, and maintain cytokine production 
better. Tertiary lymphoid structures may also provide islands of different oxygen 
levels.  
6.4.4 Increased plasticity at 3% oxygen, but reduced IL-17 production at 
constant 1% oxygen 
In 3% oxygen, CD4+ memory T lymphocytes acquired the ability to express more 
than one cytokine at a greater rate than lower oxygen levels, suggesting that this 
oxygen level both supports cytokine production more, and may promote plasticity 
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between the different T helper subsets.  An increase in the number of IFNγ+IL-4+, 
IFNγ+IL-17A+ and IFNγ+IL-10+ cells was observed at 3% oxygen. This could be due 
to Th1 cells in the population acquiring alternative phenotypes, or could be due to 
Th2 and Th17 cells upregulating Th1-associated cytokines. 
When Th17 cells were first described they were thought to be distinct in nature but 
increasing plasticity has been highlighted in recent years. It is now thought that they 
are less terminally differentiated than Th1 or Th2 cells, and there is a growing amount 
of evidence suggesting  a Th17 to Th1 switch occurs as part of the natural process of 
Th17 differentiation in vivo [93, 95, 128, 144]. Therefore, the relatively low levels of 
IL-17A production observed at all of the oxygen levels investigated in this study may 
be due to the original cell population chosen for investigation. Any Th17 cells isolated 
and subsequently used in the experiments may have initiated the next step in their 
differentiation program, thus switching to a more Th1-like phenotype after stimulation. 
With respect to physiological environments where 3% oxygen is thought to be 
prevalent; double positive IFNγ+IL-17+ cells have been observed in the inflamed joint 
[145, 358]. The increase in T-bet expression observed after 48 hours stimulation at 
3% oxygen may have maintained IFNγ production and potentially contributed to the 
plasticity of Th17 cells to a Th1-like phenotype, but would need further investigation 
as not much T-bet was found associated with IL-17 production at this time point. T-
bet expression is observed in Th17 cells that have switched to a more Th1-like 
phenotype [147]. In inflammatory murine models such as EAE, diabetes and colitis, 
Th17 cells that co-express Th1-markers, or undergo a switch to a more Th1-like 
phenotype, are more pathological [93, 128, 147, 150]. Therefore their upregulation in 
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both the RA joint, and general 3% oxygen environments, could contribute to 
inflammatory disease.  
A lack of IL-17A production both singularly and alongside less detection of both IFNγ 
and T-bet at constant 1% oxygen suggests that Th17 memory populations are not 
supported in low oxygen levels, whereas at 3% oxygen this phenotype may be more 
promoted. A small, non-significant drop in CCR6 was observed in constant 1% 
oxygen, suggesting that perhaps the original Th17 population had not expanded as 
much at this oxygen level compared to other oxygen levels. This was not expected as 
hypoxia promotes naïve T lymphocyte Th17 differentiation through the stabilisation of 
HIF-1α [243, 277]. The drop in IL-17A production at constant 1% oxygen may be a 
result of increased terminal differentiation (and therefore more of a Th1-like 
phenotype) of the Th17 CD4+ effector memory cells present, or may be a reflection 
of the depression in pro-inflammatory cytokine production observed overtime. 
Additionally, it could suggest that Th17 cells present in the memory population do not 
respond to stimulation in low oxygen levels.  
However, a mild increase in IL-17 production has been observed at the still relatively-
hypoxic 3% oxygen. This was potentially due to an increasing number of IFNγ+IL-17+ 
cells, as already discussed. A reduction in IL-17A production has previously been 
observed in naïve T lymphocytes  under Th17 polarising conditions in a model of 1% 
oxygen reperfusion injury, whereas 3% and 5% oxygen conditions were optimum for 
IL-17 production [236], supporting the results observed in this thesis. As HIF-1α is 
thought to be stabilised in 3% oxygen [230], it is possible that it was able to induce 
IL-17A production at this oxygen level. HIF-1α inhibitors have been previously 
observed to limit Th17 persistance in an in vivo model [120], and therefore it is 
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possible hypoxia does have an effect on Th17 cells. Additional factors in constant 1% 
oxygen may have negated the effect of HIF-1α on IL-17A expression, thus generating 
the contrast between these two subtlety different hypoxic oxygen levels. However, as 
ROS have previously been found to upregulate IL-17 [300], the oxidative 
environment in hypoxia may not contribute to the depression in IL-17 production, 
although initial experiments in this thesis (figure 5.7) did suggest that redox may 
depress IL-17A production by CD4+ memory T lymphocytes. IL-17A has also been 
recently implicated in pathology of several autoimmune diseases including RA, which 
- as discussed - is thought to have oxygen levels of around 3% oxygen [130, 131]. 
 
6.4.5 Reperfusion injury at 1% oxygen 
An increase in the number of cytokine double positive IFNγ+IL-17A and IFNγ+IL-10+ 
cells was also observed in reperfusion treatments compared to constant 1% oxygen, 
again supporting the notion that cytokine production is more supported over time 
when oxygen is re-introduced into a system. This occurred despite the cells again 
being exposed to 1% oxygen between 24 and 48 hours post-stimulation, suggesting 
the first 24 hours of increased oxygen exposure post-stimulation influenced later 
cytokine production despite a concurrent drop in oxygen.  
In spite of the slight increase in cytokine production compared to constant 1% 
oxygen, reperfusion injury did induce a reduction in expression of markers associated 
with the different T helper cell subsets investigated. T-bet, GATA-3 and Foxp3 
expression were reduced in reperfusion injury environments, suggesting that 
transcription factor expression is not sustained when oxygen levels fluctuate. This 
observation is also interesting as it suggests that later cytokine production is not 
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necessarily associated with transcription factor expression, as at constant 1% 
oxygen. Despite maintaining a higher level of transcription factor expression, cytokine 
production dropped over time in comparison. Physiologically, these results suggest 
reperfusion injury could have far-reaching effects. For example, cytokine production 
may be better supported when oxygen is re-introduced into an ischemic environment. 
Reperfusion injury is associated with the activation of local inflammatory cells and the 
upregulation of cytokine production [211-214]. It has previously been found that 
endothelial cells' activation in response to reperfusion injury induce cytokine 
production from inflammatory cells, but the observed increase that a burst of oxygen 
into a previously hypoxic site can result in better T lymphocyte cytokine production 
suggests that the oxygen environment itself may influence immune cell behaviour in 
a previously ischemic tissue. 
 
6.5 General conclusions 
In this thesis, the effect of different environmental oxygen levels on CD4+ memory T 
lymphocytes was assessed. Differences were found, such as in increased 
proliferation at 8.5% oxygen, and a more pro-inflammatory phenotype at lower 
oxygen levels. Therefore, it is possible that environmental oxygen levels have some 
influence over the behaviour and function of T lymphocytes physiologically. Recently 
it has been postulated that the strict definitions of different T helper subsets may be 
physiologically incorrect, and that tissue-specific instructions actually regulate the 
effector population of effector CD4+ T lymphocytes that are generated [361]. It was 
suggested that Th1 or Th17 responses are only used when absolutely necessary, but 
that tissues generally instructed more gentle responses – such as a Th2 response - 
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to initially deal with low level antigenic exposure. It was also suggested that pro-
inflammatory mechanisms would be switched off rapidly to limit the tissue damage 
that could occur, and listed hypoxia as a limiter of pro-inflammatory immune cells 
[361]. The data presented in this thesis certainly agrees with this idea, as a Th2 
response was observed in higher oxygen levels, but a more pro-inflammatory 
response was observed when oxygen was more deficient, but was also switched off 
more rapidly at 1% oxygen. It is perhaps possible that hypoxia acts as the ‘help’ 
signal that pushes an immune response into more drastic action (figure 6.1) but also 
acts to limit it. At 8.5% oxygen, proliferation was increased compared to the other 
oxygen levels, and this was associated with a potential increase in proximal T 
lymphocyte signalling. The lack of this, in contrast, at lower oxygen levels, may reveal 
one way in which these more dangerous inflammatory responses are regulated, as 
cytokine production was cut-off more rapidly at 1% oxygen, and proliferation limited 
(figure 6.1). Therefore, environmental oxygen levels are able to influence CD4+ 
memory T lymphocyte responses to stimulation, and need to be considered, in light 
of the disease or organ model being investigated, for in vitro work. Oxygen levels of 
21% appear to be inappropriate for the study of physiological responses. Certain 
aspects of the hypoxic environment, such as oxidative stress, may play an important 




Figure 6.1. A summary of CD4+ memory T lymphocyte responses to different 
environment oxygen levels. The five oxygen treatments chosen for assessment in 
this thesis are shown with the various aspects, such as reactive oxygen species 
(ROS) production and hypoxia-inducible factor-1α (HIF-1α) stabilisation, shown at the 
relevant oxygen levels. The main results are highlighted in this figure, such as the 
variation in Lck tyrosine 394 phosphorylation (Y394P), proliferation, cytokine 
production, CD69 expression and polarisation at different oxygen levels.  
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7. Limitations and Future work 
Limitations to the data presented within this thesis 
Firstly, this data is limited by the small number of cytokines investigated. Only 3 
cytokines deemed as ‘Th1/Th17-like’; 2 cytokines deemed as ‘Th2-like’; and one 
associated with both Th2 and regulatory T lymphocytes were investigated. Future 
work, perhaps using an array platform, would enhance understanding of cytokine 
balance at different oxygen levels. Additionally, we only assessed cytokine secretion 
at one time point (45 hours). The patterns of cytokine production can vary depending 
on the cytokine being investigated.  Examining the balance of cytokines more shortly 
after stimulation may enable further understanding into the cytokine response of 
CD4+ T lymphocytes at various oxygen levels. For example, examining cytokine 
mRNA levels 6 hours post stimulation may provide initial clues as to the preferred 
balance of cytokines in different oxygen levels. Assessing cytokine production 
beyond 45 hours would also be of benefit. CD4+ T lymphocyte cytokine production 
can extend over several days [138] and as CD4+ T lymphocytes are believed to 
inhabit the RA joint environment for longer than 2 days, their cytokine production will 
continue to contribute to the overall cytokine population present in the inflamed joint. 
The effect of different oxygen levels of maintaining cytokine production would also be 
of interest. 
Secondly, the cells used experimentally were frozen before assessment. Supernatant 
measurements of IFNγ (and IL-5 to some extent) appeared to be less affected by 
freezing than the other cytokines investigated, and intracellular staining of IFNγ was 
also less affected by freezing than the IL-4 and IL-10 after 24 hours stimulation. 
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Therefore using cells that had been frozen may have skewed the response to appear 
more pro-inflammatory than it was.  
Future work 
Making the environment of the cell more physiological and improving culture 
conditions. 
Future work using fresh cells would be of benefit to confirm the patterns observed 
and would be of more physiological relevance. Furthermore, more physiological 
stimulation methods, such as using peptide-loaded APCs, may give more relevant 
results regarding inflammation.  
Furthermore, it has been previously reported that a longer stimulation period results 
in a more delayed re-expression of the TCR:CD3 complex [322] and in this study 
cells were not removed from stimulation plates. Future investigations where cells are 
removed from stimulation plates after a shorter amount of time may provide more 
clarity as to the effect of different oxygen levels on TCR:CD3 expression.Studies 
where cell medium was replenished mid-experiment may help to determine whether 




In the chronic inflammatory environment, cells may be part of the tissue for much 
longer than the 48-72 hours investigated in this thesis. Therefore, cytokine production 
and CD69 expression over a longer duration would be of benefit.  
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Studies probing the activation status of Lck over time would be beneficial in 
determining whether fluctuations in activation status occur, as this may lead to better 
understanding of acute and more chronic responses to hypoxia.  
Furthermore, due to its nature as a ‘late’ activation marker, it is possible HLA-DR 
expression needs to be assessed over a longer timescale.  
It is possible that the upregulation of GATA3 at 48 hours had not yet resulted in 
increased IL-4 and IL-5 expression. Intracellular cytokine staining of IL-5, and 
perhaps IL-13 (another Th2-associated cytokine), at various time points may provide 
more clarity with respect to this.  
 
More detailed studies of subsets 
A better investigation of RORγ may give more details about the effect of different 
oxygen levels on Th17 cells. Furthermore, the analysis of STAT protein function at 
different oxygen levels would also allow for better understanding of the different 
signals involved. MAF, a possible transcriptional regulator of IL-10 [362], also needs 
to be assessed.  
The relationship of T-bet with IL-17 and IL-10 production would also be of benefit for 
future investigation.  
Furthermore, the different iTreg populations could be better examined in future, 
including, perhaps, a panel investigating IL-10 and TGFβ production alongside 
surface markers associated with Tregs and Foxp3 expression. Suppressive assays 
would also be very interesting to perform at oxygen levels where an increase in 
regulatory phenotype was observed.  
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Distinct cell populations 
Prior separation of central and effector memory T lymphocytes before exposure to 
antigenic stimulation at different oxygen levels may allow for better delineation of 
what occurs in the tissue compared to what occurs in the lymph node. Additionally, it 
would allow for better understanding of proliferative and cytokine responses at 
different oxygen levels.  
It would also be interesting to investigate naïve T lymphocytes over a long time frame 
in future, including assessment of the effect of re-stimulating at various oxygen 
levels.  
 
Better investigation of mechanisms 
Alternative hypoxia mimetics, such as cobalt chloride, could be utilised in the future to 
further assess the effect of HIF-1α on Lck activation status. This may negate the anti-
oxidant effect of DFX. Furthermore, as NAC is also known to inhibit NFκB [367] it 
would need to be further confirmed that the redox environment was involved in the 
effect of low environmental oxygen on CD4+ memory T lymphocytes. 
 
Increasing cell repeats.  
The increase in Th2-like phenotype was further suggested in experiments performed 
on naïve T lymphocytes, where stimulation at 8.5% resulted in the highest CCR4 MFI 
values, even in Th1 and Th0-polarising conditions.  However, this work was limited 
by the lack of experimental repeats, and warrants future confirmation. Experiments 
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looking at the effects of DFX and H2O2 were also limited in cell number, and need to 




Panel design of pro-inflammatory and anti-inflammatory markers 
Antigen Colour/ filter Surface/ intracellular 
CXCR3 (CD183) APC/ FL8 surface 
CCR6 (CD196) PECy7/ FL5 surface 
IFNγ Pacific Blue/ Fl6 intracellular 
IL-17A PE/ FL2 intracellular 
T-bet PerCP/ Cy5.5// FL4 intracellular 
RORγt FITC/ FL1 intracellular 
Table 8.1 Details of the pro-inflammatory staining panel for flow cytometry 
Antigen Colour/ filter Surface/ intracellular 
CCR4 (CD194) PerCP/ Cy5.5// FL4 surface 
CTLA-4 (CD152) PE/ FL2 surface 
IL-4 FITC/ FL1 intracellular 
IL-10 PECy7/ FL5 intracellular 
GATA-3 Alexa Fluor® 647/ FL8 intracellular 
Foxp3 eFluor® 450/ FL6 intracellular 




Details of the Human Th17 for autoimmunity and Inflammation microarray  
Well Symbol Description 
A1 CACYBP Calcyclin binding protein 
A2 CCL1 Chemokine (C-C motif) 
ligand 1 
A3 CCL2 Chemokine (C-C motif) 
ligand 2 
A4 CCL20 Chemokine (C-C motif) 
ligand 20 
A5 CCL22 Chemokine (C-C motif) 
ligand 22 
A6 CCL7 Chemokine (C-C motif) 
ligand 7 
A7 CD247 CD247 molecule 
A8 CD28 CD28 molecule 
A9 CD34 CD34 molecule 
A10 CD3D CD3d molecule, delta 
(CD3-TCR complex) 
A11 CD3E CD3e molecule, epsilon 
(CD3-TCR complex) 
A12 CD3G CD3g molecule, gamma 
(CD3-TCR complex) 
B1 CD4 CD4 molecule 
B2 CD40LG CD40 ligand 
B3 CD8A CD8a molecule 
B4 CEBPB CCAAT/enhancer binding 
protein (C/EBP), beta 
B5 CLEC7A C-type lectin domain 
family 7, member A 





B7 CSF3 Colony stimulating factor 
3 (granulocyte) 
B8 CX3CL1 Chemokine (C-X3-C 
motif) ligand 1 
B9 CXCL1 Chemokine (C-X-C motif) 
ligand 1 (melanoma 
growth stimulating activity, 
alpha) 
B10 CXCL12 Chemokine (C-X-C motif) 
ligand 12 
B11 CXCL2 Chemokine (C-X-C motif) 
ligand 2 
B12 CXCL5 Chemokine (C-X-C motif) 
ligand 5 
C1 CXCL6 Chemokine (C-X-C motif) 
ligand 6 (granulocyte 
chemotactic protein 2) 
C2 S1PR1 Sphingosine-1-phosphate 
receptor 1 
C3 FOXP3 Forkhead box P3 
C4 GATA3 GATA binding protein 3 
C5 ICAM1 Intercellular adhesion 
molecule 1 
C6 ICOS Inducible T-cell co-
stimulator 
C7 IFNG Interferon, gamma 
C8 IL10 Interleukin 10 
C9 IL12B Interleukin 12B (natural 
killer cell stimulatory factor 
2, cytotoxic lymphocyte 
maturation factor 2, p40) 
C10 IL12RB1 Interleukin 12 receptor, 
beta 1 




C12 IL13 Interleukin 13 
D1 IL15 Interleukin 15 
D2 IL17A Interleukin 17A 
D3 IL17C Interleukin 17C 
D4 IL17D Interleukin 17D 
D5 IL17F Interleukin 17F 
D6 IL17RB Interleukin 17 receptor B 
D7 IL17RC Interleukin 17 receptor C 
D8 IL17RD Interleukin 17 receptor D 
D9 IL17RE Interleukin 17 receptor E 
D10 IL18 Interleukin 18 (interferon-
gamma-inducing factor) 
D11 IL1B Interleukin 1, beta 
D12 IL2 Interleukin 2 
E1 IL21 Interleukin 21 
E2 IL22 Interleukin 22 
E3 IL23A Interleukin 23, alpha 
subunit p19 
E4 IL23R Interleukin 23 receptor 
E5 IL25 Interleukin 25 
E6 IL27 Interleukin 27 
E7 IL3 Interleukin 3 (colony-
stimulating factor, 
multiple) 
E8 IL4 Interleukin 4 
E9 IL5 Interleukin 5 (colony-
stimulating factor, 
eosinophil) 
E10 IL6 Interleukin 6 (interferon, 
beta 2) 
E11 IL6R Interleukin 6 receptor 
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E12 IL7R Interleukin 7 receptor 
F1 IL8 Interleukin 8 
F2 ISG20 Interferon stimulated 
exonuclease gene 20kDa 
F3 JAK1 Janus kinase 1 
F4 JAK2 Janus kinase 2 
F5 MMP13 Matrix metallopeptidase 
13 (collagenase 3) 
F6 MMP3 Matrix metallopeptidase 3 
(stromelysin 1, 
progelatinase) 
F7 MMP9 Matrix metallopeptidase 9 
(gelatinase B, 92kDa 
gelatinase, 92kDa type IV 
collagenase) 
F8 NFATC2 Nuclear factor of activated 
T-cells, cytoplasmic, 
calcineurin-dependent 2 
F9 NFKB1 Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 1 
F10 RORC RAR-related orphan 
receptor C 
F11 SOCS1 Suppressor of cytokine 
signaling 1 
F12 SOCS3 Suppressor of cytokine 
signaling 3 
G1 STAT3 Signal transducer and 
activator of transcription 3 
(acute-phase response 
factor) 
G2 STAT4 Signal transducer and 
activator of transcription 4 
G3 STAT5A Signal transducer and 
activator of transcription 
5A 
G4 STAT6 Signal transducer and 
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activator of transcription 6, 
interleukin-4 induced 
G5 SYK Spleen tyrosine kinase 
G6 TBX21 T-box 21 
G7 TGFB1 Transforming growth 
factor, beta 1 
G8 TIRAP Toll-interleukin 1 receptor 
(TIR) domain containing 
adaptor protein 
G9 TLR4 Toll-like receptor 4 
G10 TNF Tumor necrosis factor 
G11 TRAF6 TNF receptor-associated 
factor 6 
G12 YY1 YY1 transcription factor 
H1 B2M Beta-2-microglobulin 
H2 HPRT1 Hypoxanthine 
phosphoribosyltransferase 
1 




H5 ACTB Actin, beta 
H6 HGDC  Human Genomic DNA 
Contamination 
H7 RTC  Reverse Transcription 
Control 
H8 RTC  Reverse Transcription 
Control 
H9 RTC  Reverse Transcription 
Control 
H10 PPC  Positive PCR Control 
H11 PPC  Positive PCR Control 
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H12 PPC Positive PCR Control 
Table 8.3. Details of the Human Th17 for autoimmunity and inflammation 
microarray used (Qiagen Cat. No. 330231). Well position in the plate is listed 
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